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Abstract 
The 70kDa members of the heat shock protein family (eg. Hsp70) function as 
molecular chaperones by binding to exposed hydrophobic patches on nascent 
polypeptides forming non-covalent interactions, thereby preventing their aggregation 
and facilitating their proper folding. The folding reaction comprises of cyclic binding 
and release of the unfolded substrate powered by ATP hydrolysis. Hsp70 requires the 
assistance of a co-chaperone, generally provided by the Hsp40 group of proteins, for 
the cycle of protein folding. Biochemical analyses have mapped the possible sites of 
interaction between the Hsp70 and Hsp40 proteins and predicted a bipartite mode of 
interaction between Hsp70 and Hsp40. However, structural investigations into the 
mechanistic features of the folding cycle have been hampered by the transient nature of 
interaction. The underlying theme for this work was to therefore structurally 
understand the assembly of Hsp70 proteins with the Hsp40 co-chaperones as a 
complex during the Hsp70-assisted folding cycle. This study was carried out using 
human Hsc70 and HSJ1b as representatives of the Hsp70 and Hsp40 families 
respectively. The first step to understand this co-operation was to develop a strategy to 
isolate a complex of Hsc70 and HSJ1b suitable for structural studies. Previous studies 
have reconstituted the Hsp70/Hsp40 complex in vitro by combining the two proteins in 
molar ratios in the presence of ATP. In this work a co-expression system was 
developed and a recombinant form of the human Hsc70/HSJ1b complex was 
successfully purified using a bacterial expression system. Biochemical characterisation 
revealed that this chaperone complex can protect ~85% of substrate protein from 
thermal aggregation. Gel filtration analysis revealed that the complex was composed of 
a heterogenous mix of ~220 kDa and hetero-oligomeric co-polymer species. Analytical 
ultracentrifugation confirmed that these hetero-oligomeric co-polymer species were 
not aggregates, and molecular weight for this species was estimated to be 1.1 MDa. 
These two species represent potentially two different states of association between 
Hsc70 and HSJ1b. ATP and heat treatment at 42oC with luciferase were identified as 
factors which promote the conversion of the oligomeric Hsc70/HSJ1b species to the 
~220 kDa Hsc70/HSJ1b species.  Domain variants of Hsc70 were then generated and 
their ability to complex with HSJ1b was investigated. Using these Hsc70 domain 
variants, the region on Hsc70 paramount for polymerisation was identified. The C-
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terminal 10 kDa lid region was found to be essential for the chaperone/co-chaperone 
interaction, since the removal of this zone alters binding, function and conformational 
properties of the Hsc70 and HSJ1b interaction. X-ray crystallography studies on the 
full length and the domain complexes were carried out, leading to the structure of the 
apo form of the nucleotide binding domain of Hsc70. Preliminary electron microscopy 
(EM) analysis was undertaken of the recombinant Hsc70/HSJ1b complex. The 
preliminary results from negative staining revealed mostly circular particles and were 
extremely encouraging. Currently work is being carried out to improve sample 
homogeneity, which will facilitate further EM studies. Thus the recombinant complex 
generated in this study is an attractive tool to further our understanding of the 
functional and structural features of the interactions of Hsp70 with Hsp40. 
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CHAPTER 1: Introduction  
1.1. Proteins 
Proteins form the basis of existence for living cells. They characterise the properties of 
living organisms because of their involvement in virtually every function of the cell. 
From storage and transport, to catalysing biological functions as enzymes; proteins are 
important macromolecules for living organisms (Creighton, 1993; Stryer et al., 2002). 
The conversion of genetic information on the DNA into a more functionally and 
structurally significant macromolecule - protein, is a central tenet of Biology. Figure 
1.1 is a schematic representation of this ideology, where genetic information on the 
DNA is transcribed to form mRNA which upon translation gives rise to the nascent 
polypeptide (Stryer et al., 2002). 
 
 
Figure 1.1: Schematic pathway of the translation of genetic material into functional 
proteins 
One of the central dogmas of Biology explains simplistically the conversion of genetic information on 
the DNA into a more functionally and structurally significant form – proteins. DNA transcribes to form 
RNA which is translated by ribosomes to form the polypeptide. The string of amino acids emerging 
(polypeptide) from the ribosome needs to attain its native tertiary structure to become a fully functional 
protein. 
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Proteins are linear chains made up from a combination of the 20 essential amino acids, 
which differ only in the order of occurrence of the amino acids on the polypeptide 
chains and their post-translational modifications (Stryer et al., 2002). Protein structure 
can be considered at five different levels, the primary, secondary, super secondary, 
tertiary and quaternary structures (Venkatraman et al., 2001). The linear sequence of 
amino acids – the primary structure, can only partly explain the functional diversity 
seen in proteins. This function is dependent on the nascent polypeptide folding into its 
native 3-dimensional structure which is essential in allowing it to fulfil its functional 
fate (Branden and Tooze, 1999).  
Failure to attain this native structure or misfolding of the polypeptide results in 
proteins unfit to carry out their biological activities (Radford and Dobson, 1999). The 
problem of misfolding is compounded when the misfolded proteins make unwanted 
interactions with other cellular proteins leading to a potentially toxic situation in the 
cells – protein aggregation. Alterations to protein folding have been implicated in 
several disease conditions. Cystic fibrosis has been attributed to mutations in the cystic 
fibrosis transmembrane conductance regulator (CFTR) gene which renders the protein 
incapable of folding, while deposition of insoluble protein material (referred to as 
amyloids) on degenerating nerve cells have been implicated in the development of 
Alzheimer’s disease (Thomas et al., 1995; Qu et al., 1996; Barral et al., 2004). Some 
of the other conditions caused by problems in protein folding are Bovine spongiform 
encephalopathy (also known as Mad Cow disease) and Marfan’s syndrome (Thomas et 
al., 1995). Table 1.1 lists some of the disease conditions caused by protein misfolding 
resulting in altered or in some cases total loss of function (Thomas et al., 1995).  
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Table  1.1: Diseases that result from loss of function, mislocalisation or aggregation of 
proteins (data taken from Boshoff et al., 2004). 
1.1.1. Spontaneous folding pathway 
Modern theories on protein folding have evolved from Anfinsen’s seminal work on the 
spontaneous refolding of ribonuclease for which he was awarded the Nobel Prize in 
1973. He demonstrated that ribonuclease in a denatured and reduced state could refold 
into its active form ‘spontaneously’ (Anfinsen, 1973). He concluded that spontaneous 
refolding was possible because the information needed for a protein to attain its active 
conformation is all contained in its amino acid sequence. Thermodynamically, the 
conformation adopted would be the one favoured by the lowest Gibbs free energy for 
the system (Anfinsen, 1973; Yon, 2001). Under optimal in vitro folding conditions, 
Goldberger and colleagues observed that ribonuclease could take up to 20 minutes to 
refold (Goldberger et al., 1963). This time span is extremely ‘slow’ in the cellular 
context. If this was true, then even a small 100 amino acid long protein would take 
over a billion years to attain its correct conformation, which would be unrealistic under 
in vivo conditions (Levinthal, 1968). To counter this, Levinthal suggested that the 
folding process of a nascent polypeptide, therefore, could not be a random event and 
proposed the existence of specific folding pathways for proteins which allowed them 
to fold within seconds or minutes as required in the biological context.  
Several folding models have emerged since then, and commonly, all try to address 
what is now famously called Levinthal’s paradox. The classical nucleation-propagation 
model, the diffusion-collision model, the Jigsaw model and the hydrophobic collapse 
model are examples of some of the proposed models to decipher protein folding 
Disease  Protein involved Molecular phenotype 
α-Antitrypsin deficiency 
Amyotrophic lateral sclerosis 
Bardet-Biedel Syndrome 
Cancer 
Alzheimer’s disease 
Huntington’s disease 
Parkinson’s disease 
Retinosa Pigmentosa 
α-Antitrypsin 
Superoxide Dismutase 
MKKS 
p53 
β-Amyloid 
HD 
α-synuclein 
Rhodopsin 
Mislocalisation 
Misfolding 
Loss of chaperone activity 
Misfolding 
Aggregation 
Aggregation 
Aggregation 
Mislocalisation 
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Intermediate 
pathways (Radford, 2000; Yon, 2001). The folding funnel hypothesis is a new 
approach based on the energy landscape theory, and proposes the existence of multiple 
micropathways, rather than a single pathway (Tsai et al., 1999). Figure 1.2 is a 
schematic representation of the possible course of events occurring during the folding 
cycle of a protein. Folding is triggered by hydrophobic collapse of the polypeptide 
chain, leading to the formation of secondary structure. The progression of unfolded 
protein to its native fold is often challenged kinetically by the formation of misfolded 
and energetically unfavourable intermediate forms resulting in protein aggregates 
(Yon, 2001). The occurrence of transient intermediate forms has been identified in 
studies conducted with lysozyme (Wetlaufer and Ristow, 1973) and bovine pancreatic 
trypsin inhibitor (Creighton, 1974). The rich molten globule state, on rearrangement 
gives rise to the native folded protein. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2:  Proposed folding pathway for an unfolded protein adapted from Yon J.M 
(2001). 
During the very fast event of protein folding, the unfolded protein sifts through various folding 
intermediates to attain the native folded state.  Side reactions could push the intermediates into the ‘off 
pathway’ ultimately leading to aggregation and accumulation of the unfolded protein species. 
The principles of protein folding established by in vitro studies generally hold true 
under in vivo conditions for small, single domain proteins (Hartl, 1996). However, the 
same principles do not extend satisfactorily to explain folding of complex multidomain 
proteins. It is now recognised that under in vivo cellular conditions not all proteins fold 
spontaneously and require additional assistance to reach their native fold (Ruddon and 
Bedows, 1997).  
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1.1.2.  Chaperone assisted folding  
One of the main factors which cannot be replicated during in vitro folding studies is 
the complex cellular environment. Nascent polypeptides emerging from the ribosome 
are exposed to a complex medium in the cytoplasm where macromolecules such as 
cellular proteins and RNA are crowded together at concentrations as high as 300 g of 
protein per litre (Minton, 1999). This environment promotes the formation of unwanted 
intermolecular interactions which pose a threat to the proper folding and can lead to 
aggregation. Also, during protein synthesis the emerging polypeptide can begin to fold 
before the entire chain has been synthesised. It therefore exists in an energetically 
favourable but a partially folded or unfolded intermediate state, which could 
potentially expose normally buried hydrophobic regions (Radford, 2000; Nicoll et al., 
2005). This is a scenario that could potentially promote aggregation. Intervention and 
assistance in the folding process comes in the form of a class of proteins called the 
molecular chaperones (Slepenkov & Witt, 2002).  
Molecular chaperones represent a family of proteins which have been extensively 
studied over the past 40 years. Their importance is highlighted by the gathering body 
of evidence on the cell and tissue pathology caused by defective chaperones (Macario 
and Conway de Macario, 2005; Nardai et al., 2006). Historically, the term molecular 
chaperone was first used by Laskey and co-workers to describe the behaviour of 
nucleoplasmins in promoting histone-histone interactions (Laskey et al., 1978). Ellis 
and Hemmingsen, applied this term to include families of bacterial and eukaryotic 
proteins involved in protein folding and translocation on the basis of their observations 
that chaperones were also essential for the folding of the plant protein ribulose 
bisphosphate carboxylase (Ellis, 1987).  
Chaperones are an essential part of the cellular machinery and are required for the 
proper maintenance of the protein structure, protein translocation and oligomerization. 
They assist folding of the nascent polypeptide by binding to the exposed hydrophobic 
patches of the folding intermediates. They play a key role in leading the nascent 
polypeptide to its cellular destiny during protein folding in the cell (Figure 1.3) by 
forming non-covalent interactions with the polypeptides emerging from the ribosome, 
thereby preventing their aggregation and facilitating in their folding (Bukau et al., 
2006). Polypeptides with aberrant folding are assigned to the degradation pathway 
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(Bukau et al., 2006). The structure assumed by the polypeptide is still dictated by its 
amino acid sequence. Chaperones cannot direct a protein to assume a different fold. 
Importantly, they are not part of the final folded structure (Ellis and Hartl, 1996; Hartl, 
1996).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic pathway for protein folding (adapted from Perlmutter DH, 1999). 
Nascent polypeptide emerging from the ribosome faces a crowded intracellular environment, which 
promotes the formation of unwanted interactions. Polypeptides are assisted by the chaperone proteins 
which allow them to attain their native fold or in extreme cases direct them to the proteolysis pathway. 
Currently, the term chaperone encompasses approximately 20 protein families. These 
families have varied functions, locations and structures. Different classes of proteins 
tackle specific state(s) of unfolding. The majority of proteins characterised as 
chaperones belong to the heat shock protein (HSP) family (Bukau and Horwich, 1998; 
Radford, 2000). 
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1.2. Heat shock proteins 
The heat shock response was first reported by Feruccio Ritossa in the fruit fly 
(Drosophila melanogaster) in 1963. He observed that an elevation in temperature (heat 
shock) produced chromosomal puffs in the Drosophila salivary gland (Ritossa, 1963; 
Welch 1993). In 1973, Tissieres and co-workers demonstrated that chromosomal 
puffing was accompanied by increased expression of both a 70 and a 26 kDa protein 
species (Tissieres et al., 1974). Initially this phenomenon was believed to be unique for 
Drosophila; however, it became clear that a similar response could be observed in a 
wide variety of species including bacteria, yeast, complex plants such as soybean and 
even mammalian cells (Marx, 1983). Li and Werb correlated the expression of heat 
shock proteins with conferment of thermotolerance in their studies with Chinese 
hamster fibroblasts (Li and Werb, 1982). Cells respond to thermal shock by switching 
off the synthesis of most cellular proteins, however, elevated expression of one 
particular class of proteins called the heat shock proteins (HSP) was observed 
(Lindquist and Craig, 1988). Accumulation of the heat shock proteins appears to shield 
cells from temperature induced damage and also promotes cell survival (Li and Werb, 
1982). Cells pre-exposed to non-lethal temperatures prior to exposure to lethal 
temperatures are found to acquire thermotolerance. They survive the heat shock while 
untreated cells cannot (Hanh and Li, 1982; Marx, 1983). Figure 1.4 illustrates the 
effect of heat treatment on cell viability.  
 
 
 
 
 
 
 
 
 
Figure 1.4: Acquired thermotolerance in E.coli cells subjected to elevated temperatures. 
(redrawn from http://www.tulane.edu/~biochem/med/hsp.htm) 
Panel A depicts occurrence of cell death when cells are directly exposed to lethal temperatures of 46oC. 
Panel B shows increased cell viability when cells are exposed to sub-lethal temperature of 42oC prior to 
heat shock at 46oC.  
Panel A Panel B 
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It has now been established that factors other than heat also promote the over 
expression of heat shock proteins. For example, exposure to amino acid analogues (Li 
and Lazlo, 1985), heavy metals (Levinson et al., 1980) and depleted ATP levels 
(Welch 1993) are some of the conditions that have been shown to induce this response. 
Other physiological, pathological and environmental agents for induction of heat shock 
proteins are listed in Table 1.2. 
Physiological Pathological Environmental 
Cycle of cell division 
Growth factors 
Cell differentiation 
Tissue development 
Hormonal stimulation 
Viral, bacterial and 
Parasitic  infections 
Fever 
Inflammation 
Ischemia 
Hypertrophy 
Oxidant injury 
Malignancy 
Autoimmunity 
Heat shock 
Heavy metals 
Metabolic inhibitors 
Amino acid analogues 
Ethanol 
Antibiotics 
Radiation 
Table  1.2: Physiological, pathological and environmental conditions that induce the heat 
shock response (Schlesinger, 1990). 
1.2.1. Types of heat shock proteins 
The heat shock protein family are highly conserved in both eukaryotes and prokaryotes 
(Gupta & Singh, 1992). They are classified into six subfamilies based on their 
molecular weights. These proteins can be constitutively present or exhibit induced 
expression and can be distributed in different cellular compartments such as the 
cytosol, mitochondria, endoplasmic reticulum (ER) and nucleus (Bukau and Horwich, 
1998). While, members of the mammalian HSP70 family are distributed in the 
aforementioned compartments, the HSP60 and HSP10 families are localised in the 
organelles and HSP100, HSP90 and HSP20 family members have been mainly 
detected in the cytosol. Table 1.3 tabulates the major heat shock families identified, 
their eukaryotic and prokaryotic counterparts of each family and their cellular 
distributions.  
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Table  1.3: Classification of the heat shock protein family, distribution in different 
organisms and also their subcellular localization (adapted from Bukau and 
Horwich, 1998). 
The family is represented by ‘HSP’. Protein members are suffixed by ‘Hsp’ and a numerical designation 
that represents the characteristic molecular weight of family members in kDa 
 
Family Organism Chaperone Localisation 
HSP100 E.coli 
S.cerevisiae 
C1pA,B,C 
Hsp104 
Cytosol  
Cytosol 
HSP90 E.coli 
S.cerevisiae 
Mammals 
 
HtpG 
Hsp83 
Hsp90 
Grp94 
Cytosol  
Cytosol 
Cytosol 
ER 
HSP70 E.coli 
S.cerevisiae 
 
 
 
Mammals 
 
DnaK 
Ssa 1-4 
Ssb 1,2 
Kar2 
Ssc1 
Hsc70 
Hsp70 
BiP(Grp 78) 
mHsp70 
Cytosol  
Cytosol 
Cytosol 
ER 
Mitochondria 
Cytosol/Nucleus 
Cytosol/Nucleus 
ER 
Mitochondria 
HSP60 
(Group I 
and II) 
E.coli 
S.cerevisiae 
Plants 
Mammals 
 
Archaebacteria 
GroEL(GroupI) 
Hsp60 (GroupI) 
Cpn60 (GroupI) 
Hsp60 (GroupI) 
TCP1(GroupII) 
Thermosome (GroupII) 
Cytosol 
Mitochondria 
Chloroplasts 
Mitochondria 
Cytosol 
Soluble 
 
HSP40 E.coli 
S.cerevisiae 
Mammals 
 
DnaJ 
YdJ1 
Hsp40 members such 
as HDJ1, HDJ2, 
Cytosol 
Cytosol/Nucleus 
Cytosol 
 
Small 
HSP’s 
E.coli 
S.cerevisiae 
Mammals 
 
1bp a and B 
Hsp27 
αA and αB crystalline 
Hsp27 
Cytosol  
Cytosol 
Cytosol 
Cytosol 
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1.2.2. Regulation of the hsp gene expression 
Expression of the hsp genes is regulated at the transcriptional level. Studies on cellular 
response to stress carried out in Saccharomyces cerevisiae by Finkelstein et al., 
concluded that transcriptional activity is remarkably altered after heat shock. The 
observed accumulation of heat shock proteins is directly correlated with an increased 
rate of transcription of the corresponding genes (Finkelstein et al., 1982). Such 
regulation is observed in both eukaryotic and prokaryotic systems (Bukau, 1993; 
Morimoto, 1993). In E.coli the heat shock genes are arranged in a regulon of 20 genes 
(Bukau, 1993). It is regulated by the σ32 subunit of RNA polymerase (RNAP). The σ32 
subunit is a product of the rpoH gene and confers specificity to the core RNAP for 
transcription of the hsp genes (Grossman et al., 1984; Landick et al., 1984; Cowing et 
al., 1985).  
In eukaryotes, heat shock transcriptional activation is mediated by heat shock 
transcription factor called the heat shock factor (HSF, Morimoto, 1993). The promoter 
regions of hsp genes hosts multiple adjacent and inverse iterations of the motif 5′-
nGAAn-3′ called heat shock promoter elements (HSE) (Morimoto, 1998). In 
mammalian unstressed cells HSF exists in an inactive monomeric state, bound to HSP 
(Schlesinger, 1990). The stress response triggered by an increasing accumulation of 
unfolded/aggregated protein (Morimoto et al., 1993) induces binding of heat shock 
factor (HSF) to the HSE (illustrated in Figure 1.5). First, HSF bound to HSP separates 
from the HSP. The free HSF in turn is phosphorylated by a serine/threonine kinase 
resulting in a homotrimer structure which then enters the nucleus (Hensold et al., 
1990; Sarge et al., 1993; Cotto et al., 1996). The trimeric HSF binds to the HSE and 
undergoes further phosphorylation by HSF kinase. This results in transcriptional 
activation of hsp genes and their subsequent translation. Interestingly, Hsp70’s play a 
regulatory role in the activation of HSF during the heat shock response. Upon 
attenuation of the heat shock response, unengaged Hsp70 binds to HSF, which 
converts HSF to its inactive form, thus auto-regulating the heat shock response (Kiang 
and Tsokos, 1998; Morimoto, 1993). 
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Figure 1.5: Transcriptional regulation of hsp gene expression (adapted from Kiang and 
Tsokos, 1998). 
Transcription factor, (HSF), during the unstressed state is bound to HSP and is inactive. Accumulation 
of non-native proteins induces the heat shock response. Activated HSF separates from the HSP, 
undergoes phosphorylation and enters the nucleus. There it binds to the HSE on the promoter region and 
activates transcription of the hsp. 
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1.2.3. Functional roles 
The diverse roles fulfilled by the different HSP families are summarised in Table 1.4. 
Proteins from the 60, 70 and 90 kDa families exhibit chaperone functions and bind to 
unfolded proteins. The HSP70 and HSP60 families, although structurally unrelated, 
bind to unfolded polypeptides in an adenosine tri-phosphate (ATP) dependent manner 
(Becker and Craig, 1994; Fink 1999). HSP60’s also known as chaperonins, allow 
misfolded polypeptides to unfold and refold in their central cavity (Bukau and 
Horwich, 1998). HSP90 on the other hand, binds to and regulates the function of 
folded proteins such as tyrpsin kinase, steroid hormone receptors, actin and tubulin in 
an ATP dependent manner (Becker and Craig, 1994; Csermely et al., 1998; Lindquist 
and Craig 1988).  
 
Table  1.4: Functional roles fulfilled by the different HSP families 
Family Function 
HSP100 Stress tolerance; helps resolubilisation of heat inactivated 
proteins from insoluble aggregates 
HSP90 Signal transduction (e.g., interaction with hormone receptors 
and kinases); autoregulation of the heat shock response; role 
in cell cycle and proliferation 
HSP70 Acts as molecular chaperones; provides cytoprotection; anti-
apoptotic activity; in E.coli essential for lambda phage 
replication 
HSP60 Acts as molecular chaperones; may facilitate protein 
degradation as cofactor of proteolytic systems. 
HSP40 Co chaperone activity with Hsp70 proteins 
Small HSP’s Regulates actin cytoskeleton; acts as molecular chaperone; 
provides cytoprotection 
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For the purpose of this thesis, the rest of this chapter will concentrate on the 70 kDa 
heat shock protein family, its function, structure and co-chaperone partner proteins due 
to their relevance to the work described in this thesis. 
1.3. The HSP70 chaperone family 
The HSP70 class of proteins are a ubiquitous family expressed under various 
physiological stress conditions (Morishima, 2005). They have been identified in all 
eukaryotes and prokaryotes and in some but not all of archaea (Boorstein et al., 1994; 
Conway De Macario and Macario, 1994; Macario et al., 1999). Certain members of the 
archaeal kingdom such as some methanogens, extreme thermophile and halophiles 
have been shown to not produce the protein (Macario et al., 1999). The number of 
members of the HSP70 family expressed varies from organism to organism. Thirteen 
Hsp70 proteins have been identified in humans, whilst only 3 have been detected in 
E.coli (Vos et al., 2008). All identified hsp70 genes are highly conserved and show at 
least 50% identity (Boorstein et al., 1993). Some of the well characterised members of 
the HSP70 family are DnaK from E.coli, SSA and SSB proteins from S.cerevisiae, the 
mammalian cystolic Hsp70 and BiP from the mammalian ER (Bukau and Horwich, 
1998). In the mammalian cytosol there are two forms of Hsp70 protein, one is the 
inducible Hsp70, also referred to as Hsp72 while the other is the constitutive form also 
know as heat shock cognate (Hsc70) or Hsp73 (Brown et al., 1993; Welch, 1993; Jolly 
and Morimoto et al., 2000). The amino acid sequence of Hsc70 shows 90% identity 
with the inducible Hsp70 (O’Malley et al., 1985; Moon et al., 2001). Multiple 
sequence alignment performed using ClustalW (Figure 1.6) highlights the high degree 
of conservation between the Hsp70 proteins from evolutionarily divergent organisms, 
bacterial and bovine and also between the human inducible and constitutive forms.
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HumanHsc70  (P11142)     MSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFT-DTERLIGDAAKNQV 59 
BovineHsc70 (P19120)     MSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFT-DTERLIGDAAKNQV 59 
HumanHsp70  (P08107)     MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFT-DTERLIGDAAKNQV 59 
DnaK        (P0A6Y8)     --MGKIIGIDLGTTNSCVAIMDGTTPRVLENAEGDRTTPSIIAYTQDGETLVGQPAKRQA 58 
            (P0A6Y8)        .  :******* ***.:::  . .:: * :*:***** :*:* * * *:*:.**.*. 
 
HumanHsc70  (P11142)     AMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEV 119 
BovineHsc70 (P19120)     AMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEV 119 
HumanHsp70  (P08107)     ALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEI 119 
DnaK        (P0A6Y8)     VTNPQNTLFAIKRLIGRRFQDEEVQRDVSIMPFKIIA-ADNGDAWVEVKGQ--KMAPPQI 115 
                   . ** **:*  ******:* *  ** *:.  ** ::  ... .. *. **:   : * :: 
 
HumanHsc70  (P11142)     SSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAA 179 
BovineHsc70 (P19120)     SSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAA 179 
HumanHsp70  (P08107)     SSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAA 179 
DnaK        (P0A6Y8)     SAEVLKKMKKTAEDYLGEPVTEAVITVPAYFNDAQRQATKDAGRIAGLEVKRIINEPTAA 175 
                     *: **.***: ** *** .**:**:********:********* ****:* ********* 
 
HumanHsc70  (P11142)     AIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDG----IFEVKSTAGDTHLGGEDFDN 235 
BovineHsc70 (P19120)     AIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDG----IFEVKSTAGDTHLGGEDFDN 235 
HumanHsp70  (P08107)     AIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDG----IFEVKATAGDTHLGGEDFDN 235 
DnaK        (P0A6Y8)     ALAYGLDKGTG-NRTIAVYDLGGGTFDISIIEIDEVDGEKTFEVLATNGDTHLGGEDFDS 234 
                     *:*****:    :*.: ::********:**: *::      *** :* ***********. 
 
HumanHsc70  (P11142)     RMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGID--- 292 
BovineHsc70 (P19120)     RMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGID--- 292 
HumanHsp70  (P08107)     RLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGID--- 292 
DnaK        (P0A6Y8)     RLINYLVEEFKKDQGIDLRNDPLAMQRLKEAAEKAKIELSSAQQTDVNLPYITADATGPK 294 
                     *::*::: ***:.:  *: ::  *::**: *.*:**  ***: *:.:::  :  .      
 
HumanHsc70  (P11142)     -FYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQ 351 
BovineHsc70 (P19120)     -FYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQ 351 
HumanHsp70  (P08107)     -FYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQ 351 
DnaK        (P0A6Y8)     HMNIKVTRAKLESLVEDLVNRSIEPLKVALQDAGLSVSDIDDVILVGGQTRMPMVQKKVA 354 
                      :  .:***::*.*  **.. :::*:: **:** *. ::*.*::****.**:* :** :  
 
HumanHsc70  (P11142)     DFFNGKELNKSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMT 411 
BovineHsc70 (P19120)     DFFNGKELNKSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMT 411 
HumanHsp70  (P08107)     DFFNGRDLNKSINPDEAVAYGAAVQAAILMGDKSENVQDLLLLDVAPLSLGLETAGGVMT 411 
DnaK        (P0A6Y8)     EFF-GKEPRKDVNPDEAVAIGAAVQGGVLTGD----VKDVLLLDVTPLSLGIETMGGVMT 409 
                     :** *:: .*.:******* *****..:* **    *:*:*****:*****:** ***** 
 
HumanHsc70  (P11142)     VLIKRNTTIPTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGV 471 
BovineHsc70 (P19120)     VLIKRNTTIPTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGV 471 
HumanHsp70  (P08107)     ALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGV 471 
DnaK        (P0A6Y8)     TLIAKNTTIPTKHSQVFSTAEDNQSAVTIHVLQGERKRAADNKSLGQFNLDGINPAPRGM 469 
                     .** :*:*****::* *:* .***..* *:* :***  : **: **:*:* ** *****: 
 
HumanHsc70  (P11142)     PQIEVTFDIDANGILNVSAVDKSTGKENKITITNDKGRLSKEDIERMVQEAEKYKAEDEK 531 
BovineHsc70 (P19120)     PQIEVTFDIDANGILNVSAVDKSTGKENKITITNDKGRLSKEDIERMVQEAEKYKAEDEK 531 
HumanHsp70  (P08107)     PQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEV 531 
DnaK        (P0A6Y8)     PQIEVTFDIDADGILHVSAKDKNSGKEQKITIKASSG-LNEDEIQKMVRDAEANAEADRK 528 
                     ***********:***:*:* **.:** :****. ..* *.:::*::**::**     *.  
 
HumanHsc70  (P11142)     QRDKVSSKNSLESYAFNMKATVEDEKLQGKINDEDKQKILDKCNEIINWLDKNQTAEKEE 591 
BovineHsc70 (P19120)     QRDKVSSKNSLKSYAFNMKATVEDEKLQGKINDEDKQKILDKCNEIINWLDKNQTAEKEE 591 
HumanHsp70  (P08107)     QRERVSAKNALESYAFNMKSAVEDEGLKGKISEADKKKVLDKCQEVISWLDANTLAEKDE 591 
DnaK        (P0A6Y8)     FEELVQTRNQGDHLLHSTRKQVEEAG--DKLPADDKTAIESALTALETALKGE---DKAA 583 
                      .: *.::*  .   .. :  **:    .*:   **  : .    : . *. :   :*   
 
HumanHsc70  (P11142)     FEHQQKELEKVCNPIITKLYQSAGGMPG----GMPGGFPGGGAPPSGGASSGPTIEEVD- 646 
BovineHsc70 (P19120)     FEHQQKELEKVCNPIITKLYQSAGGMPGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD- 650 
HumanHsp70  (P08107)     FEHKRKELEQVCNPIISGLYQGAG-GPG------PGGF--GAQGPKGGSGSGPTIEEVD- 641 
DnaK        (P0A6Y8)     IEAKMQELAQVSQKLMEIAQQQHAQQQT-------AGADASANNAKDDDVVDAEFEEVKD 636 
                     :* : :** :*.: ::    *  .           .*   ..  ....   .. :***.  
 
HumanHsc70  (P11142)     -- 
BovineHsc70 (P19120)     -- 
HumanHsp70  (P08107)     -- 
DnaK        (P0A6Y8)     KK 638 
 
 
 
 
Figure 1.6: Multiple sequence alignment of selected HSP70 family members 
Multiple sequence alignment of HSP70 protein sequences of E.coli, human and bovine origin was 
performed using ClustalW (Thompson et al., 1994). Thier UniProt ids are indicated in brackets. 
Asterisks indicate an identical match, colons indicate conserved substitutions and full stops indicate 
semi- conserved substitutions.Small and hydrophobic amino acid are coloured red, acidic coloured blue, 
basic residues in magenta, hydroxyl in green. 
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The Hsp70’s perform a number of important cellular functions. The role of Hsp70 in 
assisting unfolded protein was first identified by Haas and Wabl while working on Bip, 
the Hsp70 of the ER. They showed that Bip was capable of binding incompletely 
assembled immunoglobulin heavy chains (Haas and Wabl, 1983). Some Hsp70’s have 
also demonstrated the ability to solubilise protein aggregates with the aid of the 
Hsp100 family (Glover and Lindquist, 1998). DnaK on its own can effectively 
solubilise and refold small aggregates of glucose-6-phosphate dehydrogenase, however 
larger aggregates of up to 10 monomers required the assistance of the bacterial Hsp100 
homologue, ClpB (Diamant et al., 2000). 
Mammalian cytosolic Hsp70’s have also been shown to be involved in protein 
translocation. Proteins carrying a pentapeptide motif (KFERQ) have been reported to 
be targeted to the lysosome for degradation by Hsp70 (Chiang and Dice, 1988). The 
E.coli counterpart, DnaK, also assists in protein translocation and is essential for the 
export of alkaline phosphatase (Wild et al., 1992). Studies with Ssa1p (Hsp70 from   
S.cerevisiae) highlighted the importance of cytosolic Hsp70’s in the post-translational 
import of proteins to the mitochondria and the outer membrane of ER.  Depletion of 
Ssa1p led to the accumulation of a mitochondrial precursor protein in the cytosol 
(Deshaies et al., 1988). Additionally, Hsc70 has also been implicated in binding and 
stabilizing locally unfolded nuclear localization signals and therefore is involved in 
nuclear protein import (Dingwall and Laskey, 1992). 
Hsp70 proteins have been found to play a role in cell survival. Deletion of the dnaK 
gene is lethal to bacteria, whilst mutations in the gene disrupts several basic cellular 
mechanisms such as host RNA and DNA synthesis (Zylicz et al., 1993), initiation of  
bacteriophage λ and P1 DNA (Zylicz et al., 1988), plasmid DNA replication 
(Sakakibara, 1988) and expression of other heat shock proteins (Tilly, 1983). 
Mammalian Hsp70s promote cell survival by blocking caspase activation and suppress 
mitochondrial damage and nuclear fragmentation, mediated through the binding of 
Hsp70 with pro-apoptotic proteins such as c-myc and p53 (Mosser, 1997). This has 
serious implication in oncogenesis and over expression of Hsp70 has been observed in 
malignant human tumors. Selective deletion of the protein induces cell death in the 
cancer cell lines (Gyrd-Hansen et al., 2004). Their involvement in signal transduction, 
cell cycle regulation, differentiation and cell death assumes relevance also in other 
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pathological conditions such as neurodegenerative diseases, auto-immune diseases and 
viral infections (Jolly and Morimoto, 2000).   
Distinct functional specificity exists between the different Hsp70’s despite their high 
degree of conservation (Suppini, 2004). Experiments conducted with the E.coli DnaK 
and yeast mitochondrial Hsp70 (mtHsp70) show that the two Hsp70’s are not 
interchangeable. Moro et al., reported that E.coli DnaK was incapable of promoting 
the import of mitochondrial precursors when introduced in place of the yeast mtHsp70 
(Moro et al., 2002). Similarly, human Hsc70 is unable to complement an E.coli DnaK 
mutant and restore growth at high temperatures and λ phage propagation.  
1.3.1. Domain architecture  
All Hsp70 homologues are composed of three conserved regions. Figure 1.7 is a 
schematic representation of the conserved domain architecture as reported for the 
human Hsp70. 
 
 
 
 
 
Figure 1.7: Domain architecture of Hsp70 proteins. 
A diagrammatic representation of the domains present in Human Hsc70 which are conserved in the 
Hsp70 family. NBD represents the nucleotide binding domain. The C-terminal region (CTR) comprises 
of the PBD which is the peptide binding domain and the distal 10 kDa lid region. 
They N-terminal region is characterised by a highly conserved 44-kDa nucleotide 
binding domain (NBD) followed by a 28-kDa C-terminal region (CTR) which can be 
subdivided into a conserved 18-kDa peptide binding domain (PBD) and a less 
conserved 10-kDa C-terminal lid region. The structures of the domains have been 
determined in isolation by X-ray crystallography.  
 
 
 
CTR 
N PBD Lid NBD 
1 393 385 646 537 
C
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1.3.1.1. Nucleotide binding domain 
The chaperone activity of Hsp70 proteins is driven by ATP hydrolysis. X-ray 
structures of the bovine apo-NBD, native and various mutants of the bovine Hsc70 
NBD complexed with ATP, ADP, AMP-PNP are available in the Protein data bank 
(PDB) (Flaherty et al., 1990; Flaherty et al., 1994; Wilbanks et al., 1994; Jiang et al., 
2007). Figure 1.8 is the ribbon representation of the bovine NBD with a bound ADP 
molecule (Pdb id: 3HSC). The NBD is a bi-lobed structure (I and II) and each lobe is 
further divided into two sub-domains (A and B). Lobes I and II are separated by a deep 
cleft. The bottom of the cleft forms the binding site for the nucleotide in complex with 
Mg2+ ion and two Na+ ions (Flaherty et al., 1990). The opening frequency of the 
nucleotide binding cleft appears to be regulated by the nature of the nucleotide bound 
in the order of nucleotide free>ADP>ADP+Pi>ATP (Gassler et al.,2001)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Nucleotide binding domain of bovine Hsc70 determined by X-ray 
crystallography 
Ribbon representation of the NBD of bovine Hsc70 generated by Pymol (Pdb id: 3HSC; Flaherty et al., 
1990). The structure is in complex with ADP, magnesium, 2 sodium ions and phosphate. In this figure 
ADP is represented by sticks and magnesium represented by an orange sphere. Sub-domains of lobes I 
and II are represented as IA, IB and IIA, IIB respectively. 
IB 
IA 
IIB 
IIA 
Nucleotide 
binding cleft 
Page 19 
However, subtle differences have been shown to exist in the NBD between members 
of the HSP70 family. This includes variations in an exposed loop in sub-domain IIB 
near the nucleotide binding cleft, the occurence of a hydrophobic patch at the top of 
the cleft and two putative salt bridges which could alter the polarity of the interface. 
Based on these differences, the HSP70 protein family can be grouped into three 
subfamilies. E.coli DnaK, E.coli HscA and human Hsc70 exemplify these sub-groups 
(Brehmer et al., 2001). The three families also differ in the ADP disassociation rates 
with DnaK having values of 0.004-0.035 s-1 in presence of inorganic phosphate. Hsc70 
has been reported to be 20-fold faster and HscA almost 700 fold faster (Brehemer et 
al., 2001). These differences influence the role played by nucleotide exchange factors 
(NEF) in the regulation of Hsp70’s ATPase activity. NEFs are further discussed in 
Section 1.5.1. 
1.3.1.2.  C-terminal region 
The C-terminal region is characterised by two sub-domains. The first sub-domain 
corresponds to the 18 kDa peptide binding domain (PBD) involved in binding to the 
unfolded regions of the substrate and the second sub-domain corresponds to the distal 
C-terminal 10 kDa lid region. The structure of the entire C-terminal domain from 
E.coli (Zhu et al., 1996) and also that of the sub domains in isolation has been 
determined (Zhu et al., 1996; Wang et al., 1998; Pellechia et al., 2000).  
Peptide binding domain 
The tertiary fold of the 18-kDa PBD comprises of a β domain followed by a single 
helix. The β domain is a sandwich comprising of two stacks of four anti-parallel β-
sheets. The loops in between the β-strands 1, 2(L1, 2) and 3, 4(L3, 4) hosts the peptide 
binding site (Morshauser et al., 1999).  
10-kDa distal C-terminal module 
The 10-kDa distal fragment is an α-helical domain comprising of five antiparallel 
helices. It is believed to function as a lid which folds over the beta sandwich of the 
PBD. But there has been no evidence of it making any contact with the bound peptide 
(Zhu et al., 1996).  
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Figure 1.9 shows the structure of the entire C-terminal region of DnaK determined by 
X-ray crystallography (Pdb id: 1dkx). The two sub-domains and the loops hosting the 
peptide binding site are indicated on the figure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Structure of the 28-kDa C-terminal region (CTR) of E.coli DnaK (Pdb id: 
1DKX) 
 
Ribbon representation of the CTR of E.coli DnaK generated by Pymol (Pdb id: 1DKX; Zhu et al., 
1996).The structure is in complex with bound peptide substrate (NRLLLTG) in stick representation. The 
18-kDa PBD comprises of β sheets and is coloured purple. Loops 1, 2 and 3, 4 form part of the substrate 
binding cavity. The 10 kDa lid region is depicted in teal. The five helices making up this region are 
labelled A-E.  
Peptide specificities 
The substrate binding mechanism and specificity of the Hsp70 group of proteins have 
been studied using short peptides. Peptides mimic the unfolded regions of polypeptide 
chains which actually serve as substrates for the Hsp70’s (Landry et al., 1992). Studies 
with DnaK indicate that Hsp70’s bind hydrophobic segments in an extended 
conformation through the peptide binding domain (Zhu et al., 1996). Using phage 
display studies and cellulose bound peptide scans; DnaK has been shown to prefer 
peptide motifs which contain a core of 4-6 hydrophobic residues flanked by basic 
residues (Gragerov et al., 1994; Rüdiger et al., 1997). An example of a high affinity 
peptide sequence for DnaK is NRLLLTG (Gragerov et al., 1994). Interestingly Hsc70 
Lid 
Helix B 
Helix A L 4, 5 L 1, 2 L 3, 4 
L 5, 6 
Helix E 
Helix D 
Helix C 
18 kDa 
PBD 
10 kDa  
C-terminal  
region 
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can bind with high affinity to two different peptide motifs. One is a basic peptide 
(NIVRKKK) while the other is a hydrophobic motif (FYQLALT) (Takenaka et al., 
1995). The binding motif of Bip was determined to be Hy(W/X)HyXHyXHy where Hy 
is a large hydrophobic residue, W is tryptophan, and X is any amino acid except 
charged residues (Blond-Elguindi et al., 1993). This amino acid selectivity confers 
substrate specificity and thereby functional diversity to the different Hsp70’s. This 
would explain the observed inability of the different Hsp70’s to function 
interchangeably (Terlecky et al., 1992; Brodsky et al., 1993). Suppini et al., reported 
that while a chimera of Hsc70 and DnaK constructed with the NBD of Hsc70 and C-
terminal domains of DnaK could complement an E. coli dnaK mutant strain at 43oC 
and support λ phage propagation, the same was not possible with either the full length 
Hsc70 or with an Hsc70-DnaK chimera constructed with the NBD of DnaK and the C-
terminal domains of Hsc70 (Suppini et al., 2004). This experiment highlights the role 
of the CTR in conferring functional diversity to the Hsp70 family members.   
1.3.1.3. Interdomain communication 
Although the two domains of Hsp70s are functional in isolation, Hsp70 chaperone 
activity requires the two domains to be physically linked. The linker region is a highly 
hydrophobic segment containing a conserved leucine triplet and the linker has been 
implicated for its role in the interdomain communication between the NBD and PBD 
(Vogel et al., 2006; Sousa and Lafer, 2006). Mutations to this region resulted in 
coupling defects in DnaK, for example, mutating two of the LL residues to DD 
abolished interdomain communication (Han and Christen, 2001). Residues R151, 
D388, D393, K155 and R167 in DnaK have been identified as multiple interaction 
points between the two domains (Vogel et al., 2006). Point mutations, T204E in the 
NBD (O'Brien and McKay, 1993) and K414I on the beta sheet sandwich of the PBD 
(Montgomery et al., 1999) have also been identified to disrupt the communication 
between the two domains. Vogel et al., reported the existence of a conserved proline in 
the NBD which acts as a ‘molecular switch’ to stabilize the conformations (Vogel et 
al., 2006).  
A structure of the full length Hsp70, protein which could help understand the 
interdomain allostery, is not available. A crystal structure of a bovine Hsc70 two 
domain construct lacking the C-terminal 10-kDa region has been reported. However 
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the protein carries two mutations (D213A/E214A) on the interdomain interface (Jiang 
et al., 2005). Figure 1.10 is a cartoon representation of the 2-domain structure of the 
bovine Hsc70 with the NBD, PBD and the short linker region connecting them 
indicated (Jiang et al., 2005). The structure, which does not have any bound 
nucleotide, reveals that interdomain contact is promoted by one side of helix A of the 
PBD which rests in a groove between sub-domain IA and IIA of the NBD. Also the 
interdomain linker is solvent exposed (Jiang et al., 2005). An NMR model of a 54-kDa 
fragment of DnaK from Thermus thermophilus in the ADP bound state has also been 
reported, however, the packing arrangement of the domains reported differs from the 
crystal structure bovine Hsc70 (Revington et al., 2005). In this model, it is the region 
of the β sub-domain near the entry point of the interdomain linker and not the helix A 
of the PBD which interacts with the cleft in the ATPase domain (Revington et al., 
2005). However since both constructs carry mutations and deletions, Swain et al., 
contemplate that these structures might not represent a physiological interdomain 
crystal packing interaction. Using NMR and other biophysical studies on a two-domain 
E.coli DnaK construct, they instead propose that the NBD and PBD interact only upon 
ATP binding, and not in the ADP or nucleotide free state (Swain et al., 2007). 
However in the absence of a full length structure, it will be difficult to decipher the 
exact mechanism of the interdomain interactions. 
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Figure 1.10: Interdomain interaction of the NBD and PBD in bovine Hsc70 
  
Ribbon representation of the crystal structure of a two domain construct of bovine hsc70 (Pdb id: 
1YUW; Jiang et al., 2005). The NBD is indicated in blue and the PBD in orange. The linker region 
involved in the interdomain communication is indicated in green, and the conserved LLLL linker 
sequence is rendered in green with the side-chain orientations shown. Helix A of the PBD rests in a 
groove between sub-domain IA and IIA of the NBD. 
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1.3.2. Hsp70 reaction cycle 
The ATP hydrolysis activity of the NBD is allosterically coupled with the substrate 
binding of the PBD (Buchberger et al., 1995; Gassler et al., 1998; Suh et al., 1999). 
ATP binding induces conformational change in the PBD and opens the substrate 
binding cavity (Suh et al., 1999). In this state, the substrates have high kon and koff 
values i.e. protein has low affinity for substrate. This state is often referred to as the 
‘open’ conformation. Substrate binding accelerates the ATP hydrolysis rate which 
causes a conformational change in the PBD resulting in the closure of the substrate 
binding cavity. This creates high affinity for substrate and represents the ‘closed’ state 
of the protein (Bukau and Horwich, 1998; Mayer et al., 2000).  
The reaction cycle of the E.coli DnaK works in co-ordination with its co-chaperone 
partners, DnaJ and GrpE. The co-chaperone requirement for the Hsp70 reaction cycle 
is discussed in detail in the section 1.6. The cycle begins with the detection of the 
unfolded protein. Two schools of thought exist relating to the binding of unfolded 
protein to DnaK. One suggests that DnaK in the ATP bound form directly binds to the 
substrate and undergoes ATP hydrolysis upon interaction with the E.coli DnaJ, a 
representative of the HSP40 family (McCarty et al., 1995). The other asserts that it is 
the DnaJ co-chaperone protein which binds to the substrate and subsequently targets 
the substrate to DnaK (Hartl, 1996). Figure 1.11 illustrates the stages determined for 
the E.coli Hsp70, DnaK from the perspective that the DnaJ recruits the unfolded 
protein. The cycle described for the E.coli DnaK chaperone is generally accepted to 
represent the reaction cycle of other Hsp70 members, although certain differences do 
exist on the basis of co-chaperone requirement. The various steps of the DnaK cycle 
are as follows: 
Step 1:  Association of Hsp40 with substrate 
Step 2: Transfer of the substrate to the ATP-bound form of Hsp70. First, DnaJ 
interacts transiently with DnaK to form an intermediate DnaK.DnaJ.S.ATP 
complex (referred to as Step 2a in Figure 1.11). Binding of both substrate and 
DnaJ results in the stimulation of ATP hydrolysis thereby converting DnaK to 
its ADP bound form. This in turn stabilises the DnaK.DnaJ.S.ADP complex 
(referred to as Step 2b in Figure 1.11). 
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Step 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: The DnaK/DnaJ/GrpE reaction cycle (adapted from Fink, 1999). 
 
DnaJ binds to unfolded polypeptide and presents it to the ATP bound DnaK. Simultaneously DnaJ 
stimulates ATP hydrolysis by DnaK, to convert it from its low affinity ATP bound state to its high 
affinity ADP bound state. This results in the formation of a ternary complex between DnaK, DnaJ and 
the substrate. Subsequently, nucleotide exchange is facilitated by GrpE resulting in the release of the 
substrate. 
Step 3:  DnaJ disassociates from the complex to yield DnaK.ADP.S complex 
Step 4: Exchange of ADP to ATP is carried out by another co-chaperone GrpE, a 
nucleotide exchange factor found in bacteria and mitochondria. Binding of 
ATP releases the substrate, and reverts DnaK to its low substrate affinity, ATP 
bound state (Bukau and Horwich, 1998 and Fink, 1999).  
1.3.3. Hsp70 co-chaperones 
The switch between the high and low substrate affinity Hsp70 states is mediated with 
the assistance of various co-chaperones proteins (Bukau and Horwich, 1998),  that 
interact with Hsp70s to regulate and direct their chaperone activity (Caplan, 2003; 
Mayer and Bukau, 2005). Three major families of co-chaperones have been 
documented. They are the: 
 The J-domain containing Hsp40 protein family 
Key  
K-DnaK; J-DnaJ; S-Substrate 
Step 2b 
J+S 
K.ATP.S.J 
K.ADP.S.J 
K.ADP.S 
K.ATP.S 
K.ATP 
J.S 
J 
S 
ATP 
ADP 
Step 1 
Step 2a 
 
Step 4 
Step 5 
GrpE 
Step 4b 
Step 4a 
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 Nucleotide Exchange Factors (NEF) 
 Tetratricopeptide repeat (TPR) motifs containing co-chaperones  
Table 1.5 summarises some of co-chaperones identified in the eukaryotic and 
prokaryotic systems from the above mentioned co-chaperone families. Also tabulated 
is the role played by them in regulating the function of the Hsp70 proteins.   
 
 
 
 
 
Table  1.5: Hsp70 regulation by the various co-chaperone proteins 
The time span of the Hsp70.substrate complex is defined by NEFs which accelerate 
disassociation of ADP from Hsp70. In E.coli, GrpE is the only family of NEF 
identified (Harrison et al, 1997), while three types of human NEFs have been 
identified. They are BAG-1, HspBP1 and Hsp110 (Hohfeld and Jentsch, 1997; 
Sondermann et al, 2001; Shomura et al, 2005). BAG-1 belongs to the Bcl-2-associated 
athanogene (BAG)-family of proteins. They are characterised by a conserved C-
terminal domain termed the BAG domain (Takayama et al., 1999). The BAG domain 
has been implicated in interacting with the NBD of the eukaryotic cytosolic Hsc70 and 
trigger nucleotide exchange (Hohfeld, 1997; Alberti et al., 2003). Although the 
molecular mechanism of BAG-1 differs from that of GrpE, the conformational switch 
induced in the NBD by the both NEF’s are similar. Both proteins induce a 14o rotation 
in the lobe II of the NBD of Hsp70 (Sondermann et al 2001; Mayer and Bukau, 2005). 
Human HspBP1 (Hsp70 binding protein 1) was identified as a eukaryotic NEF and 
homologues have been identified in several eukaryotic domains and in S.cerevisiae 
(Raynes and Guerriero 1998; Chung et al. 2002; Kabani et al. 2002a). In contrast no 
such homologue of the BAG-1 protein has been identified. HspBP1 not only functions 
as a NEF but it can also stimulate the ATPase activity of Hsc70 along with Hsp40 
Co-chaperone Role played with Hsp70 
HSP40 family 
GrpE 
BAG-1 
Hsp110 
Hip 
Hop 
Chip 
Catalyses ATP hydrolysis by Hsp70 
Nucleotide exchange factor in prokaryotes 
Nucleotide exchange factor in eukaryotes 
Nucleotide exchange factor in eukaryotes 
TPR containing, stabilises Hsp70-ADP state 
TPR containing, connects Hsp70 and Hsp90 
TPR, Ubox, ubiquitin ligase 
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(Shomura et al., 2005). X-ray crystallographic studies have revealed that the structural 
mechanism of nucleotide exchange mediated by HspBP1 is different from that reported 
for GrpE and Bag-1 (Shomura et al., 2005). HspBP1 promotes nucleotide release by 
wrapping around lobe II of the ATPase domain, which causes a subsequent 
displacement of lobe I (Shomura et al., 2005).  In contrast, BAG-1 and GrpE triggers 
nucleotide release through a conformational change in lobe II of the ATPase domain 
(Harrison et al., 1997; Sondermann et al., 2001). Another structurally unrelated 
eukaryotic NEF recently identified is HSP110, a subclass of the Hsp70 superfamily, 
was identified in yeast (Andréasson et al., 2008). Thier domain architecture is similar 
to that of Hsp70, only differing by an extended C-terminal domain and the insertion of 
an acidic region between in the β-sheet sub-domain of the PBD (Easton et al., 2000; 
Liu and Hendrickson, 2007). No other NEF possess a PBD, and in the Hsp110, this 
domain makes contact with the lobe II of the Hsp70 NBD (Schuermann et al., 2008).  
The co-chaperone protein family containing Tetratricopeptide repeat (TPR) motifs 
possess a 34-amino-acid motif with a loose consensus that functions as a protein-
protein interaction module (Blatch, 1999). Hsc70-interacting protein (Hip; also known 
as p48), Hsc70-Hsp90-organizing protein (Hop; also known as p60 or Sti1) and the 
carboxyl terminus of Hsc70-interacting protein (CHIP) are three eukaryotic TPR-
containing proteins that have been identified as interacting with the Hsc70. Hip has 
been found to stabilize the ADP bound form of Hsc70 (Höhfeld et al., 1995), while 
Hop connects the Hsc70 to Hsp90 (Smith et al., 1993) and CHIP negatively regulates 
the ATPase activity of Hsc70 (Ballinger et al., 1999). 
The Hsp40 class of co-chaperones plays a key regulatory role by stimulating the rate of 
ATP hydrolysis of Hsp70 proteins (Laufen et al., 1999) and is dealt in detail in the 
following section. 
1.3.4. Hsp40 co-chaperone family 
 Forty-two known Hsp40 homologues have been identified in humans, six in E.coli 
and around twenty in S.cerevisiae. Their cellular distribution is widespread having 
been identified in the cytosol, ER, nucleus, endosome, mitochondria and ribosome 
(Qiu et al., 2006) and their localisation dictates the function of the Hsp40 proteins. The 
HSP40 family, unlike the other the heat shock protein families is highly diverged and 
only shares a conserved region of seventy amino acids called the J-Domain (Cheetham 
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& Caplan, 1998). Members of the the HSP40 family can be classified as type I, type II 
and type III depending upon the additional domains that are coupled to the conserved 
J-domain (Bukau et al., 1998; Walsh et al., 2004; Westhoff et al., 2005). The domain 
architecture of the subtypes of Hsp40 family is illustrated in Figure 1.12. Members of 
the type I subgroup are similar to E.coli DnaJ and are characterised by the presence of 
a J-domain, a Gly/Phe rich region and cysteine repeat region. The type II subgroup 
only possess the Gly/Phe rich region in addition to the J domain, while the type III 
members do not have any conserved features other than the J domain (Qiu et al.,2006).  
 
 
 
 
 
 
 
Figure 1.12: Classification and domain architecture of the Hsp40 family of proteins (adapted 
from Cheetham & Caplan, 1998). 
 
A diagrammatic representation of the domains present in the three types of Hsp40’s. They are composed 
of the conserved J domain, G/F stands for the glycine-phenylalanine rich region and cysteine repeats 
represents the zinc finger-like motifs.  
The J-domain is usually located at the N-terminus; although in some proteins such has 
auxillin the J-domain is located at the C-terminus. In fact, in type III Hsp40 members 
the J-domain can occur anywhere along the length of the protein (Cyr et al., 1994; 
Cheetham and Caplan, 1998). The J-domain of DnaJ alone is not sufficient to stimulate 
ATP hydrolysis in DnaK, however when coupled with the G/F region it can stimulate 
hydrolysis, albeit to a lesser extent than the full length protein (Wall et al., 1994; 
Karzai et al., 1996). It is important to note that maximal stimulation of ATPase activity 
can be achieved by the J-domain only in the presence of a peptide substrate (Karzai et 
al., 1996). The three dimensional structure of the J Domain of human Hsp40 (HDJ1) 
(see figure 1.13, Qian et al., 1996) and the J domain of E.coli DnaJ have been solved 
by NMR (Hill et al., 1995; Pellechia et al., 1996). The different structures confirm that 
the tertiary fold for the J-domain is conserved.  
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Figure 1.13: NMR structure of the J Domain of human hsp40 (1HDJ, Qian et al., 1996). 
A ribbon representation of the J domain of human HDJ1 (Pdb id: 1HDJ) determined by NMR. The 
figure was generated in Pymol. The four helices making up the J-domain are labeled 1 to 4 on the figure. 
The conserved HPD motif is located on the loop region between helix II and III. 
 
The domain is made up of 4 helices (Figure 1.13). Helices II and III are anti-parallel 
and are stabilized by a hydrophobic core. Helices I and IV serve to stabilise the 
interactions of helix II and III. The conserved HPD motif characteristic of all J-
domains is positioned in the loop region between Helix II and III (Burkholder et al., 
1996; Qian et al., 1996). An exception to this are the ring infected erythrocyte surface 
antigen (RESA) proteins of Plasmodium falciparum (Bork et al. 1992), the E. coli 
DjlB/DjlC family of proteins (Kluck et al. 2002) and the S.cerevisiae protein 
Tim16/Pam16 (Truscott et al., 2003; Walsh et al. 2004). 
Although type I and type II proteins differ in their domain composition, it has been 
reported that they are functionally similar. Both sub-groups can bind to non-native 
substrates and target them to the Hsp70 chaperone (Johnson and Craig, 2001). A 
peptide binding region has been identified in the C-terminus of both the type I and II 
proteins (Li and Sha, 2005). Rűdiger et al., deduced the substrate binding specificity of 
DnaJ using a cellulose-bound peptide scan. DnaJ was observed to prefer peptides 
enriched in aromatic and large hydrophobic aliphatic residues (Rűdiger et al., 2001).  
For the type I DnaJ-like proteins, the zinc finger-like motif has been implicated in 
peptide binding (Szabo et al., 1996). The NMR structure of the motif reveals it as a V-
shape with two zinc atoms bound, with the conserved hydrophobic pocket in the 
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middle of the motif proposed as the peptide binding site (Martinez-Yamout et al., 
2000). The type II proteins bind substrate through the C-terminal region (Sha et al., 
2000), while the type III proteins show no evidence of binding to non-native 
polypeptides and appear to have specialized functions. The type III proteins are 
functionally and structurally diverse. Additional motifs such as transmembrane helices 
have been observed for the E.coli DjlA, S.cerevisiae Sec63 and human DjC9/hSec63 
(Cheetham and Caplan, 1998; Mayer and Bukau, 2005). 
1.3.5. Mechanism of interaction between Hsp70 and Hsp40 
proteins 
Hsp40 proteins cooperate with their Hsp70 partner to fulfill various cellular functions. 
In E.coli, DnaJ has been reported to behave independently as a chaperone, although 
refolding activity requires the presence of DnaK (Mayer et al., 2000). The role of 
Auxillin and G-associated kinase (GAK) in Hsc70 mediated clathrin disassociation is 
well documented (Greener et al., 2000). TRP2 mediates transfer of substrate from 
Hsp90 to Hsp70 and Csp mediated involvement of Hsc70 in exocytosis has been 
reported (Caplan et al., 1993). The interaction of Hsp70 with Hsp40 as a bipartite 
mechanism has been proposed for DnaK/DnaJ system (Figure 1.14, Hennessy et al., 
2005). It has been proposed that helix II and possibly helix III on the J-domain of DnaJ 
are suggested to interact with the negatively charged underside cleft of the DnaK 
ATPase domain while helix I and II can bind to DnaK’s peptide-binding domain 
(PBD). By behaving as a peptide mimic, these helices could act to keep the PBD open 
for client substrate (Hennessy et al., 2005).  
The loop between helix II and helix III holds the highly conserved His-Pro-Asp (HPD) 
motif and is essential for the interaction of human Hsp40 with the Hsp70 (Qian et al., 
1996). Substitution mutations in the tripeptide such as H33Q and D35N have been 
shown to abolish the binding of Hsp40 to Hsp70 (Burkholder et al., 1996; Hartl  et al., 
1996). Apart from the H33Q and D35N mutations, alterations in residues Y25, K26 
and F47 in E.coli DnaJ abolish J-domain functions in vivo (Genevaux et al., 2002). 
Genevaux et al. observed that most of these mutations are confined to a small solvent 
exposed face of the J-domain. These appear to define a conserved interaction surface, 
as similar mutations on the human Hsp40; HDj1 resulted in similar loss of function 
(Genevaux et al., 2002).  
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Figure 1.14: Mechanism of binding of DnaJ to DnaK (redrawn from Hennessy et al., 2005). 
 
Panel A: Helix II and III of the DnaJ’s J-domain interact with the underside of the DnaK NBD. Helix I 
and IV of the J-domain of DnaJ are suggested to act as a client protein mimic and interact with the PBD 
of DnaK  
Panel B: When an appropriate client peptide is presented, helix I and IV are displaced by the client 
substrate coupled with ATP hydrolysis. This results in closure of the lid (indicated by arrow). 
The interaction and activity of DnaJ with DnaK has been demonstrated to require a 
linked NBD and PBD (Gassler et al., 1998). Using surface plasmon resonance 
(BIAcore) Gassler and colleagues showed that DnaJ failed to interact with DnaK 
fragments containing either just the NBD (amino acids 1-385) or the C terminus 
spanning from residues 386-638. Successful interaction of DnaJ was observed only in 
experiments performed with full length DnaK and DnaK 1-538 (Gassler et al., 1998).  
BIAcore assays have also revealed that only the ATP bound form of DnaK could bind 
to DnaJ immobilized on the sensor chip.  
 
 
Unfolded substrate 
 
DnaK 
J domain of DnaJ 
Colour scheme 
Panel A Panel B 
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Experiments conducted by Suh et al., have also demonstrated that the interaction of 
DnaJ with DnaK is dependent on ATP binding and that the formation of the DnaK-
DnaJ complex required ATP hydrolysis (Suh et al., 1999). Previous experiments have 
shown that DnaK undergoes conformational changes upon ATP binding (Liberek et 
al., 1991b). From these data and the results from BIAcore assays, Su et al., concluded 
that the two domain requirement demonstrated by DnaJ is because the formation of the 
DnaK-DnaJ complex requires ATP induced conformational change of DnaK (Suh et 
al., 1999). 
Reports that the J-domain alone is not sufficient to stimulate ATP hydrolysis, but 
requires the presence of either the G/F region or a substrate peptide raised the 
possibility that interaction of DnaJ with DnaK is bimodal (Karzai and McMacken 
1996; Mayer et al. 1999; Suh et al. 1999). NMR perturbation mapping has shown that 
helix II and the adjacent loop host a DnaK binding site (Greene et al., 1998). Using a 
biochemical and genetic approach, Suh et al., confirmed the presence of two binding 
sites for DnaJ on DnaK, one on the underside of the NBD in the cleft between the two 
NBD sub-domains and the other binding site at or near the PBD (Suh et al., 1998). 
Recently Jiang et al., reported the structure of auxillin’s J-domain in complex with the 
NBD+linker region of bovine Hsc70 (Jiang et al., 2007). The protein complex was 
stabilized by creating a disulphide bond through the substitution of the D876 of the J-
domain and R171 of the Hsc70 NBD with cysteines. These residues have been 
previously shown to interact in the DnaJ-DnaK complex (Jiang et al., 2007). The 
authors report that the interdomain linker is critical to propagate the J-domain 
activation of Hsc70 (Jiang et al., 2007). Structural studies have shown that a mutation 
in either the Hsc70 or DnaK interdomain linker reduces or abolishes the stimulatory 
effect of the J-domain (Jiang et al., 2005). In the cross linked structure, the J-domain 
binding deflects the linker towards a hydrophobic patch on the NBD and requires the 
displacement of the interaction between PBD and NBD, leaving the PBD free to bind 
to appropriate substrates (Jiang et al., 2007). The structure of the J-domain and Hsc70 
NBD provides interesting information about the structural mechanism of interaction 
between the HSP70 and HSP40 families. However this structural information is 
incomplete because the structural data has been obtained using crosslinked protein and 
may not be representative of the native state of the complex. 
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1.4. Aims  
A structure of the full length, unmodified Hsp70/Hsp40 complex is necessary to 
understand the full extent of domain rearrangements induced by the binding of Hsp40 
co-chaperone. A major constraint so far has been the inability to isolate a stable form 
of a complex of Hsp70 and Hsp40, which will allow meaningful structural and 
biochemical analysis of their interaction. The broad objective of this thesis was to 
therefore isolate a stable form of the Hsp70/Hsp40 protein complex and undertake 
structural studies on such a purified complex. 
This study aimed to achieve the following: 
 To develop a recombinant methodology for the expression and purification 
of the chaperone/co-chaperone complex using a bacterial system. 
 
 To characterise the behaviour of the recombinant complex on the basis of 
ATP-hydrolysis, substrate protection and polymerisation. 
 
 Structural investigation of isolated complex using x-ray crystallography 
and electron microscopy and biophysical investigation such as analytical 
ultracentrifugation. 
 
 
 
 
Page 34 
 
 
 
 
 
 
Chapter 2 
 
General Materials and Methods
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CHAPTER 2: Materials and Methods  
2.1 Materials 
2.1.1 General chemicals and reagents  
General chemicals such as magnesium chloride (MgCl2), sodium chloride (NaCl), 
potassium chloride (KCl) were purchased from Fisher, Acros or Sigma and were of 
reagent grade or higher. Isopropyl-β-D-thiogalactopyranoside (IPTG) and Dithiothreitol 
(DTT) was obtained from Melford Laboratories Ltd. All restriction enzymes and T4 DNA 
ligase were obtained from New England Biolabs (NEB), UK. Oligonucleotide primers for 
amplification were synthesized by Invitrogen, UK. Taq master mix used for Polymerase 
chain reaction (PCR) amplification was obtained from Promega, UK. The Ni-NTA resin 
was obtained from Qiagen, UK. ATP-agarose, Superdex-200 and Mono-Q resins were 
obtained from Sigma. All other common reagents used during the course of cloning, 
protein expression and purification experiments were purchased either from Sigma or 
Acros and were of reagent grade. 
2.1.2 Media 
2.1.2.1 Luria Bertani (LB) 
The composition of the medium (per litre) is as follows:  
Tryptone  10 g 
Yeast Extract   5 g 
Sodium Chloride  5 g    
The pH was adjusted to 7.4 before sterilisation by autoclaving. 
For LB agar (LA) plates, bacteriological agar was added to the media to a final 
concentration of 1.5% (w/v) before autoclaving. 
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2.1.3 Kits 
2.1.3.1 Molecular biology kits 
The following kits were used obtained from Qiagen, UK. The kits provide spin columns 
containing DNA affinity resin, buffers, and collection tubes for silica-membrane-based 
purification of DNA fragments.  
QIAquick PCR Purification Kits – for purification of DNA from PCR reaction mixes. 
The purification procedure removes primers, unused nucleotides, enzymes, mineral oil, 
salts, etc from the samples. PCR products purified using the kit can then be directly used 
for restriction digestion reactions. 
QIAquick Gel Extraction Kits – for the extraction and purification of DNA from agarose 
gels after enzymatic reactions. It is a silica-membrane-based purification of DNA 
fragments from gel slices (up to 400 mg slices). 
2.1.4 Bacterial strains   
The following E. coli strains were used during the course of this thesis: 
 
STRAIN  GENOTYPE SOURCE 
DH5α T1 
phage 
resistant cells 
F-, φ80dlacZ∆M15,∆ (lacZY- argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, mk+), 
phoA, supE44, λ-thi-1, gyrA96, relA1tonA 
Invitrogen, UK 
One Shot 
BL21(DE3) 
cells 
F– ompT gal dcm lon hsdSB (rB- mB- )λ 
(DE3 [lacI lacUV5-T7 gene 1 ind1sam7 
nin5]) 
Novagen, UK 
Table 2.1: The strains used in this study and their respective genotypes 
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2.1.4.1 Maintenance of bacterial strains 
Bacterial strains were maintained in glycerol solution for long-term storage at -80oC 
(Morrison, 1977). Using a wire loop, the desired bacterial cultures were streaked out onto 
LB agar plates and allowed to grow overnight at 37oC.  A single colony from such plates 
were grown overnight in 10 ml LB broth. Glycerol stocks were prepared the following 
morning by adding 15% (v/v) sterile glycerol to the cell culture. One ml aliquots were 
prepared and stored at -80oC. 
2.1.5 Vectors 
2.1.5.1 pGEM®-T Easy Vector  
The pGEM®-T Easy Vector System (Figure 2.1), purchased from Promega, is 3015 bp in 
size. It is prepared by cutting with EcoRV and with the addition of 3’ terminal thymidine 
to both ends provides a compatible overhang for PCR products generated by Taq 
polymerases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1:  pGEM®-T Easy Vector map (adapted from the pGEM®-T Easy Vector 
technical manual, Promega)   
  
This vector contains T7 and SP6 RNA polymerase regions for sequencing of PCR insertion regions. 
These flanking multiple cloning sites and α-peptide region labelled LacZ of β-galactosidase enzyme for 
blue and white colony screening. It also has an ampicillin resistance gene shown as (AmpR),) and f1 
origin of replication shown as (f1 ori). 
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2.1.5.2 pET-16b 
The pET-16b plasmid (Figure 2.2) is 5711 base pairs in size and is used for the cloning 
and expression of recombinant proteins in E. coli. The target genes are under the control 
of the strong bacteriophage T7 promoter and expression can be induced by isopropyl-β-D-
thiogalactopyranoside (IPTG), provided a source of T7 RNA polymerase under similar 
IPTG inducible control is in the host cell. The presence of an N-terminal His•Tag® 
sequence that is fused in frame with the cloned gene allows purification of the expressed 
protein by affinity chromatography. The pET-16b plasmid was purchased from Novagen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2:  pET-16b vector map (adapted from the Novagen technical manual) 
The pET-16b vector carries an ampicillin resistance gene (brown). The multiple cloning site (MCS) is 
shown in purple and carries three cloning sites (BamHI, NdeI and XhoI). The origin of replication (ori) and 
lac repressor gene (lacI) are shown on the vector. 
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2.1.5.3 pET-24a 
The pET-24a plasmid (Figure 2.3) is 5310 base pairs in size and has a kanamycin 
resistance gene as selectable marker. The pET-24a plasmid was obtained from Novagen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3:  pET-24a vector map (adapted from the Novagen technical manual. 
This vector has a kanamycin resistance gene as selectable marker. The multiple cloning site carries BamHI, 
NdeI and XhoI restriction sites. The origin of replication (ori), f1 origin of replication (f1 ori) and lac 
repressor gene (lacI) are shown on the vector. 
2.1.6 Antibodies 
Primary antibody 
Anti-Hsc70: Biotin conjugate monoclonal antibody (SPA-815B) was obtained from 
Stressgen, UK. The antibody was supplied at a concentration of 1 mg/ml. It was used at  a 
1:500 dilution in Western Blotting experiments. 
DnaK mouse monoclonal antibody (SPA 880D) was also obtained from Stressgen, UK. 
The antibody was supplied at a concentration of 1 mg/ml and used at a 1:1000 dilutions. 
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Secondary probes 
Horse radish peroxiase (HRP) conjugated streptavidin (Pierce) was used as secondary 
probe with Hsc70 primary antibody and used at a 1:10000 dilution.   
Anti-Mouse IgG (whole molecule)–peroxidase antibody produced in goat (Sigma) was 
used as secondary with the DnaK primary antibody at a 1:10000 dilution. 
2.2 Preparation of chemically competent cells 
Using a wire loop, bacteria from glycerol stocks of commercial competent cells were 
streaked out onto LB agar plates and allowed to grow overnight at 37oC. A single colony 
from this plate was grown overnight in 10 ml LB broth. The overnight culture was diluted 
1 in 100 into fresh LB media and grown at 37oC with shaking until it reached an 
absorbance, OD595 of 0.4 for E.coli DH5α cells and 0.5 for E.coli BL21(DE3) cells 
respectively. The cultures were then chilled on ice for 30 minutes. All subsequent 
procedures were carried out at 4oC. All buffers and materials used were sterilized by 
autoclaving and pre-chilled prior to use.  
The cells were centrifuged at 3,500 rpm for 7 min using a Sorvall SuperT100 centrifuge 
(Thermo Scientific, UK) SL250T rotor at 4oC. The pellets were gently re-suspended in 
100 mM ice-cold magnesium chloride (MgCl2). The volume of MgCl2 used was 25% of 
the culture volume (CuV). The cell suspensions were centrifuged at 3,500 rpm for 7 min 
and the cell pellet was again gently re-suspended in 50% CuV equivalent with 100 mM 
calcium chloride (CaCl2). The cell suspensions were incubated on ice for 30 min and 
pelleted as before. Finally, the cell pellets were re-suspended in 2% CuV of 100 mM 
CaCl2 plus 15% glycerol v/v. 50 µl aliquots were transferred into chilled, sterile 1.5 ml 
Eppendorf tubes and flash frozen in liquid nitrogen or on dry ice before being transferred 
to -80oC. 
2.3 Small-scale preparation of plasmid DNA 
Plasmid DNA extraction was performed according to the standard alkaline lysis mini prep 
protocol of Sambrook et al., (1989). A single colony of transformed E. coli cells was 
picked and grown in 10 ml of LB broth with appropriate antibiotic selection at 37oC 
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overnight in a shaking incubator. The cells were centrifuged for 10 minutes at 4,000 rpm 
in a Sorvall SuperT100 centrifuge using an SL250T rotor. The resulting pellet was 
resuspended in 250 µl of ice-cold Solution I (50 mM glucose, 25 mM Tris-HCl (pH 8), 10 
mM EDTA). The suspension was mixed well by vortexing and transferred to a sterile 
Eppendorf tube. In the next step, 250 µl of freshly prepared solution II (0.2 M sodium 
hydroxide (NaOH) and 1% w/v sodium dodecyl sulphate (SDS)) was added to the tube 
and mixed by inverting gently. Finally, 300 µL of ice-cold Solution III (3 M potassium 
acetate set to pH 5 with glacial acetic acid) was added to the tube and mixed well by 
inversion. The tubes were stored on ice for 3-5 minutes and then centrifuged at 13,000 
rpm for 12 minutes in a microfuge. To the supernatant an equal volume of 
phenol:chloroform (1:1) was added and then spun at 13,000 rpm for 10 minutes to achieve 
segregation of DNA from free proteins and cell debris. The top aqueous layer was 
transferred to a sterile fresh tube and DNA was precipitated by the addition of an equal 
volume of Isopropanol. The tube was then centrifuged at 13000 rpm for 20 minutes in a 
microfuge. The resultant DNA pellet was spun with ice cold 75% (v/v) ethanol for 5 
minutes at 13000 rpm. The supernatant was discarded and spun again for 1 minute to 
remove all traces of ethanol. The DNA pellet was either air dried at room temperature or 
dried at 37oC. The final pellet containing DNA was dissolved in 35 µl autoclaved distilled 
water and stored at -20oC until required.  
2.4 Separation of DNA by agarose gel electrophoresis 
DNA was routinely analysed on a 0.8% (w/v) agarose gel prepared by melting agarose in 
1X TAE Buffer (40 mM Tris-HCl, 1 mM EDTA and 20 mM acetic acid, and pH 8.2). 
Ethidium bromide (10 mg/ml stock) was added to the gel mix at a final concentration of 
0.5 µg/ml and the agarose was allowed to set in a sealed gel platform. DNA was mixed 
with 6X sample buffer (0.4% (w/v) orange G, 0.03% (w/v) bromophenol blue, 0.03% 
(w/v) xylene cyanol FF, 15% (w/v) Ficoll 400 in 1X TAE buffer) and loaded into the 
wells of the gel submerged in 1X TAE buffer. The samples were resolved for at least 40 
minutes at 100 V. The DNA fragments were detected using a UV Transilluminator (Ultra-
Violet Products Ltd, UK). Long wavelength UV light (315-400 nm) was used to analyse 
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the gel when the DNA was to be used for cloning purposes, and short wavelength UV 
light (200-280 nm) was used when photographic images of gel were taken.    
2.5 PCR amplification  
PCR reactions were usually set up using the Promega Taq Master Mix unless otherwise 
stated. The master mix contained: 50 U/ml Taq DNA polymerase (in Promega proprietary 
reaction buffer), 400 µM dATP, 400 µM dGTP, 400 µM dCTP, 400 µM dTTP and 3 mM 
MgCl2.  
 
 
 
 
 
 
 
Table 2.2: Components of the PCR reaction 
The components of the PCR reaction and their concentrations are listed in Table 2.2. The 
PCR reaction was overlaid with 50 µl of mineral oil (Sigma, UK) and the amplification 
was carried out in a DNA Thermal Cycler 480 (Perkin Elmer, UK). The amplification 
quality and size was confirmed by agarose gel electrophoresis of the product on a 0.8% 
agarose gel along with Promega’s 1 Kb DNA ladder. Amplified PCR products were 
purified using the Qiagen PCR purification kit according to the QIAquick DNA 
purification protocol (Qiagen). 
 Briefly, five volumes of Buffer PBI (the composition of the buffer is proprietary of 
Qiagen; contains guanidine hydrochloride and propan-2-ol) was added, the sample was 
mixed and applied to the QIAquick column and centrifuged at 16000 x g for 60 seconds. 
The flow through was discarded and the column washed with 750 µl of Buffer PE before 
centrifugation at 16000 x g for 60 seconds. The DNA sample was eluted from the column 
with 50 µl sterile distilled water.   
Component Final concentration 
PCR Master Mix (2X) 1X 
Primers (Forward and reverse primers) 10 µM each 
Template 3 ng 
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2.6 Restriction digestion 
2.6.1 Restriction digestion of PCR products and their purification  
Restriction digests were set up using the conditions recommended by the New England 
BioLab’s (NEB) technical manual. Typically the template was incubated with the 
appropriate restriction buffer (to a final concentration of 1X) and 10 U of each restriction 
enzyme and incubated at 37oC for 3-4 hrs. At the end of the incubation period, the 
digested PCR product was re-purified using the Qiagen PCR purification kit (as described 
in section 2.5) and finally eluted in 12-15 µl of water. The purified PCR product was used 
for the ligation reaction (see section 2.7). 
2.6.2 Restriction digestion and purification of vector DNA 
Vector DNA was extracted from a 10 ml overnight culture grown with the appropriate 
antibiotic. The plasmid extraction was performed by the alkaline lysis protocol as 
described in the section 2.4. Restriction digestion of the vector was carried out following 
the same protocol as that for the PCR product (section 2.6.1).  At the end of the incubation 
period 1 U of Calf Intestinal Phosphatase (CIP, NEB) was added to remove the terminal 
phosphate residues of the linear DNA and the reaction mixture was further incubated for 
30 minutes at 37oC. The digested vector was analysed on a 0.8% agarose gel and the 
fragment corresponding to size of vector was excised from the gel under a long 
wavelength UV transillumination and purified from the gel using the Qiagen Gel 
extraction kit according to manufacturer’s protocol.  
Briefly, to the DNA fragment excised from the gel, three volumes of Buffer QG (the 
composition of the buffer is proprietary of Qiagen; contains guanidine thiocyanate) was 
added and incubated at 50oC until the gel slice had dissolved. One gel volume of 
isopropanol was added and the sample was mixed. 800 µl of the sample was applied to the 
QIAquick column and centrifuged at 16000 x g for 60 seconds. The flow through was 
discarded and the column washed with 750 µl of Buffer PE before centrifugation at 16000 
x g for 60 seconds. The flow through was again discarded and the column centrifuged at 
16000 x g for 60 seconds to remove any residual buffer. The column was placed in a clean 
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1.5 ml eppendorf tube and the digested vector was eluted in 15-20 µl of sterile water and 
was used in subsequent ligation reactions. 
2.7 Ligation 
Usually a 10 µl ligation reaction was set up. The vector and insert were mixed at a ratio of 
1:3 along with T4 DNA ligase (NEB) and 1X ligase buffer and incubated either at room 
temperature for 4 hrs or overnight at 4oC. The reaction mixture was transformed into       
E. coli DH5α cells. 
2.8 Transformation protocol 
Chemically competent cells were transformed using the heat-shock methodology (Mandel 
and Higa, 1970). Briefly, 50 µl aliquots were gently thawed on ice for 5 min. 10 µl of 
ligation mixture or 1 µl of purified plasmid was added to the tubes which were incubated 
on ice for a further 30 minutes. The cells were heat-shocked at 42oC in a water bath for 60 
seconds and returned to ice for 5 minutes. LB media was added (0.5-1 ml) and the cells 
were incubated at 37oC for one hour and subsequently plated onto LB Agar plates 
containing the appropriate antibiotic.  
2.9 Confirmation of clones 
Plasmid DNA was isolated from transformed bacterial colonies (as described in section 
2.4) and positive clones were identified by restriction digest analysis of the isolated 
plasmid DNA (as described in section 2.6). The digestion reactions were analysed on a 
0.8% agarose gel along with Promega’s 1 Kb DNA ladder. Positive clones were identified 
by digestion products which yielded DNA fragments of the correct insert and vector size 
(compared with the DNA ladder). Clones were sequenced to confirm the lack of any 
undesirable mutations through a commercial arrangement with the Advanced 
Biotechnology Centre (ABC), Imperial College, UK. 
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2.10 Protein expression and purification  
2.10.1 Expression of recombinant proteins 
To study protein expression, the appropriate recombinant plasmids were transformed into 
E. coli BL21(DE3) cells and selected for, using drugs to which the E. coli host was now 
resistant. A single colony was grown overnight in LB broth plus antibiotics at 37oC in a 
shaking incubator at 250 rpm. The overnight culture was used as an inoculum into fresh 
LB medium (plus antibiotics) which was then grown at 37oC until an OD595 of 0.6-0.8. 
Protein expression was induced by the addition of IPTG to a final concentration of 0.4 
mM and growth was continued for a further 3 hrs at 37oC. The induced cells were 
harvested via centrifugation with a Sorvall Super T21 centrifuge and SL250T rotor at 
6,000 rpm for 15 minutes at 4oC. The supernatant was discarded and the pellet was re-
suspended in lysis buffer and stored at -80oC until required. The lysis buffer composition 
specific for each protein, depending on the chromatography being employed, is described 
in the subsequent chapters. 
2.10.2 Purification of poly-histidine tagged proteins 
All purification procedures were performed at 4oC. Lysozyme and phenylmethylsulphonyl 
fluoride (PMSF) were added to the thawed cell pellet to a final concentration of 2.0 µg/ml 
and 100 mM respectively in lysis buffer. The lysis buffer composition specific for each 
protein has been described in the subsequent chapters. The cell lysate was disrupted by 
sonication (6 x 30 seconds ON cycles, Status 200, MS73 probe set to 40% maximum 
power output). The cell debris was removed by centrifugation at 18,000 rpm for 45 
minutes at 4oC with a Sorvall Super T21 centrifuge and SL50T rotor. The soluble, 
supernatant fraction was applied to a 4 ml nickel-nitrilotriacetic acid (Ni-NTA) agarose 
column pre-equilibrated with the lysis buffer. The column was washed with 5 column 
volumes of lysis buffer and again with 5 column volumes of lysis buffer containing 30 
mM imidazole. The protein was eluted with 3 column volumes of lysis buffer containing 
200 mM imidazole. The elution profiles of the recombinant proteins were analysed by 
12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). 
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2.10.3 Ion exchange chromatography 
The protein fractions eluting from the Ni-NTA column with 200 mM imidazole were 
diluted to 25 mM NaCl using dilution buffer (50 mM Tris-HCl, pH 8.0) and were applied 
to a 20 ml Q sepharose column (Sigma). The column was pre-equilibrated with 
equilibration buffer (50 mM Tris-HCl pH 8.0, 25 mM NaCl and 5% (v/v) glycerol). The 
resin was next washed with 2 column volumes of equilibration buffer. The protein was 
step eluted with equilibration buffer containing 100, 250, 500 and 1000 mM NaCl. The 
elution profile was monitored by SDS-PAGE.   
2.10.4 Size exclusion chromatography 
The recombinant proteins were evaluated by gel filtration chromatography. A 90 ml 
Superdex 200 column (exclusion limit of 600 kDA, purchased from Sigma, UK) was 
packed in house. The chromatography was performed at 4oC with 20 mM Tris-HCl pH 8.0 
plus 100 mM potassium chloride. The molecular weight standards (obtained from Sigma) 
used for calibrating the column are tabulated in Table 2.3 
The void volume was determined using blue dextran and was found to be 36 ml. The 
protein sample was applied to the column pre-equilibrated with two column volumes of 
gel filtration buffer. The gel filtration buffer composition specific for each protein is 
described in the subsequent chapters. The sample volume was usually concentrated down 
to less than 2% of the column volume using 30 kDa molecular weight cut off centricon 
(YM-30, Millipore). One ml fractions were collected from after the void volume. The 
fractions were analysed for protein content using a Bradford assay (described in section 
2.10.6) and a graphical plot of the absorbance on the y-axis versus the elution volume on 
the x-axis was used as a representation of the chromatogram. The protein peak fractions 
(determined by Bradford assay) were analysed by SDS-PAGE electrophoresis. 
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Table 2.3: Standard proteins used for calibrating the gel filtration chromatography 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Calibration curve of the Superdex 200 size exclusion column.  
The chromatography was performed as described using the standard proteins listed in table 2.4.  A 
calibration curve using partition coefficient (kav) versus the logarithm of the protein molecular weight 
was prepared. The partition coefficient was calculated using the formula Kav = Ve-Vo/ Vt-Vo where Ve 
= elution volume of the protein, Vo = void volume of the column and Vt is the total bed volume.  
2.10.5 SDS polyacrylamide gel electrophoresis 
Protein samples were resolved using a modification of the standard method (Laemmli, 
1970). The Mini-Protean® 3 Cell electrophoresis unit (Bio-Rad, UK) was used for 
running the gels. Generally a 12% separating gel and a 4% stacking gel were used. The 
Standard protein Molecular weight in kDa 
Porcine thyroglobulin 660 
β-amylase 200 
Alcohol dehydrogenase 150 
Bovine serum albumin 66, 132 
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reagent compositions of the 12% separating gel and 4% stacking gel are tabulated in 
Tables 2.4 and Table 2.5 respectively.  
Reagent Volume (ml) 
Sterile distilled water 4.3 
1.5 M Tris-HCl (pH 8.8) 2.5 
10% sodium dodecyl sulphate 0.1 
40% acrylamide/bisacrylamide (29:1) 3 
10% ammonium persulphate 0.1 
TEMED 0.01 
Total volume = ~10 ml 
Table 2.4: Composition of 12% separating gel 
Reagent Volume (ml) 
Sterile distilled water 3.1 
0.5 M Tris-HCl (pH 6.8) 1.25 
10% sodium dodecyl sulphate 0.05 
40% acrylamide/bisacrylamide (29:1) 0.5 
10% ammonium persulphate 0.05 
TEMED 0.005 
Total volume = ~5.0 ml 
Table 2.5: Composition of 4.0% stacking gel 
Samples were prepared in 4X SDS-PAGE sample buffer (0.0625 M Tris-HCl, pH 6.8, 
10% glycerol (v/v), 2% SDS (w/v), 5% β-mercaptoethanol (v/v), 0.05% bromophenol blue 
(w/v)) and boiled for 5 minutes in a heating block set to 95oC. The gel was run in 1X 
SDS-PAGE gel running buffer (10X SDS-PAGE gel running buffer 0.25 M Tris base, 
1.92 M glycine and 1% SDS (w/v)). The samples were resolved at 200V until the blue dye 
front had reached the end of the gel plates. The gel was then stained with Coomassie 
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staining solution (90% water, 10% glacial acetic acid (v/v) and 0.25% Coomassie Brilliant 
Blue R350 (w/v)) and then destained with (40% methanol (v/v), 50% water and 10% 
glacial acetic acid (v/v)).   
2.10.6 Determination of protein concentration  
Protein concentrations were determined using a Bradford assay (Bradford, 1976). 
Bradford reagent was commercially purchased from Bio-Rad, UK. The assay was 
performed in 1 ml reactions as follows. 200 µl of Bradford reagent was added to the 
sample (usually 5 µl) and the volume was made up to 1 ml with water or appropriate 
sample buffer. The reaction was incubated for 5 min at room temperature and the 
absorbance was read at 595 nm using a NovaSpec II Spectrophotometer, (GE Healthcare, 
UK). The protein concentration was estimated from a standard curve plotted using the 
absorbance values obtained for 1-5 µg of BSA.   
2.10.7 Dot blot protocol 
First, the nitrocellulose membrane was soaked in TBS-T buffer (10 mM Tris-HCl,        
150 mM NaCl, 0.05% Tween-20 (v/v), pH 8.0) for 1 min. Then 2 µl of the protein sample 
was spotted onto the membrane. To minimise the area that the solution penetrated the 
protein spot was allowed to dry and if necessary more sample was applied. The membrane 
was allowed to dry and then stained with 0.2% (w/v) Ponceau S in 10% (v/v) acetic acid 
for 1 min to visualise the protein samples. Non-specific sites were blocked in 5% (w/v) 
BSA in TBS-T for 2 hrs at room temperature. The membrane was next incubated with 
primary antibody (either anti-DnaK or anti-Hsc70) diluted in TBS-T (dilution factor 
mentioned in section 2.1.6) for 2 hours at room temperature. At the end of the incubation 
the membrane was given three, five minute washes with TBS-T and then probed with the 
secondary antibody conjugated with HRP by incubating at room temperature for 30 min 
with shaking. The membrane was then washed three times with TBS-T (15 min once and 
5 min twice). The bands were visualised using 3 ml of 3,3′,5,5′-Tetramethylbenzidine 
(TMB) Liquid Substrate System (Sigma-Aldrich, UK).  
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CHAPTER 3: Isolation of the Hsc70/HSJ1b complex  
3.1 Introduction 
Extensive biochemical analyses have been carried out to understand the interactions of 
the chaperone and co-chaperone proteins using various Hsp70/Hsp40 model systems, 
such as the E. coli DnaK/DnaJ proteins (Laufen et al., 1999), the human Hsc70/HDJ1 
proteins (Minami et al., 1996) and the S. cerevisiae Ssa1p/YDJ1p proteins (Cyr et al., 
1992). In this study, we have worked with the human Hsc70 - the constitutively 
expressed member of the Hsp70 family and the human Hsp40 homologue-HSJ1b 
protein. Hsc70 has been reported to facilitate protein folding and is also involved in 
normal cellular process such as protein assembly and translocation (Kiang and Tsokos, 
1998; Meimaridou et al., 2009). Hsc70 also ensures that damaged proteins are 
subjected to degradation, either by the ubiquitin-proteosome system (UPS) or via the 
lysosomal degradation machinery (Majeski & Dice, 2004). The Hsc70 protein along 
with the HSJ1b co-chaperone protein has been directly implicated in the sorting of 
ubiquitylated client proteins into the proteosomal degradation pathway (Chapple et al., 
2004). HSJ1b is the larger isoform of the neuronally enriched HSJ1 family of proteins. 
HSJ1 proteins have been reported to regulate the ATPase and substrate binding 
activities of the Hsc70 protein (Chapple & Cheetham, 2003). It is a type II Hsp40 
protein, and is targeted to the cytoplasmic face of the ER and also undergoes 
prenylation (Chapple & Cheetham, 2003). Other than the conserved J-domain, the 
protein is also characterised by the presence of ubiquitin-interacting motifs (UIM) 
(Westhoff et al., 2005). The interaction of the Hsc70 and HSJ1b co-chaperone is 
thought to exemplify the co-operation between the chaperone and the UPS, a crucial 
aspect for protein quality control (Gao and Hu, 2008). The Hsc70/HSJ1b protein 
complex was therefore an interesting chaperone/co-chaperone model system to use in 
our study.  
Most often Hsp70/Hsp40 complexes have been studied by combining the two 
individually purified proteins in molar ratios and in the presence of ATP. Using the 
above approach, Minami et al., (1996) have successfully shown the formation of a 
ternary complex between Hsc70, Hsp40 and denatured substrate. Therefore, our initial 
plan was to purify the individual full length Hsc70 and HSJ1b proteins separately and 
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then mix the two homogenous proteins in appropriate molar ratios in the presence and 
absence of various substrates and ATP analogues for crystallisation trials. However 
this presented us with enormous permutations and combinations, and hitting upon the 
correct molar proportions required for crystallisation was not guaranteed. This problem 
was highlighted by Jiang et al., who reported the structure of auxillin’s J-domain in 
complex with the NBD+linker region of bovine Hsc70 (Jiang et al., 2007). Preliminary 
crystallisation trials set up by mixing the purified Hsc70 NBD+linker region and 
auxillin’s J-domain in the presence of various co-factors only yielded crystals of the 
individual proteins. Crystals of the complex were obtained only after mutating the 
residues D876 of the J-domain and R171 of the Hsc70 NBD into cysteines, thereby 
cross linking the complex via disulphide bond formation (Jiang et al., 2007). Thus a 
primary hurdle towards better structural understanding of chaperone/ co-chaperone 
interaction lies in the isolation of a stable Hsp70/Hsp40 protein complex, and this is 
the focus of the study described in Chapter 3.  
In this chapter we describe the work carried out towards developing and executing an 
alternative strategy for the isolation of an intact Hsp70/Hsp40 protein complex. A dual 
plasmid co-expression system was used, wherein, two plasmids differing in their 
antibiotic resistance were expressed simultaneously by the bacterial cells, instead of a 
single plasmid used in conventional expression systems. For this purpose the 
individual Hsc70 and HSJ1b genes were cloned into appropriate expression vectors, 
protein expression was induced using IPTG in a bacterial system and the Hsc70/HSJ1b 
complex successfully isolated by Ni-NTA chromatography. The relevant experimental 
work carried out to achieve these results is presented in the following sections.  
.
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3.2 Materials and Method 
3.2.1 PCR amplification of Human Hsc70 and HSJ1b genes 
Hsc70 gene was amplified using cDNA prepared from HB4a cells (Normal breast 
epithelial cell line) as template (cDNA kindly provided by, Dr. Anatoily Markiv from 
University of Westminster, UK). Full length human HSJ1b was amplified using a   
pET-14b_HSJ1b plasmid template obtained from Dr. Blatch from Rhodes University, 
SA. Primers were designed complimentary to the coding sequence of the respective 
genes. The primers for amplification of the Hsc70 and HSJ1b genes were obtained 
from Invitrogen and were diluted to the required concentration (10 µM, Table 3.1). 
Restriction sites were also designed into the primers as shown in Table 3.1.  
Gene  Primers (5’-3’) Restriction 
enzyme 
Product 
size 
Hsc70Fwd GGATTCCATATGTCCAAGGGACTGCAGTTGG NdeI  
1.941 
Kbps Hsc70Rev GATCGGATCCTTAATCAACCTCTTCAATGGT 
GG 
BamHI 
HSJ1bFwd GATCGGATCCCATGGCATCCTACTACGAGAT 
CCTAGACG 
BamHI  
975 bp 
HSJ1bRev GATCAAGCTTTCAGAGGATGAGGCAGCGAG 
AGG 
HindIII 
Table 3.1: Primer design, restriction sites and PCR product size for Hsc70 and HSJ1b genes. 
Base pairs underlined and highlighted in red indicate the restriction endonuclease recognition sequence 
introduced into the primers to enable directional cloning of the PCR products. 
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PCR conditions 
The parameters used for the PCR amplification reactions for the human Hsc70 and 
HSJ1b genes are listed in Table 3.2 
Table 3.2: PCR conditions for the amplification of the Human Hsc70 and HSJ1b genes 
3.2.2 Insertion of Hsc70 into pGEM-T vector 
The Hsc70 gene was initially cloned into the TA cloning vector, pGEM-T. The PCR 
product, purified using the QIAquick PCR purification kit, was ligated directly into the 
pGEM-T vector. The ligation reaction was incubated for 4 hours at room temperature 
and transformed into E. coli DH5α cells using the protocol described in Chapter 2. The 
transformed cells were plated onto LB agar plates containing 100 µg/ml ampicillin, 0.5 
mM isopropyl-β-D-thiogalactopyranoside (IPTG) and 80 µg/ml X-Gal to allow for 
blue/white colony selection. White colonies were screened for positive clones. Cells 
were grown overnight and plasmids extracted using alkaline lysis (described in Section 
2.3, Chapter 2). Clones were confirmed by restriction digestion of the extracted 
plasmid. The plasmid generated in the pGEM-T vector will be henceforth referred as 
pGEMt-Hsc70. 
3.2.3 Generation of pET-16b-Hsc70 and pET-16b-HSJ1b 
constructs  
The Hsc70 and HSJ1b genes were cloned into the pET-16b bacterial expression vector. 
The pET-16b DNA was extracted from a 10 ml overnight culture grown with 100 
µg/ml of ampicillin using alkaline lysis (Sambrook et al., 1989). The vector was 
prepared for ligation as described in Chapter 2. First, the purified plasmid DNA was 
Segment Number of cycles Temperature (oC) Time 
Initial Denaturation 1 95 1 minute 
Denaturation, primer 
annealing  and 
extension 
30 95 
60 
72 
1 minute 
1 minute 
2 minutes for Hsc70 
1 minute for HSJ1b 
Final extension 1 72 7 minutes 
Final Hold 1 4 Indefinite 
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digested with restriction endonucleases compatible with the sites present on the 
corresponding PCR product and incubated for 3-4 hrs at 37oC. At the end of the 
incubation period 1U of CIP was added for the removal of the terminal phosphate 
residues and the reaction mixture was further incubated for 30 minutes. The digested 
vector was analysed on a 0.8% agarose gel and the 5.7 Kb fragment (corresponding to 
size of digested pET-16b vector) was extracted from the gel and purified using 
Qiagen’s Gel purification kit. The digested and CIP treated vector was finally eluted in 
15-20 µl of water.  
The HSJ1b PCR product was prepared for ligation as described in Chapter 2. Briefly, 
the PCR product was purified using Qiagen’s PCR purification kit, digested with 
BamHI and HindIII enzymes and re-purified using the same PCR purification kit prior 
to ligation. Similarly the Hsc70 insert was obtained by restriction digestion of the 
confirmed pGEMt-Hsc70 plasmid with BamHI and NdeI enzymes and then gel 
purified from a 0.8% agarose gel purified using Qiagen’s Gel purification kit.  
The vector and insert were ligated together at a ratio of 1:3 and transformed into E.coli 
DH5α cells using protocols previously described in Chapter 2. Clones were confirmed 
by restriction digest analysis of plasmid DNA isolated by alkaline lysis from 
transformed colonies (protocol described in Chapter 2). The sequence of the obtained 
pET-16b-Hsc70 and pET-16b-HSJ1b plasmids were confirmed by sequencing the 
plasmids at the Advanced Biotechnology Centre (ABC), Imperial College, UK. 
3.2.4 Generation of pET-24a-HSJ1b construct  
To generate the pET-24a-HSJ1b construct, the HSJ1b insert was obtained by 
restriction digestion of the pET-16b-HSJ1b clone with BamHI and HindIII restriction 
enzymes. The pET-24a DNA was purified by the alkaline lysis method and was 
prepared for ligation by digestion with BamHI and HindIII (refer to Chapter 2). The 
insert and vector were ligated as previously described (3.2.3) and transformed into 
E.coli DH5α cells. The identities of the constructs were confirmed by sequencing the 
plasmid at the Advanced Biotechnology Centre (ABC; Imperial College, London). 
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3.2.5 Co-transformation of Hsc70/HSJ1b plasmids 
Plasmids pET-16b-Hsc70 and pET-24a-HSJ1b vector were co-transformed into the    
E. coli expression strain BL21(DE3). The transformation protocol described in Chapter 
2, section 2.8 was followed. Both plasmids were added in equal amounts to the 
competent cells. The transformed cells were plated onto LB agar containing 50 µg/ml 
of ampicillin and 25 µg/ml kanamycin and incubated overnight at 37oC.  
3.2.6 Confirmation of plasmid stability by colony PCR 
Individual BL21(DE3) colonies transformed with pET-16b-Hsc70 and pET-24a-
HSJ1b plasmids were picked using sterile 10 µl pipette tips and suspended in 10 µl 
sterilised distilled water. 1 µl of the bacterial suspension was used as a template and 
two amplification reactions were set up for each colony; one with Hsc70 specific 
primers and other with HSJ1b specific primers. PCR reactions were set up as described 
in section 2.5 and the amplification conditions were the same as those described in 
Table 3.2. The results of the amplification was analysed on a 0.8% agarose gel. 
3.2.7 Expression studies 
Over-expression of Hsc70 and HSJ1b  
Small-scale expression studies were carried out with 10 ml of LB broth. Individual 
Hsc70 and HSJ1b proteins were expressed using the pET-16b-Hsc70 and pET-24a-
HSJ1b plasmids. The individual plasmids were transformed into BL21(DE3) cells.  A 
single colony was used for overnight inoculation into LB broth containing 100 µg/ml 
of ampicillin or 50 µg/ml kanamycin and grown at 37oC. 10 ml LB was inoculated with 
a 1 in 100 dilution of the overnight culture. Cells were grown at 37oC to an OD595 of 0.6-
0.8. Protein expression was induced by the addition of IPTG to a final concentration of 
0.4 mM. After induction, cells were grown for a further 3 hrs. The cells were harvested 
via centrifugation as described Chapter 2, section 2.10.1. The supernatant was 
discarded and the cell pellet was re-suspended in 200 µl of 1X SDS-PAGE sample 
buffer. The expression profile of the recombinant proteins was analysed on a 12% 
SDS-PAGE gel. The samples were boiled at 95oC for 15 minutes and 10 µl of each 
sample was loaded on the gel. 
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Co-expression of Hsc70/HSJ1b  
Growth and induction for the Human Hsc70/HSJ1b complex was carried out using the 
protocol described in Chapter 2, section 2.10.1. Plasmids, pET-16b-Hsc70 and pET-
24a-HSJ1b were co-transformed into BL21(DE3) cells and grown in the presence of 
ampicillin at a concentration of 50 µg/ml and kanamycin at 25 µg/ml concentrations. 
Small-scale expression studies were carried out with 10 ml cultures and the expression 
profile analysed as described in previously for Hsc70 and HSJ1b. For large scale 
production, the culture volume was scaled up to 2 l. The cells were harvested via 
centrifugation as described in Chapter 2, section 2.10.1, using a Sorvall Super T21 
centrifuge and SL250T rotor at 6,000 rpm for 15 minutes at 4oC. The supernatant was 
discarded and cell pellet was re-suspended in the lysis buffer (50 mM Tris-HCl pH 8.0, 
100 mM NaCl and 5 mM imidazole) and stored at -80oC until required for purification.  
3.2.8 Ni-NTA purification  
All purification procedures were performed at 4oC. Purification of the recombinant 
was performed following the protocol for the purification of poly histidine tagged 
proteins described in Section 2.10.2 in Chapter 2. Briefly, the re-suspended cell pellet 
was lysed by sonication (6 x 30 seconds ON cycles, Status 200, MS73 probe set to 
40% maximum power output), followed by centrifugation at 18,000 rpm for 45 min at 
4oC. The lysate was applied to pre-equilibrated Ni-NTA resin and the protein was 
eluted with lysis buffer containing 200 mM imidazole (Chapter 2; 2.10.2).  The elution 
profiles of the recombinant proteins were analysed on a 12% SDS-PAGE gel. 
3.2.9 Ion Exchange chromatography 
Ion exchange chromatography was performed as described in chapter 2, section 2.10.3. 
The Hsc70/HSJ1b complex fractions from the Ni-NTA column containing 200 mM 
imidazole were diluted to 25 mM NaCl using dilution buffer (50 mM Tris-HCl, pH 
8.0) and were applied to a pre-equilibrated 20 ml Q sepharose column (Sigma). The 
resin was washed with 2 column volumes (CV) of equilibration buffer and the protein 
step eluted with 100, 250, 500 and 1000 mM NaCl. The elution profile was monitored 
by SDS-PAGE.   
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3.2.10 ATP-agarose chromatography 
ATP-agarose chromatography was performed by following a protocol modified from 
Ménoret (2003). The ATP-agarose slurry (Sigma) was prepared according to the 
manufacturer’s protocol. A 5 ml column was packed and washed with 10 CV of 
equilibration buffer (20 mM Tris-HCl pH 8.0, 20 mM NaCl, 15 mM β-
Mercaptoethanol and 3 mM MgCl2). The Hsc70/HSJ1b elution fraction from Ni-NTA 
chromatography was diluted in 20 mM Tris-HCl pH 8.0, 15 mM β-Mercaptoethanol 
and 3 mM MgCl2 to bring down the final concentration of NaCl in the sample to 25 
mM. The protein was loaded onto the column and washed with 5 CV of equilibration 
buffer. The agarose was incubated in elution buffer (20 mM Tris-HCl pH 8.0, 20 mM 
NaCl, 15 mM β-Mercaptoethanol, 3 mM MgCl2 plus 3 mM ATP) for 30 minutes 
before the fractions were collected. The elution profile was monitored by SDS-PAGE 
analysis. 
3.2.11 2-Dimensional analysis  
3.2.11.1 IEF/SDS-PAGE analysis  
First dimension: Isoelectric focusing 
Protein samples were dialysed against water at 4oC overnight. A 10 µg aliquot of the 
protein was then mixed with rehydration buffer (6 M urea, 2M thiourea, 0.5% (w/v) 
CHAPS, 0.4% (w/v) DTT, 0.5% Pharmalyte 3-10) to give a final volume of 120 µl. 
The mixture was loaded on a 7cm IPG strip pH 3-10 (Bio-Rad) using a re-swelling 
tray (Amersham Biosciences). The strip was rehydrated overnight at room temperature 
according to the method described by Görg et al. (2004).  Isoelectric focusing was 
carried out on the following day using the Multiphor II apparatus (Pharmacia 
BIOTECH.) as described in the handbook of 2-D electrophoresis (GE Healthcare, 
2004). Briefly, focussing was performed at 20°C under the following conditions: 300V 
for 30 min; 600V for 45 min; 3500V for 2 hours and 45 minutes using an Amersham 
EPS 3501 power pack. After focussing the IPG strip was stored at -80oC until analysed 
by SDS-PAGE. 
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Second dimension: SDS-PAGE 
In the second dimension, the focussed strips were equilibrated for 15min in 50 mM 
Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 1% (w/v) DTT for 15 
min in 50 mM Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 2.5% 
(w/v) iodoacetamide. Equilibrated strips were loaded onto a 12% acrylamide gel, 
covered with sealing buffer (0.5%  (w/v) agarose, 25 mM Tris-Base, 192 mM glycine, 
0.1% (w/v) SDS, trace of bromophenol blue) and run at 150 V in running buffer (25 
mM Tris, 192 mM Glycine, 0.1% (w/v) SDS). 
3.2.11.2 Native/SDS-PAGE analysis 
First dimension: Native PAGE 
In the first dimension, protein samples were separated on an 8% native gel. The 
composition for an 8% native gel is shown in Table 3.3. The gel comprised solely of 
the separating layer and did not have a stacking layer. The gels were resolved using a 
Mini-Protean® 3 Cell electrophoresis unit (Bio-Rad, UK). 
 
 
 
 
 
 
Table 3.3: Composition of 8% native gel 
Protein samples were prepared in 4X Native-PAGE sample buffer (0.0625 M Tris-
HCl, pH 6.8, 10% (v/v) glycerol and 0.05% (w/v) bromophenol blue) and were loaded 
without boiling at 95oC to avoid denaturation. The gel was run in 1X Native-PAGE gel 
running buffer (25 mM Tris base and 192 mM glycine). The samples were resolved at 
100V at 4oC until the blue dye front had reached the end of the gel plates. 
 
Reagent Volume (ml) 
Sterile distilled water 5.3 
1.5 M Tris-HCl (pH 8.8) 2.6 
40% Acrylamide/Bis acrylamide (29:1) 2 
10% ammonium persulphate 0.1 
TEMED 0.01 
Total volume = 10.0 ml  
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Second dimension: SDS-PAGE 
For the second dimension, the lanes carrying the protein sample was cut from the 
native gel. It was equilibrated in 1X SDS-PAGE sample buffer for 15 minutes at room 
temperature. The equilibrated strip was loaded onto a 12% acrylamide gel and run at 
150 V in running buffer (25 mM Tris, 192 mM Glycine, 0.1% (w/v) SDS). 
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3.3 Results 
A co-expression system was used for the isolation of recombinant Hsc70/HSJ1b 
proteins expressed and purified from E. coli. The experimental strategy involved in 
this chapter has been outlined in Figure 3.1. The work described in this chapter was 
divided into two stages. In stage 1, the Hsc70 and HSJ1b genes are both individually 
cloned into the pET-16b vectors. Since the proteins will be expressed with a histidine 
tag, these clones were used to purify the individual Hsc70 and HSJ1b proteins using 
Ni-NTA chromatography, and, this will be discussed in Chapter 5. We then proceeded 
to use these clones in stage 2 of the experiment, which was the development of the co-
expression system. In this system, two plasmids differing in their antibiotic resistance 
are expressed simultaneously by the bacterial cells, instead of a single plasmid used in 
conventional expression systems. For this purpose, the HSJ1b gene was sub-cloned 
into the pET-24a vector and used in conjunction with Hsc70 cloned into the pET-16b 
vector. Though the two carry incompatible origins, they carry different antibiotic 
resistance genes – ampicillin in pET-16b and kanamycin in pET-24a. Purification of 
the complex was performed by affinity chromatography over Ni-NTA resin. The 
individual steps are described in detail in the following sections.  
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Figure 3.1: Experimental design for the co-expression studies. 
A flow chart listing step-by-step the methodologies followed to establish co-expression system for the 
expression and purification of the Hsc70/HSJ1b complex from E. coli. 
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3.3.1 Cloning of the Hsc70 gene 
3.3.1.1 PCR amplification of Hsc70 
The nucleotide sequence of the Homo sapiens Hsc70 ORF (1-1941 bp) was obtained 
from the NCBI database (accession number NM_006597). Primers complementary to 
the 5’ and 3’ ends of the nucleotide sequence of the polypeptide were designed 
(sequences given in section 3.2.1). cDNA prepared from HB4a cells was used as a 
template for amplification of the Hsc70 gene by PCR. The amplification reaction was 
successful and the product was consistent with the expected size for the Hsc70 gene of 
1941 bp when analysed by electrophoresis (Figure 3.2). The Hsc70 PCR product was 
subjected to a confirmative restriction digest. HindIII cleavage occurs at positions 337 
and 1043 in the coding sequence and releases fragments sized 337 bp, 706 bp and 897 
bp respectively. Figure 3.2 shows the results of this HindIII restriction digestion 
reaction. Lane 1 is the undigested PCR product and lane 3 clearly shows the expected 
706 bp and 897 bp products however the 337 bp band is much fainter and cannot be 
clearly identified.  
  
 
 
 
 
 
 
 
 
 
Figure 3.2: Diagnostic restriction analysis of Hsc70 PCR product 
10 µl of the PCR product was subjected to restriction digestion by HindIII. The digestion products were 
analysed on a 0.8% agarose gel along with 10 µl of undigested PCR product for comparison. . The DNA 
was visualised by staining with ethidium bromide at 0.5 ug/ml and photographed under UV 
illumination.  Lane 1 contains 10 µl of the undigested PCR product, lane 2 is a blank lane, lane 3 
contains HindIII digested PCR product and lane 4 contains 6 µl of Promega 1Kb DNA Ladder 
(molecular weight marker). 
1 2 3 4 
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3.3.1.2 Insertion of the Hsc70 gene into pGEM-T vector 
Despite repeated attempts, ligation of Hsc70 gene directly into the pET-16b vector was 
unsuccessful. Therefore cloning of the gene into pGEM-T vector was undertaken. The 
pGEM-T vector is a TA-cloning vector system and the vector (from Promega) is 
supplied with a 5’ ‘T’ (thymine) overhang. This complements with the ‘A’ (adenine) 
overhang introduced into the PCR product by the Taq polymerase. The ‘TA’ 
complementation increases the ligation efficiency allowing the purified PCR product 
of Hsc70 to be directly ligated into the pGEM-T vector. Screening of colonies in 
pGEM-T was based on blue-white colony selection. The vector carries the lac-Z gene 
for the production of beta-galactosidase which converts the chemical substrate X-gal 
into a blue coloured product. The presence of the foreign gene insert disrupts the 
activity and function of the enzyme which is observed as a white bacterial colony. 
Plasmid DNA extracted from overnight E. coli cultures grown by inoculating selected 
white colonies was digested with the enzymes NdeI and BamHI. Digestion of the 
pGEM-T clones that contain the human Hsc70 gene yield yielded two fragments; a 
3000 bp product which is the size of the pGEM-T vector and a 1941 bp product which 
is the expected size of the Hsc70 gene (see lane 2, Figure 3.3). 
 
 
 
 
 
 
 
 
 
Figure 3.3: Restriction digest analysis of an Hsc70 clone in pGEM-T vector. 
Single white colonies were inoculated into LB broth and grown overnight with ampicillin. Plasmid 
DNA was extracted by alkaline lysis, 15 µl of which was used for restriction digestion by NdeI and 
BamHI enzymes and visualized on a 0.8% agarose gel. The DNA was visualised by staining with 
ethidium bromide at 0.5 ug/ml and photographed under UV illumination. Lane 1 is the undigested 
plasmid, lane 2 contains NdeI and BamHI digested plasmid DNA and lane 3 contains 6 µl of Promega 
1Kb DNA Ladder (molecular weight marker). 
1 
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Panel A 
 
Panel B 
 
3.3.1.3 Insertion of Hsc70 into pET-16b 
In order to over-express the Hsc70 protein in E. coli, the gene was sub-cloned from the 
pGEM-T vector into the pET-16b bacterial expression vector. Panel A in Figure 3.4 
shows the cloning region on the pET-16b vector. The 10X His Tag (pink box in Figure 
3.4) allows for the affinity purification of the expressed protein and the downstream 
Factor Xa protease cleavage site allows for the removal of the tag and release of the 
protein in its native form, if required.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Insertion of Hsc70 into pET-16b. 
Panel A) The pET-16b vector cloning region. This figure illustrates the region on the pET-16b vector 
which codes for the Histidine tag (pink box), the Factor Xa protease cleavage site and also the multiple 
cloning sites (MCS) (blue box) of the vector. 
Panel B) Confirmation of Hsc70 gene into the pET-16b vector. Plasmid DNA from a number of 
representative clones was digested with NdeI and BamHI enzymes and electrophoresed through a 0.8% 
agarose gel. The DNA was visualised by staining with ethidium bromide at 0.5 ug/ml and photographed 
under UV illumination. Lane 1, 6 µl Promega 1Kb DNA ladder molecular weight marker, lanes 2-6 
shows NdeI/BamHI digested plasmid DNA.  
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The gene was inserted between the NdeI and BamHI restriction sites of the pET-16b 
vector to generate the pET-16b-Hsc70 plasmid. The total size of the pET-16b plasmid 
containing the vector and Hsc70 insert was 7652 bp, with the vector accounting for 
5711 bp and the gene 1941 bp. Plasmid DNA from a number clones was subjected to 
restriction digestion and analysed on an agarose gel to confirm the presence of the 
Hsc70 gene (see Panel B, Figure 3.4). Lane 2, 3, 5 and 6 in Figure 3.4 shows the 
successful release of the expected 1941 bp insert. Also, an additional band running 
higher than 5600 bp in lanes 3, 5 and 6 can be observed. This is probably due to 
incomplete digestion of the plasmid and is therefore running slower than the remaining 
fragments. The variable digestion observed could be due to inequality in the amounts 
of plasmid used for restriction digestion. Lane 4 shows no insert release and appears to 
run at the same position as digested pET-16b vector at 5711bp (compared with the 
other lanes of the gel) suggesting that this is a wild type plasmid that has probably 
arisen from the re-ligation of the vector.  
3.3.2 Cloning of the HSJ1b gene 
A plasmid carrying the HSJ1b gene was kindly provided by Professor Greg Blatch 
(Rhodes University, Republic of South Africa). Since the gene was already in a 
bacterial expression vector, pET-14b, expression studies were undertaken directly with 
the provided plasmid using E. coli BL21(DE3) cells. However no expression was 
observed (data not shown) and when the plasmid was subjected to a diagnostic 
restriction digest no insert release was obtained (data not shown). Due to the 
ambiguous nature of the plasmid map provided, it was decided to PCR amplify the 
HSJ1b gene using the pET-14b _HSJ1b plasmid as template, and clone it into the pET-
16b expression vector. 
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3.3.2.1 Insertion of HSJ1b into pET-16b 
The nucleotide sequence of the Homo sapiens HSJ1b ORF (1-975 bp) was obtained 
from the NCBI database (accession number NM_006736.5). Primers complementary 
to the 5’ and 3’ ends of the nucleotide sequence of the polypeptide were designed 
(sequences given in section 3.2.1) and BamHI and HindIII cleavage sites were 
introduced at the 5’ and 3’end’s respectively. The forward primer also carried an extra 
nucleotide after the BamH1 restriction site to ensure that the translation product of the 
gene was in frame with that of the vector. The HSJ1b gene was successfully amplified 
and the PCR product obtained was of the expected size of 975 bp (as seen in 3.5, panel 
A, lane 2). The PCR product was subjected to a diagnostic restriction digest using the 
enzyme EcoRI which cuts at position 313 in the HSJ1b sequence. Figure 3.5, Panel A, 
lane 3 shows the results of the restriction digest and the expected 313 bp and 662 bp 
digest fragments obtained. Insertion of the HSJ1b into the pET-16b vector was 
confirmed by BamHI/HindIII digestion. Analysis by agarose gel electrophoresis 
revealed two bands - one at 975 bp corresponding to the HSJ1b gene size and the other 
at 5711 bp tallied with the size of the pET-16b vector (as shown in Figure 3.5, panel B, 
lane 3).  
 
 
 
 
 
 
 
Figure 3.5: Analysis of the HSJ1b PCR product and its cloning into the pET-16b vector  
Panel A) Full length human HSJ1b was amplified from the pET-14b_HSJ1b plasmid DNA using gene 
specific primers. 10 µl of PCR product was taken and subjected to restriction digestion by EcoRI. The 
digestion products were analysed on a 0.8% agarose gel along with 10 µl of undigested PCR product for 
comparison. Lane 1 is 6 µl of Promega 1Kb DNA Ladder (molecular weight marker), lane 2 is the 
undigested PCR product and lane 3 shows EcoRI digested PCR product. 
Panel B) Cloning of HSJ1b into pET-16b vector. Lane 1 is the plasmid prior to digestion, lane 2 is 6 µl 
Promega’s 1 Kb DNA molecular weight markers, lane 3 is BamHI/HindIII digested plasmid.  
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3.3.2.2 Sub-cloning of HSJ1b into pET-24a for co-expression 
studies 
For the successful implementation of the co-expression strategy, HSJ1b gene was sub-
cloned into the pET-24a vector. The pET-16b-HSJ1b plasmid was digested using the 
restriction enzymes BamHI and HindIII and the released insert was purified and ligated 
into pET-24a vector between the same restriction sites. Clones were confirmed by 
restriction analysis for the presence of the 975 bp HSJ1b insert (Figure 3.6). The total 
size of the pET-24a-HSJ1b plasmid was 6285 bp, with the vector accounting for 5310 
bp and the gene 975 bp (lane 2, Figure 3.6).  
 
 
 
 
 
 
 
Figure 3.6: Cloning of the HSJ1b gene into the pET-24a vector 
To generate the pET-24a-HSJ1b construct, the HSJ1b insert was obtained by restriction digestion of the 
pET-16b-HSJ1b clone with BamHI and HindIII restriction enzymes. The pET-24a DNA was purified by 
alkaline lysis and was prepared for ligation by digestion using the same enzymes. The insert and vector 
were ligated as previously described in section 3.2.4 and transformed into E.coli DH5α cells. Overnight 
cultures of the transformants were used for plasmid extraction by alkaline lysis. 15 µl of the extracted 
plasmid DNA was used for restriction digestion by BamHI and HindIII enzymes and visualized on a 
0.8% agarose gel by staining with ethidium bromide at 0.5 ug/ml and photographing under UV 
illumination. Lane 1 is 6 µl Promega 1Kb DNA Ladder (molecular weight marker), lane 2 shows 
BamHI/HindIII digested pET-24a-HSJ1b plasmid.  
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3.3.3 Small scale expression studies 
Preliminary expression studies were carried out with the pET-16b-Hsc70 or pET-24a-
HSJ1b constructs to confirm expression of the individual Hsc70 and HSJ1b 
polypeptides in E.coli BL21(DE3). Growth and induction was carried out with 10 ml 
cultures of E. coli BL21(DE3) cells carrying either the pET-16b-Hsc70 or pET-24a-
HSJ1b plasmid, as described in the materials and methods. Expression of both the 
genes were under the control of the T7 promoter and protein production was initiated 
by the addition of the inducer, IPTG, to a final concentration of 0.4 mM. 1ml culture 
samples were collected before and after induction and centrifuged at 13,000 rpm. The 
pellet was re-suspended in 1X SDS-PAGE sample buffer and lysed by boiling. The 
soluble protein fraction was analysed by gel electrophoresis (Figure 3.7). Comparing 
the uninduced and the induced samples by SDS-PAGE gel electrophoresis, it was 
possible for us to identify induced expression of a ~70 kDa polypeptide corresponding 
to the estimated molecular weight of Hsc70 (lane 2 in panel A of Figure 3.7). This 
polypeptide is not observed in the uninduced sample (lane 1 in panel A of figure 3.7). 
Similarly, a ~38-40 kDa polypeptide was over-expressed in the BL21(DE3) cells 
carrying the pET-24a-HSJ1b plasmid (lane 2 in panel B of figure 3.7). A low level of 
basal expression was detected in the uninduced samples also (lane 1 in panel B of 
Figure 3.7). 
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Figure 3.7: Expression profile for Hsc70 and HSJ1b proteins 
The individual plasmids (pET-16b-Hsc70 and pET-24a-HSJ1b) were transformed into E.coli 
BL21(DE3) cells.  Single colony was used for overnight inoculation into 10 ml LB broth containing 100 
µg/ml of ampicillin and grown at 37oC. 10 ml LB was inoculated with a 1 in 100 dilution of the 
overnight culture. Cells were grown at 37oC to an OD595 of 0.6-0.8. Protein expression was induced by 
the addition of IPTG to a final concentration of 0.4 mM. 1 ml cultures were collected before and after 
induction and spun down at 13,000 rpm. The supernatant was discarded and the pellet was re-suspended 
in 120 µl of 1X SDS -PAGE buffer and analysed on a 12% gel. Panel A) Lanes 1 and 2, Samples before 
(lane 1) and after (lane 2) induction for cells carrying Hsc70 plasmid, lane 4 Bio-Rad precision plus 
molecular weight marker proteins (broad range) Panel B) Samples before (lane 1) and after (lane 2) 
induction for E.coli BL21(DE3) cells carrying HSJ1b plasmid  lane 3 Bio-Rad precision plus molecular 
weight marker proteins (broad range). Putative Hsc70 and HSJ1b protein species are highlighted by 
black arrows.   
Once expression of the individual genes were confirmed, small scale co-expression 
studies were carried out as described in section 3.3.4 using 10 ml cultures of E. coli 
BL21(DE3) cells carrying both the pET-16b-Hsc70 and pET-24a-HSJ1b plasmids. The 
co-transformed E.coli BL21(DE3) cells were selected with two antibiotics – ampicillin 
and kanamycin to ensure that both the plasmids were retained. One ml culture samples 
were collected before and after induction with IPTG and spun down. The pellet was re-
suspended in 1X SDS-PAGE sample buffer and lysed by boiling. The sample was 
analysed by gel electrophoresis (Figure 3.8). 
 
 
 
Panel A 
 
Panel B 
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Figure 3.8: Expression of both Hsc70 and HSJ1b polypeptides under co-expression conditions 
Plasmids pET-16b-Hsc70 and pET-24a-HSJ1b were co-transformed into the E. coli expression strain 
BL21(DE3). Single colony was used for overnight inoculation into 10 ml LB broth containing 50 µg/ml 
of ampicillin and 25 µg/ml kanamycin and grown at 37oC. 10 ml LB was inoculated with a 1 in 100 
dilution of the overnight culture. Cells were grown at 37oC to an OD595 of 0.6-0.8. Protein expression 
was induced by the addition of IPTG to a final concentration of 0.4 mM. 1ml cultures were collected 
before and after induction and spun down at 13,000 rpm. The supernatant was discarded and the pellet 
was re-suspended in 120 µl of 1X SDS -PAGE buffer and analysed on a 12% gel. Lanes 1 and 2, 
Samples before (lane 1) and after (lane 2) induction for E.coli BL21(DE3) cells co-transformed with 
pET-16b-Hsc70 and pET-24a-HSJ1b plasmids. Putative Hsc70 and HSJ1b protein species are 
highlighted by black arrows. Moleuclar weightd (kDa) are indicated to the right of the gel. 
 
Under the co-expression conditions, the production of both the 70 kDa and 40 kDa 
polypeptides were observed (indicated by arrows in lane 2 of Figure 3.8), after the 
addition of IPTG. The relative amounts of the two proteins suggested that the HSJ1b 
was better expressed than the larger Hsc70 protein.  Also a 70 kDa species was 
observed in the uninduced sample. This could be attributed either due to leaky 
expression of the Hsc70 or the 70 kDa polypeptide could correspond to E. coli’s 
endogenous Hsp70- DnaK.  
3.3.4 Confirmation of plasmid stability during co-transformation 
To confirm definitively that the E.coli BL21(DE3) colonies grown with dual antibiotic 
selection actually maintained both the Hsc70 and HSJ1b plasmids, individual colonies 
were selected, re-suspended in distilled water and subjected to PCR. Two PCR 
reactions were carried out for each colony, using two different set of primers. One set 
of primers was specific for the Hsc70 gene and the second specific for the HSJ1b gene. 
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The reactions were performed on two different BL21(DE3) colonies. The results of the 
amplification reactions were analysed on a 0.8% agarose gel (Figure 3.9). Panel A of 
Figure 3.9 showing amplification of a product at 1941 bp (lanes 2 and 3) confirms the 
presence of the Hsc70 gene, while panel B of Figure 3.9 showing amplification of a 
975 bp fragment (lanes 2 and 3) confirms the presence of the HSJ1b gene in the same 
BL21(DE3) colony. The expected amplification size was calculated using the gene 
sequence.  
Figure 3.9: Confirmation of co-transformation into BL21 (DE3). 
Single BL21(DE3) colonies transformed with both the Hsc70 and HSJ1b plasmids were picked and re-
suspended in 10 µl of water. 1 µl was then used as a template for PCR under the conditions previously 
described for both the genes (see materials and methods) using the gene respective primers detailed in 
table 3.1. The results were analysed on a 0.8% agarose gel with the DNA being visualised by staining 
with ethidium bromide at 0.5 ug/ml and photographing under UV illumination. Colonies carrying the 
gene show an amplification corresponding to the respective gene size which is indicated to the right-
hand side of each respective gel. PCR was performed on two colonies.  
Panel A) Lane 1 has the NEB 1Kb DNA Ladder (molecular weight marker) lanes 2 and 3 shows 
positive amplification of a 1941 bp product in colony 1 and 2 respectively. Panel B) Lane 1 has the 
Promega 1Kb DNA Ladder (molecular weight marker) lanes 2 and 3 shows amplification of a 975 bp 
product in colony 1 and 2 respectively. 
 
In order to confirm that neither plasmid was lost due to segregation during the course 
of growth and induction, a sample of the induced cells were plated onto LB agar plates 
containing both antibiotics. Overnight incubation at 37oC gave rise to colonies, thereby 
confirming that both plasmids were present at the end of the 3 hour incubation period. 
Panel A Panel B 
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3.3.5 Purification of Hsc70/HSJ1b co-expressed proteins 
The co-expressed Hsc70/HSJ1b proteins were isolated using a one-step, Ni-NTA 
affinity column. Cells co-expressing the human Hsc70 and HSJ1b proteins were lysed 
as described in section 2.10.2 and the soluble fraction was loaded onto a Ni-NTA 
column. Protein was eluted using 200 mM imidazole and analysed by SDS-PAGE 
(Figure 3.10). Hsc70 expressed from pET-16b has a molecular weight of 73.4 kDa 
while the untagged HSJ1b has a calculated molecular weight of 35.5 kDa. From the 
SDS-PAGE analysis of the polypeptide co-eluting from the nickel resin the HSJ1b 
protein displays anomalous migration, running at ~40 kDa (Figure 3.10).  From the 
gel, it was observed that a part of the Hsc70 and HSJ1b proteins expressed remained 
soluble while a significant percentage was detected in the insoluble pellet (comparing 
lane 1 and lane 2, Figure 3.10).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10:  Chromatography profile of the Hsc70/HSJ1b complex on Ni-NTA resin 
Recombinant Hsc70/HSJ1b proteins were co-expressed in E. coli BL21(DE3) cells by induction with 
0.4 mM IPTG for three hours at 37oC. The lysed, soluble extract was applied to a Ni-NTA column, 
extensively washed with buffer A (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM imidazole) 
containing 30 mM imidazole and eluted with buffer A containing 200 mM imidazole. The polypeptide 
composition was analysed by SDS-PAGE (12% resolving gel) stained with Coomassie Brilliant Blue 
and photographed: Lane 1 soluble extract, lane 2 insoluble pellet, lane 3 column flow through, lane 4 
Wash with 30 mM imidazole, lane 5 Bio-Rad precision plus pre-stained molecular weight marker (broad 
range), lanes 6 & lane 7 200 mM imidazole elution 
 
 One of the reasons for the insolubility could be the inability of the cells to handle very 
high levels of over expression as observed for the complex. Despite only 50% 
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solubility observed in the expressed protein, typical yield from a 2 litre culture was up 
to 6-8 mg of protein, which was sufficient for our studies. Hsc70 expressed from the 
pET-16b vector carries a 10X Histidine tag suitable for affinity purification by nickel 
chelating resin, while the HSJ1b does not express any affinity tag. Thus only the 
Hsc70 is capable of binding to the Ni-NTA column and the tagless HSJ1b can remain 
on the column only if it associates with the Hsc70 moiety. HSJ1b which failed to 
associate with the tagged Hsc70 protein was observed in the flow through and wash 
fractions (lane 3 and 4, Figure 3.10). This could be either as a result of the complex 
dissociating during the wash or more likely as a result of excess expression of the 
HSJ1b. Figure 3.10 also shows that both Hsc70 and HSJ1b remain bound to the 
column after extensive washing and co-elute when 200 mM imidazole is applied to the 
column.  This strongly suggests that the two proteins have formed a complex when 
expressed recombinantly (lane 6 and 7, Figure 3.10). A complex comprising of a 70 
kDa polypeptide and a 40 kDa polypeptide (molecular weight corresponding to Hsc70 
and HSJ1b) is observed in the 200 mM imidazole elution (lane 6 and 7, Figure 3.10). 
Whilst it is not possible to be completely accurate about the stoichiometry of the 
complex the relative intensities of the Coomassie staining suggest a 1:1 association. 
The recombinant Hsc70/HSJ1b complex isolated from bacterial cells using Ni-NTA 
chromatography will be referred to as rHH henceforth. 
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3.3.6 Absence of non specific binding of untagged HSJ1b to Ni-
NTA beads 
To confirm that the HSJ1b observed in the rHH elution fraction was not due to non- 
specific binding of the expressed HSJ1b protein to the Ni-NTA beads, pET-24a-HSJ1b 
plasmid was expressed individually under the same conditions as rHH and processed 
over Ni-NTA resins. Figure 3.11 is the analysis of the elution profile of this 
chromatography by SDS-PAGE. The absence of untagged HSJ1b in the 200 mM 
imidazole elution fraction (lane 6, Figure 3.11) confirms that the ~40 kDa band 
observed in the purified rHH was not due to non-specific binding of HSJ1b to the Ni-
NTA agarose beads. 
 
Figure 3.11: Chromatography of untagged HSJ1b protein over Ni-NTA resin. 
The pET-24a-HSJ1b was expressed in E. coli BL21(DE3) by induction with 0.4 mM IPTG for three 
hours at 37oC. The soluble extract was applied to a Ni-NTA column and eluted was performed with 200 
mM imidazole. The polypeptide composition was analysed by SDS-PAGE (12% resolving gel) and the 
gel stained with Coomassie Brilliant Blue: Lane1 soluble extract, lane 2 insoluble pellet, lane 3 column 
flow through, lane 4 Wash with buffer A (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM imidazole), 
lane 5 Wash with buffer A containing 30 mM imidazole, lane 6 with buffer A containing 200 mM 
imidazole elution & lane 7 Bio-Rad precision plus prestained molecular weight marker (broad range).  
  
3.3.7 Stability of the isolated complex 
We next wanted to confirm that the isolated complex was stable and that the HSJ1b 
protein that was seen in the wash and flow-through fractions of the Nickel column was 
there because of the excess HSJ1b being expressed not because the complex was 
gradually dissociating. The integrity of the complex isolated by Ni-NTA 
chromatography was assessed by reloading the rHH complex onto the Ni-NTA 
column. Imidazole washing and elution was carried out as described earlier in the 
Materials and Methods. If the complex was unstable, re-chromatography over the Ni-
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NTA column might destabilise the protein complex. Analysis of the rHH complex 
once rebound to Ni-NTA resin showed that the complex remains intact, eluting with 
200 mM imidazole (Figure 3.12, lane 5) and showing no signs of HSJ1b dissociation 
during column washes with buffer (Figure 3.12, lanes 3 and 4).   
 
 
Figure 3.12: Re-chromatography of the rHH protein over the Ni-NTA column. 
An aliquot of the rHH protein eluted from the Ni column, described in section 3.3.4.2, was diluted with 
buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl) to bring down the imidazole concentration to 20 mM 
and reloaded onto 200 µl of Ni-NTA agarose. The protein was eluted with buffer  (50 mM Tris-HCl pH 
8.0, 100 mM NaCl, 5 mM imidazole) containing 200 mM imidazole and the fractions were analysed on 
a 12% gel. Lane 1 is an aliquot from which the rHH protein sample was used for the chromatography, 
lane 2 column flow through, lane 3 Wash, lane 4 Wash with 30 mM imidazole, lane 5 200mM imidazole 
elution & lane 6 Bio-Rad precision plus prestained molecular weight marker (broad range). 
3.3.8 Additional Purification strategies 
The rHH complex purified by Ni-NTA chromatography was isolated with variable 
purity; compare the preparation shown in figure 3.10 with figure 3.12. Ion exchange 
was undertaken to further purify the rHH protein obtained after Ni-NTA 
chromatography for the purposes of obtaining a pure complex that could be used in 
crystallographic analysis. The rHH complex was predicted to have a pI point of 5.78 
suggesting it would bind to the anion exchange resin, Q-sepharose.  A trial analysis 
was undertaken by binding a sample of the rHH from the Ni-NTA resin to Q sepharose 
resin. The protein was eluted using a step gradient of NaCl up to 1 M concentration. At 
250 mM NaCl, elution of the complex was observed (Figure 3.13), however the 
stoichiometry of the Hsc70/HSJ1b complex eluting from the column was not 
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consistent with that loaded onto the column (compare lanes 1 and 4, Figure 3.13). 
Furthermore, a proportion of the Hsc70 eluted independently at 500 mM NaCl and it is 
not clear where the rest of the HSJ1b protein has gone. The predicted pI point of 
HSJ1b alone, 5.6, suggests that this protein will not bind any more tightly than Hsc70 
(pI point 5.9) to Q-sepharose. No polypeptide species corresponding to HSJ1b elutes 
with up to 1 M NaCl applied to the column.  The most likely explanation was that the 
protein was lost in the lower NaCl wash fractions, which were unfortunately not 
analysed by gel electrophoresis. It was concluded that ion-exchange chromatography 
does not represent a useful means of further enhancing the purity of the complex.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Elution profile of rHH complex separated by ion exchange chromatography  
Ion Exchange chromatography was performed using Q sepharose ion exchange resin.  The Hsc70/HSJ1b 
complex fractions from the Ni-NTA column containing 200 mM imidazole were diluted to 25 mM NaCl 
using dilution buffer (50 mM Tris-HCl, pH 8.0). The protein was applied to a 20 ml Q sepharose 
column pre-equilibrated with buffer B (50 mM Tris-HCl, pH 8.0. The resin was washed with 2 column 
volumes of equilibration buffer and the protein step eluted with a NaCl step gradient from 0-1 M in 
buffer B. 100, 250, 500 and 1000 mM NaCl. The elution profile was monitored by SDS-PAGE Lane1 
Bio-Rad precision plus prestained molecular weight marker proteins, lane 2 rHH complex load, lane 3 
flow through from the column, lanes 4 & 5 250 mM NaCl elution fractions, lane 6 500 mM NaCl 
elution, lane 7 1 M NaCl elution 
 
An alternative purification strategy used frequently to remove contaminants from 
Hsc70 is the use of ATP-agarose chromatography. Schlossman and co-workers first 
used it to purify Hsc70 from bovine brain (Schlossman et al., 1984), and since then it 
is used routinely in the purification of Hsp70 proteins (Ménoret, 2004, Nicoll et al., 
2006). There were initial misgivings about the use of an ATP-agarose column with the 
Hsc70/HSJ1b complex, since re-binding of ATP to any Hsp70/Hsp40 complex could 
stimulate the release of its Hsp40 co-chaperone partner. However based on the reports 
of Motohashi et al who have used this chromatography technique to successfully 
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purify a native DnaK/DnaJ complex from Thermus thermophilus, small scale 
experiment was carried out by binding a sample of the rHH from the Ni-NTA resin to 
an ATP-agarose column (Figure 3.14).   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Elution profile of rHH complex separated by ATP-agarose chromatography  
5 ml of the ATP-agarose slurry was packed into a column that was washed with 10 column volumes 
(CV) of equilibration buffer (20 mM Tris-HCl pH 8.0, 20 mM NaCl, 15 mM β-Mercaptoethanol and 3 
mM MgCl2). The Hsc70/HSJ1b elution fraction from Ni-NTA chromatography was diluted in 20 mM 
Tris-HCl pH 8.0, 15 mM β-Mercaptoethanol and 3 mM MgCl2 to bring down the final concentration of 
NaCl in the sample to 25 mM. The protein was loaded onto the column and washed with 5 CV of 
equilibration buffer. The agarose was incubated in elution buffer (20 mM Tris-HCl pH 8.0, 20 mM 
NaCl, 15 mM β-Mercaptoethanol, 3 mM MgCl2 plus 3 mM ATP) for 30 minutes before the fractions 
were collected. The elution profile was analysed by denaturing 12% SDS-PAGE and Coomassie 
brilliant blue staining. Lane 1 flow through from the column, lane 2 Wash with equilibration buffer and 
lane 3 Elution with 3 mM ATP 
 
The protein was eluted using 3 mM ATP. It was observed that only a fraction of the 
complex was bound to the column, since a fraction of the complex was also detected in 
the flow through from the column (lane 1, Figure 3.14). The reason for this is not clear. 
Also, the stoichiometry of the Hsc70/HSJ1b complex detected in the flow through was 
not consistent with that loaded onto the column (compare lanes 1 in Figure 3.14 with 
lane 7 in Figure 3.10).  Analysis of the wash and elution fraction (lanes 2 and 3, Figure 
3.14) confirmed that a proportion of the complex was disassociating over the column. 
HSJ1b from the separated complex is observed in the flow through fraction (lane 2, 
Figure 3.14), while Hsc70 eluted independently with 3 mM ATP (lane 3, Figure 3.14). 
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It was concluded that ATP-agarose chromatography was not a suitable additional 
purification strategy because of its destabilising effect on the complex.  
3.3.9 Assessment of DnaK contamination 
Usage of a bacterial system for the isolation of recombinant Hsp70’s has been reported 
to carry the risk of the protein preparation getting contaminated with the endogenous 
bacterial Hsp70, DnaK (Ménoret, 2004). In order to confirm that the 70 kDa 
polypeptide band observed on the SDS-PAGE corresponded solely to Hsc70 and does 
not have any contamination from endogenous E. coli DnaK, a dot blot was performed 
on the Ni-NTA elution fractions using anti-DnaK and anti-Hsc70 antibodies. Results 
from the dot blot however indicated that the rHH protein indeed had contamination 
from DnaK protein (panel A, Figure 3.15). Panel B in Figure 3.15 was the control 
reaction performed with Hsc70 antibodies. Hsc70 and DnaK have different pI values. 
The pI calculated for Hsc70 is 5.9 while that of DnaK is 4.8. This difference in pI 
values between Hsc70 and HSJ1b was exploited to determine the percentage of DnaK 
contamination. Protein was separated in the first dimension by isoelectric focussing 
followed by 2nd dimension resolution by SDS-PAGE. Panel C, Figure 3.15 shows the 
successful separation of the DnaK contaminant fragment from the total rHH protein. 
The percentage of contamination was estimated by densitometry at 3.5 % of the total 
and was therefore considered to be negligible. Similarly the rHH protein was probed 
for the presence of contaminating DnaJ protein. The pI value for HSJ1b is 5.6 while 
that of DnaJ is 7.98. From Figure 3.15, panel D, the level of E. coli DnaJ 
contamination in the rHH preparation can be considered negligible.  
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Figure 3.15: Qualitative and quantitative detection of DnaK contamination of the rHH protein 
fraction. 
Panel A and B are the results of the dot blot analysis (described in section 2.10.7, chapter 2). The rHH 
protein purified by Ni-NTA chromatography was immobilised on the nitrocellulose membrane soaked in 
TBS-T buffer (10 mM Tris-base, 150 mM NaCl, 0.05% (v/v) Tween-20, pH 8.0) for 1 min.  2 µl of the 
protein sample was spotted onto the membrane; membrane dried and blocked in 5% (w/v) BSA in TBS-
T for 2 hrs at room temperature. The membrane was next incubated with primary antibody (either anti-
DnaK or anti-Hsc70) diluted in TBS-T (dilution factor mentioned in section 2.1.6) for 2 hours at room 
temperature. At the end of the incubation the membrane was given three, five minute washes with TBS-
T and then probed with the appropriate secondary antibody conjugated with HRP. The bands were 
visualised using 3 ml of 3,3′,5,5′-Tetramethylbenzidine (TMB) Liquid Substrate System (Sigma-
Aldrich, UK). 
Panel A: Dot blot performed using anti-DnaK antibody. Sample 1 is the DnaK positive control and 
sample 2 is the rHH protein being probed for the presence of DnaK contamination. 
Panel B: Dot blot performed using anti-Hsc70 antibody. Sample 1 is the Hsc70 positive control and 
sample 2 is the rHH protein. 
Panel C and D shows the 2DE separation of rHH proteins. 15 µg of protein was loaded onto a linear 7 
cm IPG strip in the pH range 3-10 overnight. Isoelectric focusing was carried out on the following day 
using the Multiphor II apparatus (Pharmacia BIOTECH.) as described in the handbook of 2-D 
electrophoresis (GE Healthcare, 2004). Briefly, focussing was performed at 20°C under the following 
conditions: 300V for 30 min; 600V for 45 min; 3500V for 2 hours and 45 minutes using an Amersham 
EPS 3501 power pack. The strip was sealed onto the top of a 12% SDS-polyacrylamide gel and 
separated at 150 V. 
Panel C: Identification of contaminating DnaK species based on their in pI value. The black arrow 
indicates the putative position of the acidic DnaK and the red star marks the position of Hsc70.  
Panel D:  Identification of contaminating DnaJ species based on their in pI values. The black arrow 
indicates the putative position of the DnaJ and the red star marks the presumed position of HSJ1b.  
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3.3.10 Two-dimensional analysis of by native/SDS-PAGE 
analysis  
To verify the nature of the interaction between the Hsc70 and HSJ1b components of 
the observed recombinant complex, two-dimensional analysis was undertaken. For the 
first dimension, Ni-NTA fractions containing the rHH complex were separated on an 
8% native gel where separation of polypeptides is based solely on the charge-mass 
ratio. From the native gel, under the electrophoretic condition studied, the complex 
resolved into multiple bands on the gel (see Figure 3.16). The lowest molecular weight 
component was observed at ~140 kDa with several higher molecular weight 
components. The presence of several bands on the 1st dimension separation by native 
gel suggests that the complex assumes more than one oligomeric state and possibly the 
different forms could indicate different states of association or disassociation of the 
complex. Next, gel strips carrying the separated protein fractions were treated with 1X 
SDS-PAGE sample buffer before being transferred onto a second dimension SDS-
PAGE gel. In the presence of SDS, protein complexes dissociate and therefore, in the 
resulting second dimension gel the subunits of a protein complex are ordered 
according to their molecular weight in vertical rows. From the 2nd dimension analyses 
the protein species migrating at 140 kDa on the native gel, comprised predominantly of 
Hsc70 (running at 70 kDa, indicated by a red circle on Figure 3.16). The higher 
molecular weight species from the native gel appeared to correspond to intact 
Hsc70/HSJ1b complex (as evidenced by the presence of both the 70 kDa and 40 kDa 
polypeptide in the 2nd dimension). Thus the 2D analysis by Native and SDS-PAGE 
successfully demonstrates that the isolated rHH protein contains a complex of Hsc70 
chaperone with its co-chaperone partner -HSJ1b proteins. 
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Figure 3.16: Two-dimensional analysis by native and denaturing gel electrophoresis of rHH 
protein 
The rHH complex was resolved in the first dimension on an 8% native gel. Protein samples were 
prepared in 4X Native-PAGE sample buffer (0.0625 M Tris-HCl, pH 6.8, 10% (v/v) glycerol and 0.05% 
(w/v) bromophenol blue) and were loaded without boiling at 95oC. The gel was run in 1X Native-PAGE 
gel running buffer (25 mM Tris base and 192 mM glycine). The samples were resolved at 100V at 4oC 
until the blue dye front had reached the end of the gel plates. The native gel was run with BSA (66,132 
kDa) and β-amylase (200 kDa) as markers. The lane of the native gel containing the complex was cut 
out, equilibrated in 1X SDS-PAGE sample buffer and transferred horizontally on a 12% SDS-PAGE in 
the second dimension with Bio-Rad broad range protein markers. The gel was run at 150 V in running 
buffer (25 mM Tris, 192 mM Glycine, 0.1% (w/v) SDS), stained with Coomassie Brilliant Blue and 
photographed. 
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3.4 Discussion 
In this chapter, we sought to establish an expression system from which the 
Hsp70/Hsp40 complex, preferentially in a soluble form, could be produced. For this 
project we have used the human heat shock cognate 70 (Hsc70) and a type II neuronal 
DnaJ homologue - HSJ1b, as representatives of the Hsp70 and Hsp40 families 
respectively.  Routinely, the individual Hsp70 and Hsp40 proteins are independently 
purified, and the Hsp70/Hsp40 system has been reconstituted by mixing the two 
proteins in the presence of ATP and characterised the complex thus formed (Minami et 
al., 1996). The individual proteins have been purified either from their native source, 
for example Hsc70 has been extracted from bovine brain (Schlossman et al., 1984), or 
by employing recombinant methods (Minami et al., 1996; Chamberlain and Burgoyne, 
1997). However the mechanism of assembly into a complex upon reconstitution is not 
well understood. Also the similarity of their assosciation to the in vivo system has not 
been well studied. Alternatively, Motohashi et al., (1994) reported the isolation of the 
native DnaK/DnaJ complex purified from Thermus thermophilus. The complex, 
isolated from the strain T. thermophilus HB8 (ATCC 27634), involved four 
purification steps through DE-52 cellulose column, ammonium sulphate precipitation, 
a hydroxyapatite column, a Butyl-Toyopearl column and a final polishing step using 
gel filtration. However due to the lengthy purification procedures only a 2% recovery 
of the T. thermophilus DnaK/DnaJ complex was obtained (Motohashi et al., 1994). 
Also, the yield of protein from a native source is dependent on the relative abundance 
and distribution of the target protein and might not be a feasible option if a large 
quantity of protein is required.    
The isolation of a recombinant, co-expressed Hsc70/HSJ1b complex has been reported 
for the first time in this study. Two strategies are normally employed to co-express 
proteins in E. coli. One is to use a bicistronic vector, such as pETDuet-1 from 
Novagen, and clone two target genes into one vector. The other method is a 2-plasmid 
co-expression system in which the target genes are cloned into two separate vectors 
with compatible origins of replication and thus avoid competition in replication, 
segregation and ultimate loss of one plasmid (Johnston et al., 2000; Scheich et al., 
2007). For example, the human cell cycle and transcriptional regulatory protein 
complexes have been produced in bacteria using a 2-plasmid co-expression system 
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(Johnston et al., 2000). A variant of the above methodology was described by Yang et 
al., (2001), who successfully demonstrated co-expression of proteins using 
incompatible plasmids with the same replicon but with different antibiotic resistance 
genes. They observed that under antibiotic selection pressure, it was possible to 
maintain both plasmids in the same cell for at least 14 hours (Yang et al., 2001).  
In this work, Hsc70 and HSJ1b genes were both cloned into the pET-16b initially. The 
pET-16b-Hsc70 and pET-16b-HSJ1b clones were then used to isolate and purify the 
individual proteins. The work carried out with this regard will be discussed in detail in 
Chapter 5. For the sake of the co-expression studies, the HSJ1b gene was sub-cloned 
into the pET-24a vectors. The two plasmids (pET-16b and pET-24a) have the same 
origin of replication, but have different antibiotic selectivity and this difference is 
essential for successful co-expression of the two genes. The pET-24a vector has a 
kanamycin resistance marker, while pET-16b has an ampicillin resistance marker. 
Dual antibiotic selection allows bacterial cells transformed with pET-16b-Hsc70 and 
pET-24a-HSJ1b plasmids to maintain both the plasmids simultaneously.  
The genes were successfully overexpressed in E. coli BL21(DE3). DE3 indicates that 
the host is a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 
RNA polymerase gene, under the control of a lacUV5 promoter. Thus, this strain is 
suitable for production of protein from target genes cloned in pET vectors under the 
control of a T7 promoter, by induction with IPTG. Since the two plasmids had 
incompatible ori’s, it was necessary to ensure that both plasmids are maintained in the 
bacterial cell. Yang et al., reported that under dual antibiotic selection pressure, it was 
possible to maintain both plasmids in the same cell for at least 14 hours (Yang et al., 
2001).  In our case, cells were grown at 37oC for only 3 hours after IPTG induction. To 
further confirm the effectiveness of the dual antibiotic selection in maintaining both 
the plasmids, colony PCR of the transformed E. coli BL21(DE3) cells was undertaken. 
Colony PCR is usually used as a quick screen to confirm the presence of the gene of 
interest in bacterial cells, and was successfully used in this case to confirm the 
coexistence of both the plasmids.  
Purification of the Hsc70/HSJ1b proteins took advantage of another important 
difference between the two vectors. While pET-16b expresses a 10X N-terminal 
histidine tag , pET-24a does not carry an N-terminal tag.  Instead, pET-24a has a C-
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terminal histidine tag. However, since HSJ1b inserted into pET-24a vector has been 
amplified with a stop codon, expressed HSJ1b protein will not carry a histidine tag. 
This was an important for the successful isolation of the complex from Ni-NTA 
chromatography. Untagged HSJ1b protein is incapable of binding to Ni-NTA agarose. 
Despite this a ~40 kDa species corresponding to the molecular weight of HSJ1b was 
observed in the elution fractions along with the 70 kDa Hsc70 species. This is possible 
only if untagged HSJ1b associated with the histidine tagged Hsc70 protein and eluted 
as a complex from the Ni-NTA column. To rule out non-specific binding of HSJ1b to 
the Ni agarose, untagged HSJ1b was chromatographed over the Ni-NTA column. All 
of the expressed HSJ1b protein was present only in the flow through and wash 
fractions. No species ~40 kDa was detected in the higher imidazole elution. Also, re-
chromatography of the purified rHH complex over Ni beads failed to destabilise the 
Hsc70-HSJ1b interaction.  
The experimental design as such did not allow co-elution of the untagged HSJ1b 
subunit from the Ni-NTA column until and unless bound to the His-tagged Hsc70. 
However, it was essential to confirm that the two polypeptides detected in the Ni-NTA 
elution fractions (Hsc70 and HSJ1b) represented two interacting proteins and not 
merely an artefact of protein co-elution. 2D analysis by native and SDS-PAGE has 
been used extensively in the isolation of large protein complexes from chloroplast and 
respiratory protein complexes of mitochondria (Schagger and von Jagow, 1991, Kugler 
et al., 1997). Protein separation under native conditions in the first dimension 
conserves protein-protein interactions. Subsequent separation by SDS-PAGE causes 
disassociation of protein complexes and the subunits of distinct protein complexes are 
arranged based on their molecular weight. The interaction between the two subunits 
was further verified using 2-Dimensional electrophoresis. Analysis of the migration 
pattern of the recombinant Hsc70/HSJ1b complex confirmed the interactions of the 
Hsc70 and HSJ1b subunits of the rHH complex. Thus, a complex of Hsc70/HSJ1b 
proteins was successfully isolated using an E. coli co-expression system.  
There were two major drawbacks in using an E. coli expression system. One, is the 
possible contamination of the isolated Hsc70/HSJ1b complex with the bacterial Hsp70 
i.e. DnaK. Wang and Lee, (1993) have observed the co-elution of DnaK during the 
purification of rat Hsc70 from E. coli (Wang and Lee, 1993). Similarly, Ménoret haa 
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also observed contamination of recombinant Hsp70 with DnaK (Ménoret, 2004).  Dot 
blot analysis of the recombinant protein compels with anti-DnaK antibody confirmed 
the presence of DnaK contamination in our protein preparations. The extent of 
contamination was determined using 2-dimensional analysis using IEF. IEF is 
routinely used for electrophoretic separation of protein mixtures based on their 
isoelectric points (Görg et al., 2004). Using IEF/SDS-PAGE analysis, a DnaK (pI of 
4.8) species was clearly separated from Hsc70 (pI of 5.9) protein and the percentage of 
DnaK contamination was calculated. Since this was less than 5% of the total protein 
the contamination was considered to be negligible. The two dimensional analysis also 
confirmed that the protein preparation was free from DnaJ (pI of 7.9), the endogenous 
bacterial Hsp40. 
The other drawback of expressing a chaperone complex in E. coli is the co-elution of 
several contaminating protein species (Nicoll et al., 2006). A plausible explanation for 
observed contamination could be the affinity of the chaperone/co-chaperone complex 
to bind to unfolded substrates present in the bacterial cytosol, thereby co-eluting with 
contaminants even after the Ni-NTA chromatography. The presence of its Hsp40 
partner exaggerates this problem since it stimulates ATPase activity of Hsc70 and 
converts it to its high substrate affinity ADP bound form (Frydman et al., 1994). 
Routinely, ATP-agarose (Welch and Feramisco, 1985) and ion exchange 
chromatography (Nam and Walsh, 2002) have been used as additional Hsp70 
purification procedures. Both these methods have also been used to combat DnaK 
contamination in recombinant HSP70 preparations. It has been observed by Ménoret 
that the DnaK and Hsp70 bind to the ATP agarose under different conditions and 
therefore this represents a useful method to isolate the rHH complex from the DnaK 
contaminant protein (Ménoret, 2004).  Also, HSP70 proteins have low affinity for 
substrates when bound to ATP (Palleros et al., 1993; Bukau and Horwich, 1998), 
therefore chromatography using ATP-agarose has been shown to limit the extent of 
contamination (Welch and Feramisco, 1985). Similarly, differences in elution of 
Hsp70 and DnaK from the DEAE-Sephacel column have also been observed. DnaK 
was found to elute at a salt concentration higher than 150 mM, while 50% of Hsp70 
could be recovered with a 100 mM NaCl elution from the column (Ménoret, 2004). 
Therefore these two chromatography techniques were used to further purify the rHH 
elutions from the Ni-NTA column.  However both chromatography methods, when 
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used for the rHH complex, resulted in destabilisation of the complex leading to the 
separation of the protein into two subunits, Hsc70 and HSJ1b. Therefore further 
purification of the rHH protein was abandoned and protein eluates from the Ni-NTA 
column were used for the characterisation experiments. An alternative avenue to 
investigate in the future is the use of tandem affinity purification to achieve higher 
purity of the rHH protein. This can be achieved by introducing a second affinity tag 
such as the glutathione-S-transferase (GST) tag in addition to the 10X Histidine tag. 
This tag can be introduced via PCR either on the Hsc70 or HSJ1b gene sequence, and 
will permit a simple two-step purification strategy.   
In this chapter the successful purification of a recombinant form of the human 
chaperone/co- chaperone complex using a T7 expression system has been described.  
To date there have been no reports of the full length Hsp70/Hsp40 complex being 
produced by recombinant methods. This is also the first report of the use of a co-
expression system to express and purify the complex (represented by the Hsc70/HSJ1b 
complex) using E. coli as the expression host. The success of this strategy provides an 
attractive method to isolate and study various other chaperone/co-chaperone 
complexes from different systems and organisms. The complex isolated in the above 
described manner has been characterised with regards to its substrate protection 
capabilities and polymerisation. The results from the characterisation are discussed in 
the next chapter.  
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CHAPTER 4: Characterisation of the recombinant 
Hsc70/HSJ1b complex 
4.1. Introduction 
Hsp70’s interaction with its Hsp40 co-chaperone and the subsequent stimulation of 
Hsp70’s functional activities have been the subject of extensive studies. These studies 
have looked to facilitate understanding of the biochemical, structural and mechanistic 
features of the folding reaction. The chaperone cycle of Hsp70 is an ATP-hydrolysis 
driven, substrate folding reaction. The cycle in its simplest form alternates between 
two states: the low substrate affinity, ATP-bound state of Hsp70, when the substrate 
binding pocket is open and the high affinity, ADP-bound state when the binding 
pocket is closed, thereby resulting in cyclic peptide binding and release (Palleros et al., 
1994; Bukau and Horwich, 1998). Hsp70 on its own is known to have low intrinsic 
ATPase activity (Russell et al., 1999). However in the presence of its Hsp40 co-
chaperone partner, the rate of ATP turnover has been shown to increase by several fold 
(McCarty et al., 1995). Stimulation of ATP hydrolysis by Hsp40’s promotes substrate 
binding to Hsp70 and formation of a stable ternary complex (Laufen et al., 1999). 
 Minami et al., 1996; Chamberlain et al., 1997 and other groups have studied and 
characterised the chaperone/co-chaperone complexes by combining the two individual 
components of the complex at specific molar ratios. From their studies it has been 
established that neither the Hsp70 nor the Hsp40 protein alone was sufficient in 
preventing substrate denaturation; the combined action of a reconstituted Hsp70-
Hsp40 complex in the presence of ATP was required (Minami et al., 1996). We have 
adopted similar protocols and used them to characterise the recombinant Hsc70/HSJ1b 
complex, the isolation of which was described in detail in Chapter 3. This chapter 
describes the biochemical characterisation of the complex and its interpretation with a 
preliminary structural analysis. 
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4.2. Materials and Methods 
4.2.1. Thermal aggregation assay  
The assay followed the protocol reported by Minami et al (1996) using luciferase as 
the model substrate protein (Minami et al., 1996). 15 µl reactions containing 0.8 µM of 
luciferase (Promega) and 1.27 µM of the recombinant rHH protein (calculated using 
molecular weight 110 kDa) were made up in assay buffer (20 mM Tris-HCl pH 8.0, 50 
mM potassium chloride, 3 mM magnesium chloride and 2 mM DTT). The reaction 
was incubated for 5 minutes at room temperature and then transferred to a water bath 
set at 42oC for 10 minutes. The reactions were centrifuged at 13,000 rpm for 10 
minutes at 4oC. The pellet and supernatant fractions were separated and dissolved in 
4X SDS-PAGE buffer. The samples were boiled for 5 minutes and resolved on a 12% 
SDS-PAGE gel. The methodology for the running and Coomassie Blue staining of 
SDS-PAGE gel has been described earlier in chapter 2. Luciferase present in the 
soluble and pellet fraction was quantified by densitometry and plotted as a percentage 
of the total amount of luciferase in the reaction. For reactions containing nucleotides 
(ATP, ADP, AMP or AMP-PNP), a final concentration of 2 mM was used in the assay.  
4.2.2. Refolding of thermally denatured luciferase 
Thermal aggregation of luciferase was carried out as described in Section 4.2.1. 
Luciferase (0.8 µM) was thermally denatured at 42°C for 10 minutes, in the presence 
or absence of the chaperone complex and 2 mM ATP. Refolding was initiated by 
shifting the reactions to 25°C to allow refolding. Reactivation was monitored over a 
two hour period. At specific time intervals, 1 µl was withdrawn from the reactions, 50 
µl of luciferase assay buffer (Promega) was added and luciferase activity was 
measured using a luminometer.  
4.2.3. UV absorption spectroscopy 
Absorption measurements of purified rHH complex were obtained with a Perkin Elmer 
spectrophotometer using a 1 cm path-length quartz cuvette. The spectrum was 
measured between 200-400 nm with a 15 second delay.  
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4.2.4. HPLC analysis of nucleotide content 
Nucleotides were extracted by treating the protein samples with 0.6 M perchloric acid 
and then centrifuged at 10,000 rpm for 10 minutes in a microfuge. The supernatant was 
collected and neutralised with potassium hydroxide (KOH) and clarified by another 
centrifugation. Nucleotides were analysed by reverse-phase HPLC with a C18 column 
run at a flow rate of 1 ml/min for a total elution time of 15 minutes and samples 
detected at 254 nm. Samples were loaded onto the column with a 100 µ1 sample loop. 
The elution system was 50 mM potassium phosphate (pH 7.0). Each nucleotide was 
identified by its retention time compared to nucleotide standards. 
4.2.5. ATPase assay 
Phosphate release measurement for the rHH complex was performed using a 
colourimetric assay (Chamberlain and Burgoyne, 1997a; Chamberlain and Burgoyne, 
1997b). 50 µl reactions containing 1.27 µM of rHH complex was incubated for 5 
minutes at 37oC in 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 mM 
magnesium chloride and 2 mM DTT. The reaction was initiated by the addition of 2 
mM ATP and the reactions were incubated at 37oC for 1 hour. To study the effect of 
denatured substrate on the ATP hydrolysis, a thermal denaturation assay was carried 
out as described in section 4.2.1 and then incubated at 37oC for 1 hour. The reaction 
was stopped by the addition of 50 µl of 10% (w/v) SDS. For the colour development, 
50 µl of 1.25% (w/v) ammonium molybdate prepared in 6.5% (v/v) sulphuric acid was 
added followed by the addition of 50 µl of 9% (w/v) ascorbic acid. The reaction mix 
was further incubated for 1 hour at 37oC and readings were measured at 620 nm. A 
standard curve was set up using potassium phosphate and used to calculate the 
phosphate release attributed to Hsc70’s ATP hydrolysis activity.  
4.2.6. Limited proteolysis with trypsin and chymotrypsin 
Limited proteolytic studies were carried out using both trypsin and chymotrypsin. 5 
mg/ml stock solutions of the protease was prepared in buffer containing 10 mM Tris-
HCl pH 8.0 and 5% (v/v) glycerol and stored at -20oC. The digestion was performed at 
a protease to protein ratio of 1:300. The protease was diluted to the required 
concentration in 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 mM 
magnesium chloride and 2 mM DTT just before setting up the reaction. Digestion was 
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started by the addition of protease (trypsin or chymotrypsin) to the reaction mix. At 
specific time intervals, 15 µl aliquots were withdrawn from the reaction mix and the 
proteolysis was stopped by the addition of 0.5 µl of 10 mg/ml Trypsin inhibitor 
prepared in 10 mM Tris-HCl pH 8.0. 5 µl of 4X SDS-PAGE loading dye was added 
and the sample was incubated at 95oC for 2 minutes and stored on ice until all 
reactions were completed. The proteins were resolved on a 12% SDS-PAGE gel. The 
methodology for the running and Coomassie Blue staining of SDS-PAGE gel has been 
described earlier in chapter 2. The different digest fragments were quantified by 
densitometry. 
4.2.7. Size exclusion chromatography 
Size exclusion chromatography was performed with a 90 ml Superdex-200 column. 
The column was equilibrated with 20 mM Tris-HCl pH 8.0 plus 100 mM potassium 
chloride. 1 ml fractions were collected after 25 ml of buffer had passed. The fractions 
were analysed for protein content using Bradford assay (refer section 2.10.6). The peak 
fractions were analysed by SDS-PAGE electrophoresis. 
For analysis of the effects of ATP, rHH was incubated for 30 minutes with 2 mM ATP 
at room temperature in buffer consisting of 20 mM Tris-HCl pH 8.0, 100 mM 
potassium chloride, 3 mM magnesium chloride and 2 mM DTT. The chromatography 
was also performed in the same buffer. 
For analysis of the effects of denatured luciferase, a thermal aggregation assay was set 
up as described in section 4.2.1 using 75 µg of rHH protein with 50 µg of luciferase. 
The supernatant recovered after centrifugation at 13,000 rpm for 10 minutes was 
loaded onto the gel filtration column. The chromatography was performed in the assay 
buffer (20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 mM magnesium 
chloride and 2 mM DTT). 
4.2.8. Electron microscopy 
Protein samples were prepared for electron microscopy by dialysing the Ni-NTA 
elution fractions against 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride overnight 
at 4oC and then concentrating it to 0.8 mg/ml using a YM-100 centricon (Millipore). 
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The protein complex was negatively stained with freshly made 2% (w/v) uranyl acetate 
on thin carbon-coated grids previously glow-discharged for 15 seconds.  
4.2.9. Analytical ultracentrifugation (AUC) 
For the AUC analysis, the Ni-NTA elution fractions were dialysed against 20 mM 
Tris-HCl pH 8.0, 50 mM potassium chloride overnight at 4oC and concentrated to 0.8 
mg/ml using a YM-100 centricon (Millipore). Experiments were performed on a 
Beckman-Coulter XL-A analytical ultracentrifuge using absorbance optics. The 
samples were loaded into 2 channel cells, and buffer was used as a blank for optical 
purposes. Buffer densities and viscosities were calculated using SEDNTERP. The data 
were processed using SEDFIT (www.analyticalultracentrifugation.com) using the c(S) 
method (Schuck, 2000). For molecular weight determination, data was processed using 
ULTRASCAN (Demeler, 2005) using the genetic algorithm implemented in the 
software and the analysis was performed using the supercomputing facility accessed 
through the LIMS software interface.  
4.2.10. Protein crystallisation  
Purified protein was concentrated using centricon YM-100 centrifugal Filter Devices 
(Millipore). The final protein concentration was determined via the Bradford protein 
assay. Protein at a concentration of 4 mg/ml was used for initial screening. 
Crystallization trials were set up at room temperature using the hanging-drop vapour-
diffusion method. Preliminary trials were carried out with Crystal Screen and Crystal 
Screen 2 from Hampton Research (Jancarik & Kim, 1991; Cudney et al., 1994).
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4.3.  Results  
One of the fundamental properties defining a functional chaperone unit is its ability to 
bind unfolded protein. In this study we have evaluated the in vitro activity of the rHH 
chaperone complex in preventing aggregation of a model substrate (luciferase) and in 
addition studied the effect of the denatured substrate on the ATPase activity. Studies 
were also carried out to understand the conformational and oligomeric properties of the 
rHH complex. Preliminary structural studies were carried out using both X-ray 
crystallography and electron microscopy.  
4.3.1.  Protection of denatured substrate  
 Studies have shown that Hsp70s can bind chemically and thermally denatured protein 
substrates such as citrate synthase (CS), firefly luciferase, rhodanese, β-
galactosidase and permanently unfolded carboxymethylated α-lactalbumin (CMLA) 
(Zhang and Guy, 2006). In our studies, the ability of the recombinant complex in 
preventing substrate aggregation was studied using luciferase as a substrate. 
Aggregation of luciferase was induced by elevating the temperature to 42oC in the 
presence and absence of the co-expressed rHH chaperone complex and in the presence 
and absence of ATP to understand the effect of the nucleotide on the chaperone 
function. After 10 minutes the reactions were centrifuged to separate the soluble and 
aggregated fractions and then analysed by SDS-PAGE (Figure 4.1). In the control 
reactions, luciferase was subject to thermal denaturation in the absence of the 
chaperone complex (Panel A, Figure 4.1) where the majority of the luciferase in the 
control reactions was in the pellet fraction (Lane 2, Panel A, Figure 4.1). In the 
presence of the chaperones, by visual inspection of the gel, it was apparent that the 
majority of the ~61 kDa luciferase was present in the supernatant fraction (lanes 2 and 
4, Panel B, Figure 4.1). The amount of luciferase in the soluble and pellet fraction from 
the SDS polyacrylamide gel was quantified by densitometry and plotted as percentage 
of total luciferase present in the reaction (Figure 4.2). 
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Figure 4.1:  SDS-PAGE analysis of luciferase aggregation with rHH chaperone complex 
0.8 µM of luciferase was thermally denatured at 42oC for 10 minutes in the presence/absence of the 1.27 
µm chaperones. For the reactions containing ATP, the nucleotide was added at a concentration of 2 mM. 
The reaction was centrifuged at 13,000 rpm to separate the soluble and aggregated fractions and 
analysed by SDS-PAGE.  
Panel A) Control aggregation assay performed in the absence of the chaperone proteins. Lane 1 Bio-
Rad broad range protein markers, lane 2 and lane 3 pellet and supernatant fractions for reactions carried 
out in the absence of rHH complex. 
Panel B) Aggregation assay performed in the presence of the rHH complex. Lane 1 Bio-Rad broad 
range protein markers, lane 2 and lane 3 pellet and supernatant fractions for reactions carried out in the 
presence of the rHH complex, lane 4 and lane 5 pellet and supernatant fractions for reactions carried out 
in the presence of the rHH complex and ATP.  
  
Page 96 
In the absence of the chaperone system, 81.4% of luciferase aggregated during a 10 
minute incubation at 42°C (Figure 4.2, column 3). However, when the recombinant 
Hsc70/HSJ1b complex was present during thermal inactivation, 82.4% of the total 
luciferase protein remained soluble (Figure 4.2, column 1). Significantly this 
chaperone effect was ATP independent since addition of ATP improved the solubility 
of luciferase by only 5% (Figure 4.2, column 2). The rHH protein used in the assay 
was used directly after elution from the Ni-NTA column and contained 200 mM 
imidazole. In order to confirm that the imidazole did not play any role in the observed 
ATP independent luciferase protection, the assay was repeated with dialysed protein. 
However this did not affect the results of the assay (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Prevention of luciferase aggregation by the rHH complex. 
0.8 µM of luciferase was thermally denatured at 42oC for 10 minutes in the presence/absence of the 1.27 
µM chaperones. For the reactions containing ATP, the nucleotide was added at a concentration of          
2 mM. The reaction was centrifuged at 13,000 rpm to separate the soluble and aggregated fractions and 
analysed by SDS-PAGE. The amount of luciferase present in each fraction was quantified by 
densitometry and the percentage of soluble and aggregated luciferase for each reaction was calculated 
and plotted using MS Excel. Data for the luciferase reactions performed in the presence of rHH protein 
(+/- ATP) are expressed as mean values +/-S.E. (n = 4) 
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The nucleotide independent nature of the protection was confirmed when the assay 
was performed in the presence of different nucleotides such as ADP, AMP and AMP-
PNP (Figure 4.3).  In all cases the rHH protein showed consistent levels of luciferase 
protection. In the assay performed without any nucleotide the levels of soluble 
luciferase was observed to be 85.7% which was comparable to the percentage of 
luciferase protected in the presence of nucleotides. Thus, the percentage of luciferase 
protected by the rHH complex at 42oC appeared to be nucleotide independent. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Effect of nucleotides on the solubility of thermally denatured luciferase 
 
0.8 µM of luciferase was thermally denatured at 42oC for 10 minutes in the presence of the 1.27 µM 
chaperones. The different nucleotides (ATP, ADP, AMP, AMP-PNP) were added at a concentration of 2 
mM. The reactions were centrifuged at 13,000 rpm to separate the soluble and aggregated fractions and 
analysed by SDS-PAGE. The amount of luciferase present in each fraction was quantified by 
densitometry and the percentage of soluble and aggregated luciferase for each reaction was calculated 
and plotted on MS Excel. 
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Using the thermal aggregation assay we also studied the response of the rHH complex 
to increasing concentration of denatured substrate (Figure 4.4). Thermal denaturation 
assays were performed as described previously, only the amount of luciferase used in 
the assay was varied. The assay was carried out at constant chaperone concentration 
(1.27 µM, calculated using MW of rHH as 110 kDa) with increasing concentrations of 
luciferase (0.3-1.27 µM). It was observed that the recombinant complex could 
maintain luciferase in a soluble state up to a ratio of 1:1 (protein: luciferase) 
concentration, beyond which the efficiency of protection reduced by almost 60%. As 
with the previous studies, addition of ATP did not alter the capacity of the chaperone 
complex to bind denatured substrate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Efficiency of luciferase protection offered by the rHH complex. 
 
The assay was carried out with varying amounts of luciferase as described in the previous section. 
Briefly, 0.3, 0.6, 0.8, 1 and 1.27 µM of luciferase was thermally denatured at 42oC for 10 minutes in the 
presence of the 1.27 µM chaperones. For the reactions containing ATP, the nucleotide was added at a 
concentration of 2 mM. The reaction was centrifuged at 13,000 rpm to separate the soluble and 
aggregated fractions and analysed by SDS-PAGE. The amount of luciferase present in the two fractions 
was quantified by densitometry and represented as percentage of combined luciferase in soluble and 
aggregated fractions for each reaction and plotted using MS Excel. 
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A divalent cation in the form of magnesium is routinely used in the aggregation assay. 
However Hsc70 has been shown to be capable of binding to both calcium and 
magnesium metal ions (Flaherty et al., 1994, Sriram et al., 1997). We therefore studied 
the effect of replacing the Mg2+, normally used in the assay, with equal amounts of 
Ca2+. Replacement of Mg2+ with Ca2+ at a concentration of 3 mM had a negligible 
effect on the percentage of luciferase protection (reduced by 6%). At the same time we 
also performed the assay with Ni2+ to assess if any other cation (not just Ca2+) could 
take up the role of Mg2+ in the reaction (Figure 4.5). However, substitution of Mg2+ 
with Ni2+ completely abolished the chaperone protein’s ability to bind to denatured 
substrate. This clearly emphasised that divalent cations in the form of Mg2+ or Ca2+ are 
crucial for mediating the interaction of chaperone complex and the denatured substrate.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5:    Divalent cation requirement of the rHH complex. 
 
0.8 µM of luciferase was thermally denatured at 42oC for 10 minutes in the presence of the 1.27 µM 
chaperones, and presence/absence of 2 mM ATP in assay buffer (20 mM Tris-HCl pH 8.0, 50 mM 
potassium chloride, 3 mM magnesium chloride and 2 mM DTT). The divalent cation requirement of the 
complex for efficient substrate protection was established by performing the assay in the presence of 3 
mM Ca2+ or Ni2+. The reaction was centrifuged at 13,000 rpm to separate the soluble and aggregated 
fractions and analysed by SDS-PAGE. The amount of luciferase present in each fraction was quantified 
by densitometry and the percentage of soluble and aggregated luciferase for each reaction was 
calculated and plotted using MS Excel. 
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1 2 3 
4.3.1.1. Protection of functional activity of thermally 
denatured luciferase 
While the rHH complex could prevent aggregation in 82-88% of luciferase subjected 
to thermal denaturation assay, it was also necessary to assess if the rHH complex could 
maintain the protected luciferase in a functionally competent state. Functional activity 
of the soluble luciferase was quantified by measuring the luminescence readings for 
the reaction of luciferase with its substrate luciferin. Oxidation of luciferin by 
luciferase results in the production of light and so luminescence readings for the non-
aggregated luciferase after thermal denaturation was measured (Figure 4.6). From the 
assay it was observed that the luminescence readings for the luciferase subjected to 
thermal aggregation in the presence of chaperone proteins, but absence of ATP, was 
three fold less than in the presence of ATP. However this value was less than 1% of 
activity measured for native luciferase which was not subjected to stress at 42oC (data 
not shown). Therefore it was concluded that the luciferase, although protected from 
thermal aggregation by the rHH complex, was not functionally active. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Functional activity of the soluble luciferase 
0.8 µM of luciferase was thermally denatured at 42oC for 10 minutes in the presence of the 1.27 µM 
chaperones, and presence/absence of 2 mM ATP in assay buffer (20 mM Tris-HCl pH 8.0, 50 mM 
potassium chloride, 3 mM magnesium chloride and 2 mM DTT). The reaction was centrifuged at 13,000 
rpm to separate the soluble and aggregated fractions. To the soluble fraction, 50 µl of luciferase assay 
buffer (Promega) was added. Luminescence readings were measured for using a luminometer and 
plotted as percentage of native luciferase activity. Reaction 1 contained luciferase on its own. Reaction 2 
contained luciferase in the presence of the rHH complex and Reaction 3 contained luciferase in the 
presence of the rHH complex and ATP. 
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We next checked if reactivation of luciferase activity could be encouraged by a 
temperature downshift from 42oC to 25oC. Luminescence readings for denaturation 
reactions carried out in the presence/absence of chaperones and also in the 
presence/absence of ATP were measured every 20 minutes for up to 1 hour and 40 
minutes (Figure 4.7). Although refolding reactions carried out for in the presence of 
chaperone proteins and ATP exhibited higher and continually increasing luminescence 
readings, the readings obtained were still < 2% of activity measured for native 
luciferase which was not subjected to stress at 42oC and therefore considered to be 
insignificant. Thus, although the rHH complex could hold denaturing luciferase in a 
soluble state, it was incapable of refolding it into its functional state.  
 
Figure 4.7: Refolding of thermally denatured luciferase by rHH complex.  
Luciferase (0.8 µM) was thermally denatured at 42°C for 10 minutes in the presence or absence of the 
indicated concentrations of chaperones (1.27 µM) and then allowed to refold at 25°C. 2 µl was 
withdrawn from the reaction every twenty minutes and luciferase activity was measured after the 
addition of 50 µl of luciferase assay buffer (Promega). Activity was measured for various times using a 
luminometer and plotted as percentage of native luciferase activity. 
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4.3.1.2.  ATP hydrolysis assay  
Hsc70 displays low intrinsic ATPase activity which is stimulated by binding to 
denatured substrate (Flynn et al., 1989). The phosphate released upon the addition of 2 
mM ATP was measured using a colorimetric assay. Under normal assay conditions at 
37oC, 50 nmol/mg/min of phosphate was released (column 1, Figure 4.8). The 
stimulation of ATPase activity of rHH complex by denatured luciferase was studied by 
measuring the phosphate released from the system after thermal aggregation (columns 
2 and 3, Figure 4.8). The ATPase activity measured for the rHH protein was very 
similar irrespective of the absence (22.5 nmol/mg/min, column 2) or presence of 
unfolded substrate (25.4 nmol/mg /min, column 3). It was found that the rHH complex 
exhibited far greater phosphate release under non-denaturing conditions (37oC) than 
denaturing condition (42oC).  At 42oC phosphate release is reduced by almost 50%, 
possibly due to protein aggregation. At 42 oC, a combination of HSJ1b and luciferase 
did not produce any significant increase in Hsc70 ATP hydrolysing activity above that 
for HSJ1b alone at 42oC. ATP hydrolysis is necessary to stabilise the ternary complex 
formed between the Hsc70 and unfolded substrate. However in the case of the rHH, 
Hsc70 has probably pre-attained this stable conformation due to its interaction with 
HSJ1b.   
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Figure 4.8:  Effect of denatured luciferase on the ATPase activity of Hsc70 of the rHH complex 
 
rHH complex (1.27 µM) was  incubated in ATPase assay buffer with and without luciferase (0.8 µM) at 
42°C, and release of free phosphate was measured by a spectrophotometric method (OD620). The levels 
of phosphate released for each condition were converted into nanomoles of free phosphate liberated by 
comparison with a KH2PO4 standard. Data are expressed as means +/-S.E. (n = 3) 
 
 
1 2 3 
  
Page 104 
4.3.2. Detection of bound nucleotide 
The recombinant Hsc70/HSJ1b complex did not appear to require nucleotides for 
substrate protection activity (refer section 4.3.1). This was possible if the purified 
Hsc70/HSJ1b complex contained endogenously bound nucleotide. To determine this, a 
preliminary analysis was carried out by deriving the UV absorption spectrum of the 
purified complex between 230-400 nm (Figure 4.9). A pure protein is expected to have 
symmetric curve with a maximum at 280 nm. Also the absorbance at 320 nm is 
expected to be close to zero, since absorbance at 320nm is an indication of sample 
turbidity and protein aggregation (Aitken and Learmonth, 1998). In the case of the 
rHH protein, a symmetrical curve was not obtained and the absorbance at 260 nm and 
280 nm were determined to be 0.176 and 0.119 respectively. However, the absorbance 
at 320 nm for the complex was observed to be only 0.03 (indicated by an arrow on 
Figure 4.9), indicating the absence of aggregation in the protein sample. The 
A260/A280 ratio for pure protein should be 0.5-0.7 (Held, 2008). The 
A260/A280 ratio for the rHH protein was calculated to be 1.4, suggesting the presence 
of additional A260 absorbing material such as ATP, other nucleotides, or nucleic acid 
such as DNA or RNA.  
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Figure 4.9: UV absorption spectroscopy of the rHH complex 
 
Absorption measurements of purified rHH complex were obtained with a Perkin Elmer 
spectrophotometer using a 1 cm path-length quartz cuvette. The spectrum was measured between 200-
400 nm with a 15 second delay. The UV spectrum of rHH protein) has a maximum at approximately 
258 nm and the A260 /A280 ratio has a value of 1.4. The A320 position is indicated by a black arrow.  
In order to confirm the identity of the co-purifying nucleotides with the purified rHH 
protein, extraction of any bound nucleotide was performed using perchloric acid and 
the samples were analysed on a C18 HPLC column (Figure 4.10).  The elution profile 
of the extracted nucleotide (Panel C, figure 4.10) was compared with the elution peaks 
obtained for standard ADP (Panel A, Figure 4.10) and ATP (Panel B, Figure 4.10). 
Several low intensity elution peaks were observed at various retention times (indicated 
by an arrow in Panel C) and therefore the analysis was inconclusive. The peak 
observed between 1.5-3.0 ml in Panel C was attributed to the reagents used in the 
extraction protocol, and was observed in all samples subjected to perchloric acid based 
extraction. 
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Figure 4.10: HPLC analysis of nucleotide content of the rHH complex 
Nucleotides were extracted by treating the rHH protein sample with 0.6 M perchloric acid and then centrifuged at 10,000 rpm for 10 minutes in a microfuge. The 
supernatant was collected and neutralized with KOH and clarified by another centrifugation. Nucleotides were analysed by reverse-phase chromatography with a C18 
column and detected at 254 nm. The column was run at a flow rate of 1 ml/minutes for a total elution time of 15 minutes. The elution system contained 50 mM 
potassium phosphate (pH 7.0). Panel A is ADP elution profile, Panel B is elution profile of ATP and Panel C is that of the nucleotide extracted from rHH protein 
complex. The position of the various elution peaks are indicated by arrows in Panel C. 
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4.3.3. Partial proteolysis studies 
Limited proteolysis experiments using trypsin and chymotrypsin were undertaken to 
study the conformation flexibility in the arrangement of the Hsc70 and HSJ1b subunits 
in the rHH complex. The change in protease accessibility upon nucleotide binding was 
also investigated, and these results are presented in the following sections.  
4.3.3.1. Determination of optimal temperature for 
proteolysis 
 The optimal temperature for the proteolysis of the rHH complex using chymotrypsin 
was determined by performing the assay at both 30oC and 4oC for 15 minutes using 
chymotrypsin. Electrophoresis of the digested and undigested fragments suggested that 
at 30oC the proteolysis occurred extremely quickly, resulting in total digestion of the 
40 kDa HSJ1b species (lane 2, Figure 4.11, whereas at the lower temperature i.e. 4oC 
the proteolysis proceeds more slowly and immediate proteolysis of HSJ1b polypeptide 
does not occur (lane 3, Figure 4.11). A similar experiment was performed with trypsin 
also, and again proteolysis at 4oC was found to be a more suitable temperature to 
monitor the proteolysis (data not shown). Therefore all subsequent experiments were 
performed at 4 oC. 
 
 
 
 
 
 
 
 
 
Figure 4.11: Determination of optimal temperature for the proteolysis of rHH complex 
 
Limited proteolysis of the recombinant complex was carried out using chymotrypsin at 30oC and 4oC. 5 
µg of the protein was incubated with 0.016 µg of chymotrypsin. The digestions were performed in 
buffer containing 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 mM magnesium chloride and 2 
mM DTT for 15 minutes and the products were analysed on a 12% polyacrylamide gel stained with 
Coomassie Blue. Lane 1 is the control protein in the absence of chymotrypsin, lane 2 is the proteolysis 
performed at 30oC and lane 3 is the reaction performed at 4oC. 
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4.3.3.2. Time course for chymotrypsin proteolysis  
The Hsc70/HSJ1b complex was digested with chymotrypsin in the absence of 
nucleotides or in the presence of ATP at 4oC. The reaction was stopped at various time 
points by the addition of protease inhibitor and the digestion products were visualised 
by SDS-PAGE (Figure 4.12). Lanes 4-8 represent the proteolysis pattern obtained in 
the absence of nucleotide and lanes 9-14 were the reactions carried out in the presence 
of ATP. The HSJ1b was more sensitive to proteolysis than Hsc70. Proteolysis of 
HSJ1b (40 kDa) and the subsequent appearance of a ~30 kDa proteolysis product 
(indicated by a red arrow, Lane 4) could be observed within 10 minutes of 
commencement of the proteolysis reaction. The majority of the full length HSJ1b 
protein was proteolysed within 60 minutes. Hsc70 protein showed limited signs of 
proteolysis and no major proteolysis product arising from this subunit could be 
detected. However two minor products observed at ~49 kDa and 52 kDa are 
indications of possible Hsc70 proteolysis. 
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Figure 4.12: Time course for chymotrypsin proteolysis of the rHH complex. 
 
Limited proteolysis of the recombinant complex was carried out using chymotrypsin at 4oC. Digestion 
was started by the addition of chymotrypsin to the reaction mix. 30 µg of the protein was incubated with 
0.1 µg of chymotrypsin. At specific time intervals, 15 µl aliquots were withdrawn from the reaction mix 
and the proteolysis was stopped by the addition of 0.5 µl of 10 mg/ml trypsin inhibitor prepared in 10 
mM Tris-HCl pH 8.0. 5 µl of 4X SDS-PAGE loading dye was added and the sample was incubated at 
95oC for 2 minutes and stored on ice until all reactions were completed. The proteins were resolved on a 
12% polyacrylamide gel stained with Coomassie Blue. Lanes 1 and 9 is the control protein in the 
absence of chymotrypsin, lane 2 is the Bio-Rad molecular weight markers, lanes 4-8 are the proteolysis 
products observed at t=10, 30, 45, 60 and 75 minutes respectively and lanes 10-14 are the proteolysis 
products formed in the presence of ATP at t=10, 30, 45, 60 and 75 minutes respectively. The red arrow 
indicates the position of the potential HSJ1b cleavage product, while the black arrow marks the position 
of possible Hsc70 cleavage products. 
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The rate of proteolysis of both the subunits was monitored and quantified using 
densitometry (Panel A and B in Figure 4.13). In the absence of ATP, 86.7% of Hsc70 
remained undigested at the end of the 75 minutes. This was only 8% more than the 
undigested Hsc70 quantified in the reactions carried out in the presence of ATP (Panel 
A in Figure 4.13). Therefore the presence or absence of ATP in the proteolysis reaction 
does not appear to overtly alter the rate of Hsc70 proteolysis. Similarly, the 
presence/absence of nucleotides did not appear to alter the rate of HSJ1b proteolysis. 
Again an 8% increase in the digestion of HSJ1b was observed in the presence of ATP 
(Panel B, Figure 4.13). Thus, both the Hsc70 and HSJ1b components of the 
recombinant complex display only a very slight increase in sensitivity to proteolysis in 
the presence ATP, and almost 60% of HSJ1b is digested within 75 minutes.  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.13: Densitometric analysis of undigested Hsc70 and HSJ1b  
 
Limited proteolysis was performed as described in the previous section and the digestion products were 
analysed on a 12% polyacrylamide gel stained with Coomassie Blue. The gel used in this analysis has 
been presented in figure 4.12. From the gel, Hsc70 (Panel A) and HSJ1b (Panel B) were quantified by 
densitometry for the entire duration of proteolysis (75 minutes).  
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4.3.3.3. Time course for trypsin proteolysis  
We next subjected the rHH protein to limited proteolysis by trypsin. Chymotrypsin and 
trypsin have different amino acid cleavage specificity, and therefore this could extend 
the scope of our proteolysis studies. Trypsin predominantly cleaves peptide chains at 
the carboxyl side of the amino acids lysine and arginine, while chymotrypsin targets 
the carboxyl side of tyrosine, tryptophan, and phenylalanine (amino acids containing 
an aromatic ring) (Stryer et al., 2002). Trypsin proteolysis was carried out following 
the same protocol used for chymotrysin. Panel A Figure 4.14 is the trypsin digest 
pattern obtained in the absence (Lanes 1-7, Panel A, Figure 4.14) and presence of ATP 
(Lanes 8-14, Panel A, Figure 4.14) respectively. 
Two prominent features were noticed. Firstly, HSJ1b appears to undergo very rapid 
proteolysis. No evidence of the polypeptide is observed as early as 10 minutes into the 
reaction. This is consistent both in the presence and absence of ATP. A possible 
proteolysis product is observed at ~32-35 kDa (indicated by arrow on Figure 4.14) at 
t=10 minutes, which subsequently disappears. Also proteolysis of Hsc70 can be 
observed. The site of proteolysis appears to be at the extreme C or N-terminal region 
of the protein since the size of the resulting proteolysis product differs from the 
undigested product (73 kDa)  by only 1 or 2 kDa (~70-71 kDa).  An analysis of the 
protein sequence by the Generunner software established that the only potential 
cleavage site which can give rise to a 71 kDa product occurs in the Factor Xa site 
which follows the N-terminal His•Tag® sequence on the pET-16b expression vector. 
The resulting 71 kDa product could be therefore the native Hsc70 without the histidine 
tag. The percentage of undigested Hsc70 was calculated by densitometry. From Panel 
B in Figure 4.14 it can be observed that within 30 minutes more that 70% of the 
protein has undergone proteolysis to form the ~70-71 kDa product. The proteolysis 
proceeds in a similar fashion both in the presence and absence of ATP. No other 
proteolysis product formed by the subsequent proteolysis of 70 kDa fragment is 
apparent, suggesting that the rest of the protein is protected from trypsin proteolysis. 
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Figure 4.14: Time course for trypsin proteolysis for the rHH protein 
 
Limited proteolysis of the recombinant complex was carried out using trypsin at 4oC. Digestion was 
started by the addition of trypsin to the reaction mix. 30 µg of the protein was incubated with 0.1 µg of 
trypsin. At specific time intervals, 15 µl aliquots were withdrawn from the reaction mix and the 
proteolysis was stopped by the addition of 0.5 µl of 10 mg/ml trypsin inhibitor prepared in 10 mM Tris-
HCl pH 8.0. 5 µl of 4X SDS-PAGE loading dye was added and the sample was incubated at 95oC for 2 
minutes and stored on ice until all reactions were completed. The proteins were resolved on a 12% 
polyacrylamide gel stained with Coomassie Blue.  
Panel A) Lanes 1 and 9 is the control protein in the absence of trypsin, lane 2 Bio-Rad molecular weight 
markers, lanes 4-8 proteolysis products observed at t=10, 30, 45, 60 and 75 minutes respectively and 
lanes 10-14 proteolysis products formed in the presence of ATP at t=10, 30, 45, 60 and 75 minutes 
respectively. Putative HSJ1b proteolysis product observed at ~32-35 kDa is indicated by a black arrow 
Panel B) Densitometric analysis of undigested Hsc70 after proteolysis by trypsin 
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4.3.3.4. Effect of nucleotides on the conformation of the 
complex 
Hsp70 proteins have been shown to adopt three different conformations depending on 
the occupancy of the NBD (Buchberger, et al., 1995, Fung et al., 1996). To determine 
if Hsc70 complexed with HSJ1b also adopts different conformations, the tertiary 
structure was probed by partial digestion with chymotrypsin in the presence of various 
nucleotides and the fragments were separated by SDS-PAGE (Figure 4.15). The 
protein was digested with chymotrypsin for 10 minutes in the absence of nucleotides 
(lane 2, Figure 4.15) or in the presence of ATP (lane 3, Figure 4.15), ADP (lane 4, 
Figure 4.15) or AMP-PNP, a non hydrolysable analogue of ATP (lane 5, Figure 4.15). 
No significant difference could be observed in the proteolytic patterns of the protein in 
the presence of the different nucleotides.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Effect of nucleotides on the  proteolysis of the rHH  protein by chymotrypsin 
 
5 µg of the rHH protein was incubated with 0.016 µg with chymotrypsin at 4°C for 10 minutes. The 
digestions were performed in buffer containing 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 
mM magnesium chloride and 2 mM DTT for 15 minutes and the products were analysed on a 12% 
polyacrylamide gel stained with Coomassie Blue.  Nucleotides were added at a concentration of 2 mM.  
Lane 1 is the control protein in the absence of chymotrypsin. Lane 2 is the proteolysis performed in the 
absence of nucleotide, lane 3 in the presence of ATP, lane 4 in the presence of ADP and lane 5 in the 
presence of AMP-PNP.  
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4.3.4. Oligomeric properties of the recombinant complex 
4.3.4.1. Size exclusion chromatography 
The oligomeric composition of the co-expressed Hsc70/HSJ1b protein was studied by 
size exclusion chromatography performed using a Superdex-200 gel filtration column 
calibrated using standard proteins. The standard curve obtained has been described in 
Section 2.10.4. The rHH Ni-NTA elution fractions were pooled and loaded onto the 
column. One ml fractions were collected and proteins were detected by measuring the 
protein concentration using Bradford assay (Bradford, 1976). The protein resolved into 
two elution peaks. The first peak was detected in the void volume, eluting between 30-
44 ml with the peak fraction collected at 36 ml (represented as peak 1 on the 
chromatogram in panel A of Figure 4.16). The second peak in the included volume 
eluted between 46-60 ml. The peak fraction was obtained at 52 ml (represented as peak 
2 on the chromatogram in panel A of Figure 4.16). The molecular weight of the protein 
species in peak 2 was calculated to be ~220 kDa from the calibration curve developed 
in Section 2.10.4. This is equivalent to a dimer of the rHH heterodimer (2 molecules of 
Hsc70 + 2 molecules of HSJ1b).    
The fractions obtained from the Superdex-200 column were analysed by gel 
electrophoresis (Panel B, Figure 4.16). It was observed that both Hsc70 and HSJ1b 
subunits co-fractionate together in both elution peaks; however the stoichiometry of 
the two subunits varied for the two peaks. In peak 1 of SEC, the HSJ1b subunit 
appears to be the major species in the fraction, while in peak 2 of SEC, it is Hsc70. By 
visual inspection of the staining pattern on the gel, it appears that in peak 1 the ratio of 
Hsc70 and HSJ1b subunits seems to be 1:2 (Lanes 1-4, Panel B, Figure 4.16), while in 
peak 2, the Hsc70 subunit appears to be in excess over that of the HSJ1b subunit 
(Lanes 5-9, Panel B, Figure 4.16).   
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Figure 4.16:  Size exclusion chromatography of the rHH complex. 
 
Size exclusion chromatography was performed on a Superdex-200 column and the protein eluting from 
the column was collected as 1 ml fractions. The column volume (Vt) was 90 ml and the void volume 
(V0) was estimated to be 36 ml. Absorbance of each fraction was determined using Bradford assay. 20 
µl of protein from the indicated fractions was also analysed by SDS-PAGE gel electrophoresis. 
Panel A: Elution profile of the rHH complex from the Superdex-200 column 
Panel B: SDS-PAGE analysis of elution fractions. Lanes 1-4 are alternate fractions starting at fraction 
34 until fraction 40, while alternate fractions starting at fraction 48-56 were loaded on lanes 5 -9 and 
lane 10 is the Bio-Rad precision plus molecular weight marker (broad range). 
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To determine if the two isolated peaks were functionally active, a thermal denaturation 
assay with 0.8 µM of luciferase was carried out as described in section 4.3.2.1.  1.27 
µM of protein (calculated using MW of 110 kDa) from both the SEC peaks were used 
in the assay. The Hsc70/HSJ1b protein species from both peaks were found to be 
capable of protecting luciferase from thermal aggregation (Figure 4.17).  However the 
percentage of luciferase retained in the soluble form was much lower for the isolated 
gel filtration peaks, when compared with the un-fractionated rHH protein after Ni-
NTA chromatography. About 87% of the total luciferase remained soluble, when 
thermally denatured in the presence of the un-fractionated recombinant complex 
(columns 1 and 2, Figure 4.17). However with peak 1 ~50% luciferase was soluble 
(column 3, Figure 4.17), while peak 2 protected just over 40% (column 4, Figure 4.17). 
Both species showed a marginal increase in protection upon inclusion of ATP in the 
reaction mix (column 4 and 6, Figure 4.17), with peak 2 protecting almost 30% more 
luciferase (increase from 42.1% to 55.6%) upon addition of ATP. The reason for this 
observed functional difference between the fractionated and un-fractionated protein 
species is not clear. 
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Figure 4.17: Functional activity of two peaks obtained after SEC of rHH. 
 
Luciferase was thermally denatured at 42oC for 10 minutes in the presence of the different rHH fractions 
and nucleotide. The reaction was spun down at 13,000 rpm to separate the soluble and aggregated 
fractions and analysed by SDS-PAGE. The amount of luciferase present in each fraction was quantified 
by densitometry and the percentage of soluble and aggregated luciferase for each reaction was 
calculated and plotted on MS Excel. 
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4.3.4.2. Sedimentation velocity analysis of peak 1 
Hsc70 has been shown to oligomerise under a variety of conditions. One such factor 
which promotes the self association of Hsc70 is its association with Hsp40 partner 
protein. It was therefore necessary to determine if peak 1 obtained from size exclusion 
chromatography corresponds to well folded higher order oligomers or just undesirable 
aggregates. Peak 1 protein fractions were pooled and concentrated down to a final 
concentration of 0.8 mg/ml. The protein was then subjected to biophysical analysis by 
analytical ultracentrifugation (AUC). The experiment and analysis was performed by 
Dr. Dave Scott at the University of Nottingham. Sedimentation velocity analysis was 
performed at three different protein dilutions. Figure 4.18 is the sedimentation 
coefficient distribution obtained for all three dilutions of peak 1. The sedimentation 
peak at 10S represents the main protein peak and is consistent for all dilutions 
(represented by black arrow). Additionally, other peaks sedimenting faster than the 
main peak can also be observed. Philo, states that well resolved faster sedimenting 
peaks are indicative of aggregated protein species, while unresolved faster sedimenting 
peaks represent rapidly reversible self-associating oligomers (Philo, 2003). In the case 
of the peak 1 samples these peaks are not well resolved; thereby suggesting that peak 1 
represents non-aggregated higher order oligomeric protein species. The molecular 
weight of the peak at 10S was calculated to be around 1.1 MDa.  
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Figure 4.18:  Sedimentation coefficient distribution for peak 1 of Hsc70/HSJ1b complex. 
 
Peak 1 containing protein fractions were pooled and concentrated down to a final concentration of 0.8 
mg/ml. Sedimentation velocity experiments were performed on a Beckman XL-A analytical 
ultracentrifuge (Beckman-Coulter) and run in the gel filtration buffer (20 mM Tris-HCl pH 8.0, 100 mM 
KCl) at different protein dilutions. Plots correspond to the calculated distribution of sedimentation 
coefficients, c(s) vs. sedimentation coefficient, S, in Svedberg units. The arrow mark indicates the 
position of the 10S peak. 
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4.3.5. Factors affecting oligomerisation of the rHH complex 
From the previous sections, it was established that the two peaks obtained after SEC of 
rHH were in fact two functional forms of the complex. The next question was to 
understand the relationship between the two forms and what factors, if any, promoted 
the conversion of one form to the other. ATP and heat treatment at 42oC with 
luciferase were identified as potential factors which could alter the oligomeric 
properties of the complex.  
4.3.5.1. Effect of thermally denatured luciferase  
The effect of binding to denatured substrate on the protein oligomerisation was studied 
using the soluble fraction obtained from the thermal aggregation assays carried out in 
the presence of ATP, using the protocols described in Section 4.3.2. Size exclusion 
chromatography was performed as before. Elution profiles were compared with that of 
the untreated rHH complex (Figure 4.19). As observed for the untreated rHH complex, 
a peak corresponding to the polymerised Hsc70/HSJ1b complex was observed in the 
void volume (represented as peak 1 on the chromatogram in panel A of Figure 4.19). 
Similarly, the ~220  kDa  peak was also present; however for the protein incubated 
with denatured luciferase the peak eluted 2 ml earlier than usual. This could be due to 
the run conditions or because of luciferase binding to the protein. 
Addition of thermally denatured luciferase affects the oligomerisation of the rHH 
complex, as reflected by the difference in proportion of peak 1 compared to peak 2. 
The protein associated with denatured substrate was found to resolve more as the ~220 
kDa form compared to the untreated complex. A clearer picture emerges when the area 
under the peak was calculated for each peak and compared (Panel B, Figure 4.19). In 
the absence denatured luciferase, 64% of the rHH complex existed as oligomerised 
fraction. However interaction with thermally denatured luciferase reduced the 
percentage of oligomerisation to 28.4%. This reduction in oligomerisation was 
compensated by a corresponding increase in the ~220 kDa complex species. Thus 
denatured substrate promotes disassociation of the oligomeric peak 1 to form the ~ 220 
kDa peak 2. The recovery of the protein from the Superdex column was extremely low 
and the ternary complex between the Hsc70/HSJ1b complex and luciferase could not 
be visualised by SDS-PAGE. 
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Figure 4.19: Effect of denatured substrate on oligomerisation of the rHH complex. 
 
To obtain the C+L+A trace ,  thermal aggregation assay was set up as described in section 4.2.2 using 75 
µg of the rHH protein with 50 µg of luciferase. The supernatant recovered after centrifugation at 13,000 
rpm for 10 minutes was loaded onto the gel filtration column. The chromatography was performed in 
the assay buffer (20 mM Tris-HCl pH 8.0, 100 mM potassium chloride, 3 mM magnesium chloride and 
2 mM DTT) following the protocol described previously. 
Panel A: Comparison of the elution profile of the rHH complex (C) with complex treated with 
denatured luciferase in the presence of ATP (C+L+A). 
Panel B: Distribution of the two peaks in C and C+L+A calculated using the area under the individual 
graphs obtained from panel A. 
Panel B 
Panel A 
Elution volume in ml 
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4.3.5.2. Effect of ATP 
In order to study the effect of ATP has on the oligomeric composition of the complex; 
the protein was incubated with 2 mM ATP for 30 minutes at room temperature before 
being loaded onto the column. Elution profiles were compared with that of the 
untreated rHH complex (Figure 4.20). Comparison of the two profiles shows that the 
addition of ATP affects the extent of oligomerisation of the complex, as seen by the 
difference in proportion of peak 1 compared to peak 2. The protein associated with 
ATP was found to resolve more as the ~220 kDa form compared to the untreated 
protein. A clearer picture emerges when the area under the peak was calculated for 
each peak and compared (Panel B, Figure 4.20). Prior to addition of ATP 64% of the 
rHH complex existed as oligomerised fraction. However, addition of ATP reduced this 
to 40.5%. This reduction in oligomerisation was compensated by a corresponding 
increase in the ~220 kDa complex species. Thus ATP promotes disassociation of the 
oligomeric peak 1 to form the ~ 220 kDa peak 2. 
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Figure 4.20: Effect of ATP on oligomerisation of the rHH complex. 
 
The C+A trace was obtained by incubating 75 µg of the rHH for 30 minutes with 2 mM ATP at room 
temperature in buffer consisting of 20 mM Tris-HCl pH 8.0, 100 mM potassium chloride, 3 mM 
magnesium chloride and 2 mM DTT and then loaded onto the gel filtration column. The 
chromatography was performed in the assay buffer (20 mM Tris-HCl pH 8.0, 100 mM potassium 
chloride, 3 mM magnesium chloride and 2 mM DTT) following the protocol described previously. 
Panel A: Comparison of the elution profile of the rHH complex (C) with complex treated with ATP 
(C+A)). 
Panel B: Distribution of the two peaks in C and C+A calculated using the area under the individual 
graphs obtained from panel A. 
Panel B 
Panel A 
Elution volume in ml 
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The effect of ATP was studied further in detail to confirm that the increased proportion 
of ~220 kDa species was due to the breakdown of the oligomeric species. This was 
achieved by pooling the SEC peak 1 fractions and then treating with ATP for different 
time periods at room temperature. The samples were then analysed by gel filtration. In 
the first instance, the protein was incubated for 15 minutes at RT and its elution from 
the gel filtration column was analysed (blue trace in Figure 4.21). Clear signs of 
disassociation and formation of peak 2 can be observed. 15 minutes incubation with 
ATP resulted in the conversion of 23% of peak 1 into peak 2 (Panel B in Figure 4.21). 
Further incubation for another 15 minutes resulted in an additional 14% conversion 
(Panel B in Figure 4.21). However the maximum disassociation observed after 30 
minutes is only a 37.3% conversion. This suggests a slow rate of conversion between 
the two forms. Probably a longer incubation time can induce further conversion, or the 
possibility exists that a percentage of the protein cannot be converted since it might be 
aggregated (as observed by the multiple peaks of AUC). In order to establish that the 
observed depolymerisation was not due to spontaneous disassociation of peak 1 upon 
re-chromatography, peak 1 protein fractions were pooled together and also re-
chromatographed over the gel filtration column. From the chromatogram in Figure 
4.21 (purple trace) it is clear that the elution profile of peak 1 remains unchanged and 
no spontaneous disassociation into peak 2 is detected. Therefore the observed 
disassociation in this experiment has to be ATP induced. 
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Figure 4.21: ATP induced disassociation of peak 1 
The protein fractions of the oligomeric peak 1 were pooled and treated with 2 mM ATP for 15 and 30 
minutes at room temperature in buffer consisting of 20 mM Tris-HCl pH 8.0, 100 mM Potassium 
chloride, 3 mM Magnesium chloride and 2 mM DTT. The reactions were subjected to SEC as described 
previously in section 4.3.6.1. The column was equilibrated with 20 mM Tris-HCl pH 8.0 plus 100 mM 
KCl. 1 mL fractions were collected after 25 ml of buffer had passed. The fractions were analysed for 
protein content using Bradford assay. 
Panel A: Comparison of the elution profile of untreated peak 1 with protein treated with ATP for 15 
minutes and 30 minutes respectively.  
Panel B: Distribution of the two peaks calculated using the area under the individual graphs obtained 
from panel A. 
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Since ATP causes the oligomeric peak 1 to disassociate into peak 2, then could it also 
induce total disassociation of peak 2 into its individual components, – Hsc70 and 
HSJ1b? To answer this question, peak 2 fractions were pooled together and incubated 
for 30 minutes at room temperature with 2 mM ATP. The ATP treated protein was 
then loaded onto a Ni-NTA column and the bound proteins was eluted with 200 mM 
imidazole.  The fractions were analysed by SDS-PAGE (Figure 4.22).  If ATP results 
in the disassociation of the Hsc70 and HSJ1b subunits of peak 2, then the HSJ1b 
subunit should not be observed in the 200 mM elution fractions, as it is would no 
longer associated with the Hsc70 subunit. Analysis of the gel confirmed the same. 
Only Hsc70 was observed in the 200 mM elution fractions (lanes 5 and 6, Figure 4.22), 
while HSJ1b was observed in the flow through and wash fractions (Lanes 2 and 3, 
Figure 4.22).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: ATP induced disassociation of Hsc70 and HSJ1b subunits in peak 2 of SEC 
The protein fractions of the peak 2 were pooled and treated with 2 mM ATP for 30 minutes at room 
temperature and applied to a Ni-NTA column equilibrated with buffer A (50 mM Tris-HCl pH 8.0, 100 
mM NaCl). The protein was eluted in buffer A containing 200 mM imidazole. The polypeptide 
composition was analysed by SDS-PAGE (12% resolving gel) and the gel stained with Coomassie 
Brilliant Blue: Lane1 peak 2 protein loaded on the Ni column, lane 2 column flow through, lane 3 Wash 
with buffer A, lane 4 wash with 30 mM imidazole, lane 5 & lane 6 200mM imidazole elution, lane 7 
Bio-Rad precision plus prestained molecular weight marker. The arrows indicate the elution position of 
the individual Hsc70 and HSJ1b subunits. 
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4.3.6. Structural studies of the full length complex 
One of the primary goals of this work was to obtain structural information regarding 
the interactions of the Hsc70 and HSJ1b members of the HSP70 chaperone and HSP40 
co-chaperone families. From size exclusion chromatography, it was determined that 
the ~220 kDa peak 2 fraction was suitable for X-ray crystallographic trials while the 
1.1 MDa oligomeric peak 1 fraction could be an ideal target for preliminary electron 
microscopy analysis. The following sections describe the preliminary results from both 
experiments.   
4.3.6.1. Crystallisation trials 
An initial crystallisation screen for the peak 2 rHH fraction was set up using the 
Hampton Crystal Screens. These screens are macromolecular crystallisation kits 
composed of a selection of different crystallisation conditions, each condition 
containing different precipitants, salt and buffer solutions as suggested by Jancarik and 
Kim (Jancarik & Kim, 1991). Crystal screen and crystal screen 2 have 50 and 48 
conditions, respectively. Crystallisation trials were set up at room temperature using 
the hanging drop vapour diffusion technique. The hanging drop method is one of the 
most popular crystallisation techniques. In this method, the protein is mixed with the 
reservoir solution (containing precipitants) and the drop is suspended from a cover slip 
and sealed over a well containing the reservoir solution. Super saturation of protein 
macromolecules is achieved by vapour-diffusion. This technique depends on the 
evaporation and diffusion of water between the well solution and protein sample, 
which have different precipitant concentration as a means of achieving super saturation 
and ultimately crystallisation (Benvenuti and Mangani, 2007). During the preliminary 
screening 96 drops were set up (the first 48 conditions from Hampton Screens I and II 
respectively). The drops were monitored for the presence of crystals. The outcome of 
the preliminary screen is presented in Figure 4.23 as a compilation of the drop 
photographs recorded at a single time point 2 months after the set up. Columns 1-6 
correspond to drops set up Hampton crystal screen , and rest were set up with Hampton 
crystal screen 2. Light precipitation was observed in 33 drops and heavy amorphous 
precipitation in 11 conditions, while the rest of the drops were clear. However no 
crystals were obtained and further screening will be required to identify a potential 
crystallisation condition. 
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Figure 4.23: Hanging drop crystallisation trials of the rHH peak 2 SEC fraction with Hampton crystal screen I and II. 
Protein at a concentration of 4 mg/ml was used for crystallisation trials. Initial trials were set up at room temperature via the hanging drop vapour diffusion method. 
The ~ 220 kDa protein was screened using the commercial Hampton Crystal Screens I and II. A total of 96 conditions were set up. Columns 1-6 correspond to the 
first 48 conditions of Hampton crystal screen  and columns 7-12 correspond to that of Hampton crystal screen 2. The screens were periodically monitored and 
photographed for crystal growth.  
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4.3.6.2. Preliminary electron microscopy studies 
Initially, the Hsc70-HSJ1b complex purified from the Ni-NTA affinity-column was 
subjected to negative staining by uranyl acetate and analysed by EM. The analysis was 
carried out by Dr.Corinne Smith at the University of Warwick. Panel A in Figure 4.24 
is the image of the complex obtained at a protein concentration of 0.8 mg/ml. A good 
resolution was not obtained at this concentration. Serial dilution of the Ni-NTA protein 
sample was performed (1:5, 1:10, and 1:20), and then visualised by EM. Discrete 
particles could be observed at 1:20 dilution of the protein sample (Panel B in Figure 
4.24). The majority of the particles appeared to be circular; a magnified view of which 
can be seen in Panel C of Figure 4.24. A few particles with a flower and stalk 
arrangement could also be observed (Panel D, Figure 4.24). This is possibly as a result 
of viewing the molecule from different orientation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24: Negative staining and EM of the co-expressed Hsc70 and HSJ1b complex. 
Protein samples were prepared for electron microscopy by dialysing the Ni-NTA elution fractions 
against 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride overnight at 4oC. The dialysed protein was 
concentrated down to 0.8 mg/ml and used for negative staining electron microscopy. The protein 
complex was negatively stained with freshly made 2% uranyl acetate on thin carbon-coated grids 
previously glow-discharged for 15 s. Panel A is the staining image before dilution. Panel B the image 
obtained after 1:20 dilution. Panel C is the magnified view of the circular particles while Panel D is 
view of particles with the flower and stalk arrangement. 
Panel A 
Panel C 
Panel B 
Panel D 
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Next negative staining was performed with the peak 1 fraction isolated by SEC to 
obtain images of this component of the rHH complex. Again imaging was started 
at a protein concentration of 0.8 mg/ml, and a further 1 in 20 dilution was required 
before discrete particles could be observed (Panel A, Figure 4.25). Two different 
particle types were observed, which have been enlarged in Panel B and C.  
Preliminary image classification studies have determined the size of the larger 
particles to be 260Ǻ and that of the smaller one to be 162Ǻ. These correspond to a 
molecular weight of 1.1 MDa and 420 kDa respectively. AUC had also previously 
estimated the molecular weight of peak 1 to be 1.1 MDa. From the sizing it appears 
that the smaller particles maybe disassociation products of the larger one, possibly 
due to the uranyl acetate staining. However more images need to be collected to 
carry out a more detailed study and possible reconstruction of the arrangement of 
Hsc70 and HSJ1b in the observed particles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.25: Negative staining of the peak 1 SEC fraction of the rHH complex. 
SEC Peak 1 elution fractions were pooled together and concentrated down to 0.8 mg/ml and used for 
negative staining electron microscopy. The protein complex was negatively stained with freshly made 
2% uranyl acetate on thin carbon-coated grids previously glow-discharged for 15 s. Panel A the image 
obtained after 1:20 dilution of the protein sample. Panel B is the magnified view of a larger particle 
while Panel C is the magnified view of smaller particles. 
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4.4. Discussion 
Hsp70 proteins (both constitutive and inducible) under cellular conditions of stress 
bind to unfolding polypeptides. They prevent aggregation of these substrate proteins 
by binding to exposed hydrophobic residues and assist their refolding (Fink, 1999; 
Kampinga and Craig, 2010). A simple aggregation assay has been used routinely in the 
characterisation of chaperone proteins. Aggregation is either introduced using 
chemical agents such as urea and guanidium chloride, or by elevation of temperature 
(Daugherty et al., 1998; Nicoll et al., 2006). We demonstrated that the recombinant 
human Hsc70/HSJ1b complex had in vitro substrate protection capability using a 
luciferase based thermal aggregation assay.  Elevation of temperatures to 42oC causes 
aggregation of luciferase which has been shown to be reduced by the presence of 
chaperone proteins (Minami et al., 1996; Glover and Lindquist, 1998; Wang and 
Spector, 2001). In this assay, the rHH chaperone complex was successful in protecting 
85% of the luciferase present. Minami et al., (1996) have reported that Hsc70/HDJ1 
complex protected 70% luciferase, while Chamberlain et al., (1997) have demonstrated 
that the Hsc70/CSP1 complex could only maintain 50% of the luciferase in the soluble 
fraction. However this was observed to be ATP dependent, since in the absence of 
ATP, Hsc70/HDJ-1 proteins were only capable of protecting 25% of luciferase. 
However the rHH complex displayed an ATP independent activity. No significant 
improvement in activity was observed with the addition of ATP. This could possibly 
be due to the differences in how the protein complex was produced. In the previous 
studies, the  chaperone complexes was reconstituted by combining the individual 
purified HSP70 and HSP40 family members and where ATP is required to initiate the 
formation of Hsp70-Hsp40 complex driven by the hydrolysis of ATP by the Hsp70 
moiety (Russell et al., 1999), explaining the ATP dependent behaviour of the previous 
complexes. However in the case of the rHH protein, the preformed complex isolated 
from the Ni-NTA column is already in a competent state capable of protecting 
aggregating proteins, without any additional nucleotide requirement. 
Another interesting observation was the difference in the amount of chaperone 
complex used for the successful protection of luciferase from thermal aggregation. In 
the case of the reconstituted Hsc70/HDJ-1 complex, the amount of Hsc70 (4.7 µM) 
used was in 47 fold excess, while HDJ-1 (3.2 µM) was 32 times in excess of the 
luciferase (0.1 µM) set up for aggregation, resulting in 70% luciferase protection 
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(Minami et al., 1996). In comparison, rHH was only 1.5 fold in excess to the luciferase 
present in the reaction and yet achieved 85% protection. Furthermore, thermal 
aggregation carried out in the presence of varying amount of luciferase, revealed that 
rHH could still protect more than 70% of the substrate even in reactions performed 
with 1:1 ratio of chaperone and luciferase. This clearly indicates that recombinant 
method of forming the Hsc70/HSJ1b complex is a more efficient chaperone system, 
compared to the systems previously studied.  
Crystal structures of the ATPase domain of Hsp70 proteins of human and bovine 
origin have revealed that the Hsp70’s are capable of binding to both calcium and 
magnesium metal ions (Flaherty et al., 1994, Sriram et al., 1997). We analysed the 
divalent cation requirements of the complex in substrate protection. To maintain 
luciferase protection, the protein requires the presence of either Ca2+ or Mg2+. 
Replacement with another divalent metal, Ni2+ had a deleterious effect on the 
luciferase protection. However there was no preferential requirement for either Ca2+ or 
Mg2+ since replacing one with the other did not alter the levels of luciferase protection. 
A potential drawback of this study was the use of Ni2+ as the negative control. This is 
because it can potentially bind to the His tag on the Hsc70 and therefore hinder its 
interaction with the substrate. Also, at high concentrations Ni2+ has been shown to have 
a cytotoxic effect (Costa et al., 1994). For a more reliable interpretation, this 
experiment needs to be repeated with alternate divalent metal ions such as Mn2+, Co2+ 
or Zn2+ and in the absence of divalent metal ions. 
However despite maintaining almost 80% of thermally denatured luciferase in a 
soluble form, the rHH complex could not assist luciferase in regaining activity upon 
refolding at 25oC. This is consistent with previous reports on the inability of 
reconstituted Hsc70/Hsp40 complexes to restore functional activity of thermally 
denatured luciferase (Frydman et al., 1992; Minami et al., 1996).  Addition of diluted 
reticulocyte lysate has been shown to reactivate thermally denatured luciferase 
(Minami et al., 1996). However the exact component of reticulocyte lysate that 
enhances renaturation is as yet not completely understood (Minami et al., 1996). Thus 
although the co-expressed complex could protect 85% of luciferase from thermal 
aggregation in an ATP independent fashion, it was not successful in maintaining the 
substrate’s functional activity.  
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Hsc70 on its own has very low basal ATPase activity (Russell et al., 1999). However 
cofactors such as Hsp40 proteins or unfolded substrate stimulate the rate of ATP 
hydrolysis (Laufen et al., 1999). Hsp40 co-chaperones have been reported to cause 
several fold increase in ATP hydrolysis (Russell et al., 1999). ATP hydrolysis converts 
Hsc70 into its ADP bound form which in turn stabilises the formation of ternary 
complex with unfolded substrate (Laufen et al., 1999). A 14-fold stimulation of 
Hsc70s’ ATPase activity by Csp1 (Chamberlain and Burgoyne, 1997) and 7-fold 
stimulation of Hsc70s’ ATPase activity by Hdj1 (Minami et al., 1996) have been 
reported. Unfolded protein, apocytochrome c has been shown to stimulate ATP 
hydrolysis of mammalian Hsc70 by 2-3 fold (Sadis and Hightower, 1992). Based on 
these findings we decided to evaluate the affect that binding to denatured luciferase has 
on the ATPase activity of Hsc70 in the rHH complex. A non-radioactive assay was 
chosen to detect phosphate release due to ATP hydrolysis. The ATP hydrolysis activity 
of the rHH complex was not significantly altered by denatured luciferase. A similar 
lack of stimulation was observed upon binding of denatured luciferase to the 
Hsc70/Csp1 complex. This was attributed to non-overlapping site of interaction 
between Csp1 and luciferase with Hsc70 (Chamberlain and Burgoyne, 1997). We 
believe that in the case of the rHH complex, Hsc70 in the presence of HSJ1b is already 
in a state fit to bind unfolded protein. Therefore, no further stimulation is observed 
upon interaction with luciferase, which could occur at a different site from HSJ1b.  
This gives rise to an interesting question, how does the denatured substrate bind to the 
rHH complex without ATP and its hydrolysis. A plausible explanation would be if the 
purified Hsc70/HSJ1b complex contains endogenously bound nucleotide. The T. 
thermophilus DnaK and DnaJ complex purified as a hexameric complex was isolated 
without any bound nucleotide (Motohashi et al., 1994). This is the only other known 
report on the isolation of an intact Hsp70/Hsp40 complex. However in the case of the 
rHH complex, a convincing result could not be obtained regarding the nucleotide 
content of the rHH complex. Initial analysis was carried out by deriving the UV 
absorption spectrum of the purified complex.  The observed A260/A280 ratio was 
calculated and found to be 1.4. Use of A260/A280 ratio to detect presence of 
nucleotide has been used previously by Wegele et al., to detect co-purification of 
nucleotides during the purification of yeast Hsp70 (Wegele et al., 2003). However 
using this method one cannot be certain by the presence of additional A260 absorbing 
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material, of the identity of the nucleic acid (ATP, other nucleotides, or RNA) bound to 
Hsc70. Therefore HPLC analysis to identify the bound nucleotide was undertaken. But 
this failed to convincingly indicate the absence/presence of any bound nucleotide, 
despite several attempts. However failure to detect any nucleotide should not lead to 
the automatic assumption that the rHH complex is formed in a nucleotide free state. 
There could also be certain experimental failures which could make the results 
obtained in the case of the rHH complex misleading.  Gao et al., have reported that 
ATP and ADP binds very strongly to the Hsc70 and cannot be easily removed from the 
enzyme even after extensive dialysis or EDTA treatment (Gao et al., 1994). Nucleotide 
extraction for the HPLC analysis was carried out using the PCA extraction protocol. 
However, the efficiency of the extraction method was not evaluated and therefore 
failure to detect bound nucleotide could also be because of failure to extract the tightly 
bound nucleotide. 
The NBD of Hsc70 can have three occupancy states: nucleotide free, ADP bound or 
ATP bound (Buchberger et al., 1995; Shaner and Morano, 2007). Hsc70 is 
predominantly in the ATP bound state, in the absence of Hsp40 co-chaperones. The 
rHH complex in our preparations co-elutes with a few contaminating protein species, 
which are found associated even after gel filtration. If Hsc70 was ATP bound, the 
contaminating protein species would not be expected to remain associated with Hsc70, 
since substrates have a high on/off rate when ATP is bound to Hsc70 (Bukau and 
Horwich 1998).  This suggests that in the case of the rHH complex, the presence of 
bound ATP can be discounted. The rHH complex can either be nucleotide free or ADP 
bound. Both NBD occupancy states can satisfactorily explain the observed behaviour 
of the rHH complex as both forms exhibit high affinity for substrates (Schmid et al., 
1994, Gao et al., 1995). This would explain the observed luciferase protection in the 
absence of additional ATP. Thus the functional behaviours displayed by the rHH 
complex can be explained by the nature of occupancy of the NBD of Hsc70 in the rHH 
complex. Unfortunately, we have been unable to conclusively prove if it is ADP bound 
or nucleotide free. 
The conformational features of the complex were probed by limited proteolysis using 
trypsin and chymotrysin. Exposed and flexible regions which are accessible to 
proteases more easily undergo cleavage first, while possible sites in the highly 
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structured core of the protein molecule either remain protected or undergo cleavage at 
a slower rate (Zappacosta, 1996). Proteolysis is therefore a useful tool to study the 
conformation of native proteins and associated transitions observed on 
substrate/cofactor/ligand binding (Hubbard, 1998). For both trypsin and chymotrysin, 
initial analysis was carried out at 30oC. However at this temperature complete 
proteolysis of HSJ1b was observed within 10 minutes. This was not useful in 
furthering our understanding of the Hsc70/HSJ1b interactions. By reducing the 
temperature to 4oC, the kinetics of the enzyme action appears to slow down and it was 
possible to observe the proteolysis of the Hsc70 and HSJ1b components.  
Proteolysis of the Hsc70/HSJ1b complex by trypsin and chymotrypsin was monitored 
over a period of 75 minutes. The key observation was that irrespective of the protease 
used, the HSJ1b subunit was extremely susceptible to proteolysis, compared to the 
Hsc70 moiety. With chymotrypsin, the major proteolytic product of HSJ1b migrating 
at  ~ 30 kDa was observed within 10 minutes from the start of the proteolysis and 
majority of the HSJ1b protein was converted into this fragment by the end of 75 
minutes. Analysis of the HSJ1b protein sequence by GeneRunner software revealed 28 
possible chymotrypsin cleavage sites. 27 out of the 28 sites are clustered together at the 
first 171 amino acids, while the 28th site is at Y261. Since the NH2-terminal region 
contains 28 potential chymotrypsin cleavage sites and yet gives rise to a single 
proteolysis fragment indicates that it must represent a well folded domain. With 
trypsin, complete proteolysis of HSJ1b was observed within 10 minutes of initiating 
the digestion. This was not surprising, since a total of 43 possible trypsin recognition 
sites were predicted by the Generunner software. These sites are uniformly distributed 
throughout the protein sequence, which explains the observed rapid proteolysis of 
HSJ1b, upon addition of trypsin. 
The Hsc70 subunit on the other hand was more resistant to proteolysis. Even after 75 
minutes of treatment with chymotrypsin, 80% of Hsc70 remained undigested. Chappel 
et al., (1986) have previously reported that chymotrypsin digestion of bovine Hsc70 
resulted in a 60 kDa fragment which was subsequently proteolysed to form a 44 kDa 
fragment (Chappel et al., 1986). In the case of the rHH complex, two minor products 
observed at ~49 kDa and 52 kDa are the only indications of Hsc70 proteolysis by 
chymotrypsin, suggesting that Hsc70 adopts a different conformation in the presence 
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of the HSJ1b co-chaperone. There are a number of reports which have studied the 
influence of the Hsp40 moiety on the proteolysis of Hsp70 using trypsin. Bimston et 
al., (1998) reported that trypsin digestion of Hsc70 yields 58 kDa, 43 kDa, 20 kDa and 
18 kDa fragments. The addition of Human DnaJ homologue (HDJ-1) did not seem to 
alter the proteolysis results (Bimston et al., 1998). However their report fails to discuss 
the state of the HDJ-1 moiety. With the rHH protein, Hsc70 undergoes proteolysis 
only at the N-terminal region, on the Factor XA site adjacent to the 10 X Histidine tag 
, resulting in a proteolysis product which differs from the undigested product (73 kDa)  
by only 1 or 2 kDa (~70-71 kDa). Analysis of the Hsc70 protein sequence by 
GeneRunner software predicts 82 potential trysin recognition sites, and yet it is 
extremely resistant to proteolysis. Therefore Hsc70 subunit of the rHH complex also 
appears to be well folded.  
We studied whether any nucleotide-induced conformational changes to Hsc70 or to the 
stability of the complex could be observed. Hsp70 have been shown to adopt three 
distinct nucleotide dependent conformations: nucleotide-free, ADP-dependent, and 
ATP-dependent (Buchberger et al., 1995; Fung et al., 1996). In this study ATP, ADP 
and non-hydrolyzable ATP analogue, AMP-PNP were used. However the proteolysis 
patterns were identical to the ones obtained in the reaction where no additional 
nucleotide was added. Reactions with ATP were monitored for an extended over a 
period of 75 minutes using both trypsin and chymotrypsin; still no difference was 
detected between the nucleotide-free and ATP containing reactions. Partial trypsin 
digestion assay to test the influence of DnaJ on DnaK's conformation also shows that 
DnaJ does not noticeably alter DnaK's trypsin digestion pattern in the presence and 
absence of ATP (Wall et al., 1994). This was attributed to the possibility that DnaJ 
stimulated hydrolysis of ATP bound to DnaK prevented ATP binding/hydrolysis 
associated conformational change in DnaK or alternatively the conformational change 
experienced by DnaK was countered by rapid relaxation caused by DnaJ (Wall et al., 
1994). This could be the explanation for the absence of nucleotide dependent 
conformational changes in the rHH complex.  
Thus from the proteolysis data both the Hsc70 and HSJ1b subunits appear to be well 
folded. The altered chymotrypsin digestion pattern observed for Hsc70 indicates that 
Hsc70 displays alternate conformational features when associated with HSJ1b. Also, 
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the extreme susceptibility of HSJ1b suggests that, in the rHH complex, HSJ1b was the 
more exposed and therefore the more accessible of the two subunits.   
Oligomerisation of the rHH complex was evaluated by size exclusion chromatography 
on a superdex-200 column, which has a fractionation range of 10,000-600,000 kDa. 
The rHH protein was found to resolve into two peaks. The first peak (which contained 
>60% of total protein) eluted in the void volume (>600 kDa), while the second peak 
fractionated with an estimated molecular weight of ~220 kDa. SDS-PAGE confirmed 
the co-fractionation of both Hsc70 and HSJ1b subunits in both the elution peaks of 
rHH.  While the presence of the highly oligomerised fraction strongly hinted at 
polymerisation of Hsc70, the >600 kDa fraction could also represent protein 
aggregation. Using Analytical ultracentrifugation, it was successfully demonstrated 
that the >600 kDa protein fraction was indeed desirable protein oligomerisation and 
not undesirable protein aggregation. The major sedimentation species was observed at 
10S, along with a few other minor sedimentation species (possible due to aggregation 
of the complex) and the estimated molecular weight for this species was 1.1 MDa.  
Using size exclusion chromatography, Hsc70 has been previously shown to be a 
mixture of monomers, dimers, and high order oligomers in solution (Palleros et al., 
1991; Kim et al., 1992; Benaroudj et al., 1994). This property is a well-documented 
feature of several members the Hsp70 protein family such as BiP (Blond-Elguindi et 
al., 1993), the constitutive Hsc70 (Benaroudj et al., 1994), the inducible Hsp70 
(Brown et al., 1993) and DnaK (Schönfeld et al., 1995). One important factor that 
influences the equilibrium towards oligomerisation is the Hsp40 co-chaperone 
proteins. King et al., (1995) successfully demonstrated that Hsc70 polymerised in the 
presence of yeast DnaJ (YDJ1) but required ATP for this activity (King et al., 1995). 
Similarly Jiang et al., (1997) have reported about auxilin (DnaJ homologue) induced 
polymerization of Hsc70, by shifting the elution profile of the Hsc70 into the void 
volume of the gel filtration column. The existence of interaction between Hsc70 and 
the DnaJ homologues during the polymerization event is controversial. Barring auxilin, 
most DnaJ homologues have been reported to bind very weakly to Hsc70 (King et al., 
1995; Jiang et al., 1997; King et al., 1999). Auxilin was shown to form a complex with 
Hsc70 which then elutes in the void volume. At the same time, Angelidis et al., 2001 
have shown the existence of monomeric and aggregated forms of Hsp70s in vivo using 
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non-denaturing gradient analysis, and association of Hsp40 takes place preferentially 
through the monomeric Hsc70.  
The 1.1 MDa co-polymer species could be due to formation of the Hsc70/HSJ1b 
complex or as a result of HSJ1b induced polymerisation of Hsc70 and subsequent 
complex formation. However we do not have conclusive data to prove that the 1.1 Mda 
protein species is a polymerisation product, since Hsc70 polymerisation by Hsp40 has 
been shown to occur only in the presence of ATP; ADP, AMP-PNP, and nucleotide 
free conditions did not promote the Hsp70 polymerisation (King et al., 1995).  In the 
case of the rHH, we are not entirely sure about the factors promoting the 
polymerisation. It might be driven by of cellular ATP present during the protein 
expression, since no additional ATP was added during the course of the study.  
Thus the Hsc70/HSJ1b complex appears to be a heterogenous mix of ~220 kDa and 
hetero-oligomeric co-polymer species, and these two species actually represent two 
different states of association between Hsc70 and HSJ1b. The only other report on the 
isolation of an intact complex between DnaK and DnaJ was isolated from the bacteria 
Thermus thermophilus. The molecular weight of this complex was estimated to be 310 
kDa using gel filtration column, and no other oligomeric co-polymer was reported 
(Motohashi et al., 1994). For the first time the co-existence of both the oligomeric and 
non-oligomeric state of interaction between the Hsc70 and Hsp40 has been 
demonstrated. That, this represented a true state of interaction was further validated by 
the detection of functional activity for both forms of the complex.  Both protein 
species could protect almost 50% of luciferase from thermal denaturation in their own 
right, which further corroborates our claim that these are two functional interaction 
states between Hsc70 and HSJ1b proteins. 
The relationship between the oligomeric and ~220 kDa forms of the complex was 
further investigated. It has been reported that the equilibrium between monomeric and 
oligomeric Hsc70 species is influenced by nucleotides and unfolded proteins 
(Benaroudj et al., 1996). Hsc70 in the presence of nucleotide (ADP) and absence of 
any nucleotide, is observed to be a mixture of monomer, dimers and higher oligomers, 
while ATP  and unfolded proteins shift the equilibrium in favour of the monomeric 
form of Hsc70 (Carlino et al., 1992; Toledo et al., 1993; Palleros et al., 1993). 
Therefore the effect of unfolded substrate and ATP on the oligomeric composition of 
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the rHH complex was studied. First the protein was heat treated (at 42oC) in the 
presence of luciferase, and its effect on the oligomeric composition was studied by 
SEC. Hsc70, in vivo, exits in an aggregated form at 37 °C, which persists after heat 
treatment, however denatured luciferase was detected interacting with only the non-
aggregated forms (Angelidis et al., 1999). SEC of the rHH complex after heat 
treatment revealed the existence of both the polymerised and ~220 kDa forms, 
however with a ~two-fold increase in the proportion of ~220 kDa species. This 
signifies substrate dependent conversion of the oligomeric Hsc70/HSJ1b complex to 
the ~220 kDa Hsc70/HSJ1b complex. Similarly, ATP dependent depolymerisation was 
also observed, where the oligomeric form breaks down to form the ~220 kDa 
Hsc70/HSJ1b complex which when treated with ATP, disassociates into the individual 
Hsc70 and HSJ1b subunits.  
Our observations could signify a potential physiological relevance. Polymerisation of 
Hsc70 has been identified as a possible regulatory event, which maintains the 
chaperone in an inactive state (King et al., 1995a). Studies performed with BiP (Hsp70 
from the endoplasmic reticulum) found that polymerised BiP was observed to be free 
of protein substrates, while the monomeric form was found associated with protein 
substrate (Freiden et al., 1992). King et al., have suggested that the observed in vitro 
polymerisation of Hsp70 proteins by their Hsp40 cofactors could be of physiological 
relevance too (King et al., 1999). Angelidis et al., 1999 have shown the existence of 
monomeric and aggregated forms of Hsp70s in vivo using non-denaturing gradient 
analysis. Thus the two forms observed by gel filtration of the rHH complex could 
represent possible in vivo interaction states (illustrated in Figure 4.26). The complex of 
70 and 40 exists in a storage form (polymer ) and active form (~220 kDa). Addition of 
ATP or substrate, first converts the complex into the active form. Further treatment 
with ATP causes disassociation of the complex. The ~220 kDa form represents an 
unexplored but potentially significant intermediate 70/40 interaction state in the in vivo 
scenario. 
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Figure 4.26: Physiological relevance for the two forms of the Hsc70/HSJ1b complex isolated 
by SEC 
Preliminary structural studies on the co-expressed proteins were carried out by 
crystallography and negative EM staining. The 220 kDa gel filtration fraction was 
studied by X-ray crystallography. However no potential crystallisation condition was 
identified. The large size of the peak 1 from SEC allowed us to pursue preliminary 
structural analysis by electron microscopy. Negative EM staining normally enables 
specimens to adsorb to a carbon support film in one or a limited number of preferred 
orientations (Ohi et al., 2004). Previously, electron microscopy analysis of 
T.DnaK.DnaJ complex has been reported as a trigonal particle with a central cavity 
(Motohashi et al., 1994). Their results revealed homogeneous circular shaped particles 
with a diameter of 115 Ǻ. Preliminary results obtained from negative staining of the 
rHH protein Ni NTA elution fraction revealed mostly circular particles. However a few 
particles resembling a bunch of flowers and its stalk were also observed, which could 
represent an alternate view of the protein complex. The preliminary results from 
negative staining are extremely encouraging, and are a first step towards determining 
the structure of the Hsc70/HSJ1b complex.  
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CHAPTER 5: Comparison of the recombinant 
Hsc70/HSJ1b complex with the reconstituted 
Hsc70/HSJ1b in vitro complex 
5.1. Introduction 
Biochemical studies on the interaction of HSP70 and HSP40 family members have 
been routinely carried out using a reconstituted protein complex formed by combining 
the individual chaperone and co-chaperone components in the presence of ATP, which 
drives the formation of the complex (Jiang et al., 1997; Lu and Cyr, 1998; Laufen et 
al., 1999). A reconstituted Hsc70/HDJ-1 complex was used by Minami et al., (1996) to 
study the effects of the human DnaJ homologue (HDJ-1) on the chaperone functions of 
the human Hsc70 protein (Minami et al., 1996). Using a similar methodology, 
Chamberlain and Burgoyne, (1997) have studied the importance of the HPD motif in 
the DnaJ-like cysteine string proteins to interaction with Hsc70 (Chamberlain and 
Burgoyne, 1997). The work by Pleckaityte and co-workers is another example of the 
use of reconstituted protein system, where they have demonstrated using gel filtration 
that complex formation between Hsp70 and Hsp40 from Meiothermus ruber absolutely 
requires ATP for its assembly (Pleckaityte et al., 2003)  
In Chapter 3, isolation of a recombinant form of the Hsc70/HSJ1b (rHH) complex was 
described. The functional behaviour of this complex was studied and has been 
discussed in detail in Chapter 4. The characterisation studies carried out for the rHH 
complex suggests that its behaviour does not concur with studies carried out using a 
reconstituted complex. Could the recombinant complex represent an alternative model 
of the chaperone/co-chaperone interactions? In order to establish this, a reconstituted 
Hsc70/HSJ1b complex was generated as described by Minami et al., and others 
(Minami et al., 1996; Chamberlain and Burgoyne, 1997). The properties of the rHH 
complex was then compared with the reconstituted in vitro form. The comparison was 
based on the two complex’s substrate protection efficiency, conformational differences 
probed by partial proteolysis and polymerisation properties determined by size 
exclusion chromatography.  This chapter details the outcome of this comparative study 
and its bearing on using the recombinant complex as a model protein to study and 
understand the Hsc70 chaperone and HSJ1b co-chaperone interactions.  
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5.2. Material and Methods 
5.2.1. Expression of human Hsc70 and HSJ1b genes 
Hsc70 and HSJ1b proteins were expressed using the pET16b-Hsc70 and pET16b-
HSJ1b constructs (described in Chapter 3). Protein expression was carried out in         
E. coli BL21(DE3). The plasmids were transformed into E. coli BL21(DE3) cells and a 
single colony was used for overnight inoculation into LB broth containing 100 µg/ml 
of ampicillin, grown at 37oC. Up to 4% of the overnight seed culture was used to 
inoculate the large scale cultures the next day. Growth and induction was performed as 
described in Chapter 2, section 2.10.1. Briefly, cells were grown at 37oC to an OD595 
of 0.6-0.8. Protein expression was induced by the addition of IPTG to a final 
concentration of 0.4 mM. After induction, cells were grown for further 3 hrs. Cells 
were harvested as described Chapter 2, section 2.10.1 and the cell pellet was re-
suspended in lysis buffer (50 mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM imidazole 
and 5% glycerol (v/v)) and stored at -80oC until required. 
5.2.2. Purification of human Hsc70 and HSJ1b 
Purification of the recombinant Hsc70 and HSJ1b proteins was performed following 
the protocol for the purification of poly-histidine tagged proteins described in section 
2.10.2 in Chapter 2. Briefly, cells were lysed, centrifuged and the soluble supernatant 
fraction was applied to a 4 ml Ni-NTA column, which was pre-equilibrated with the 
lysis buffer. The column was then washed with 5 CV of lysis buffer and again with 5 
CV of lysis buffer containing 30 mM imidazole. Hsc70 and HSJ1b proteins were 
eluted from the Ni column with 3 CV’s of elution buffer (lysis buffer plus 200 mM 
imidazole). A typical yield of 4-5 mg of protein was obtained per litre of culture for 
both Hsc70 and HSJ1b. The elution profiles of the proteins were analysed on a 12% 
SDS-PAGE gel as described in section 2.l0.5 in Chapter 2. Fractions of nickel purified 
Hsc70 were pooled and dialysed against buffer containing 20 mM Tris-HCl pH 8.0, 50 
mM potassium chloride overnight at 4oC. 
5.2.3. ATP treatment of HSJ1b  
The 200 mM imidazole elution fractions containing HSJ1b protein were pooled and 
incubated with 1mM ATP, 1 mM DTT and 10 mM MgCl2 for 30 minutes at room 
temperature with rocking.
 
The ATP treated HSJ1b protein was diluted two-fold with 
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10 mM Tris-HCl pH 8.0 prior to loading onto a 4 ml Ni-NTA column pre-washed with 
10 CV of equilibration buffer (50 mM Tris-HCl pH 8.0, 200 mM NaCl). The column 
was then washed with 5 CV of equilibration buffer and followed by a second wash 
with 5 CV of equilibration buffer plus 20 mM imidazole. The protein was finally 
eluted in 1 ml fractions in 3 CV of equilibration buffer containing 200 mM imidazole. 
The elution profile was monitored by SDS-PAGE analysis. Peak fractions of the ATP-
treated HSJ1b were pooled together and dialysed against buffer containing 20 mM 
Tris-HCl pH 8.0, 50 mM potassium chloride overnight at 4oC prior to use in assays. 
5.2.4. Thermal aggregation assay 
A thermal aggregation assay was performed as described in Chapter 4, section 4.2.3, 
with luciferase as the substrate. 15 µl reactions were set up and the assay was carried 
out with the indicated combination of chaperones (2.1 µg each of Hsc70, HSJ1b and 
rHH complex) in the presence/absence of ATP. Luciferase (0.8 µM) was incubated 
with the indicated chaperones in a buffer containing 20 mM Tris-HCl pH 8.0, 50 mM 
KCl, 3 mM MgCl2 and 2 mM DTT for 5 min at room temperature. The reactions were 
incubated at 42oC for 10 min. The soluble and aggregated fractions were then 
separated by centrifugation and analysed by SDS-PAGE electrophoresis. The 
percentage of luciferase present in the soluble and aggregated fraction was quantified 
from the gel by densitometry. 
5.2.5. Partial proteolysis studies 
The protocol used for the partial proteolysis studies has been described in detail in 
Chapter 4, Section 4.2.5. Briefly, the protein was incubated with trypsin or 
chymotrypsin at a protease to protein ratio of 1:300 (w/w) in assay buffer containing 
20 mM Tris-HCl pH 8.0, 50 mM KCl, 3 mM MgCl2 and 2 mM DTT. ATP was added 
where required at a concentration of 2 mM. The individual protein concentrations used 
for the chymotrypsin and trypsin proteolysis experiments have been tabulated in Table 
5.1. Chymotrypsin reactions were performed at 4oC for 10 minutes, while trypsin 
proteolysis was carried out at 25oC for 15 minutes. The reactions were stopped at 
specified time points by the addition of trypsin inhibitor and proteolysis products were 
analysed on a 12% SDS-PAGE gel. 
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Table 5.1: Amount of protein used for trypsin and chymotrypsin proteolysis reactions. 
5.2.6. Size exclusion chromatography 
Size exclusion chromatography was performed using a Superdex-200 column. The 
column was equilibrated with 20 mM Tris-HCl pH 8.0 buffer containing 100 mM 
potassium chloride,1 mM ATP, 10 mM MgCl2 and 5 mM beta-mercaptoethanol. 214 
µg of Hsc70 was incubated with 142 µg of HSJ1b in the presence of 2 mM ATP and 
10 mM MgCl2 for 30 minutes and then loaded onto a size exclusion column. 1 ml 
fractions were collected and alternate fractions were analysed for protein content using 
Bradford assay. A plot of the absorbance on the y-axis versus the elution volume on 
the x-axis was used to monitor the chromatography. The peak fractions were also 
analysed by SDS-PAGE electrophoresis. 
 
Protein 
Amount of protein used in µg 
Chymotrypsin Trypsin 
Hsc70 2.5 NA 
HSJ1b 2.5 NA 
In vitro complex  
(Hsc70+HSJ1b) 
2.5 of Hsc70 + 
2.5 of HSJ1b 
4.4 of Hsc70 + 
2.2 of HSJ1b 
Recombinant complex (rHH) 4.4 4.4 
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5.3. Results 
5.3.1. Purification of recombinant Hsc70 
For the purpose of protein production, the gene was transformed into E. coli 
BL21(DE3). Cells were grown at 37oC and protein production was induced by the 
addition of IPTG. Recombinant Hsc70 was isolated by Ni-NTA chromatography. The 
purified Hsc70 protein was eluted with 200 mM imidazole and analysed by SDS-
PAGE electrophoresis (Figure 5.1). Hsc70 eluting from the column was observed 
migrating at 73 kDa on the gel (lane 5 and 6, Figure 5.1). The elution fractions were 
pooled and dialysed against buffer containing 20 mM Tris-HCl pH 8.0, 50 mM 
potassium chloride overnight at 4oC to remove the imidazole content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Chromatography profile of Hsc70 on Ni-NTA resin  
 
Human Hsc70 was expressed in E. coli BL21(DE3) cells by induction with 0.4 mM IPTG for three 
hours at 37oC. The lysed, soluble extract was applied to a Ni-NTA column, extensively washed with 50 
mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM β-Mercaptoethanol buffer containing 30 mM imidazole and 
eluted with 50 mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM β-Mercaptoethanol containing 200 mM 
imidazole. The polypeptide composition was analysed by SDS-PAGE (12% resolving gel), stained with 
Coomassie Brilliant Blue and photographed: Lane 1 contains Bio-Rad molecular weight marker, lane2 
soluble fraction, lane 3 cell pellet, lane 4 column flow through and lane 5&6 200 mM imidazole elution. 
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5.3.2. Purification of recombinant HSJ1b 
Expression of HSJ1b was carried out in BL21(DE3) cells. Growth was carried out at 
37oC and protein expression was induced by the addition of IPTG to a final 
concentration of 0.4 mM. HSJ1b protein present in the soluble extract was purified by 
Ni-NTA agarose chromatography. The ~44 kDa HSJ1b protein was eluted with 200 
mM imidazole and confirmed by SDS-PAGE analysis (lane 6, Figure 5.2).  
 
Figure 5.2: HSJ1b purification by Ni-NTA chromatography.  
Human HSJ1b was expressed in E.coli BL21(DE3) and induced with 0.4 mM IPTG for three hours at 
37oC. The lysed, soluble extract was applied to a Ni-NTA column and eluted with buffer 50 mM Tris-
HCl pH 8.0, 250 mM NaCl, 5% glycerol containing 200 mM imidazole. The polypeptide composition 
was analysed by SDS-PAGE (12% resolving gel) and the gel stained with Coomassie Brilliant Blue: 
lane 1 soluble fraction, lane 2 cell pellet, lane 3 column flow through, lane 4 column wash, lane 5 
column wash with 30 mM imidazole,  lane 6 200 mM imidazole elution and lane 7 protein molecular 
weight marker. The ~70 kDa contaminating species is indicated by an arrow. 
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5.3.3. ATP treatment of HSJ1b 
A ~70 kDa band was observed to be co-eluting with the HSJ1b protein eluting from 
the Ni-NTA column (indicated by an arrow on lane 6, Figure 5.2). Western blot 
analysis performed on the purified HSJ1b protein using a DnaK antibody confirmed it 
to be E.coli DnaK (data not shown). Chamberlain and Burgoyne, (1997) reported a 
similar contamination during the expression of recombinant cysteine string proteins. 
They recommend the use of an Mg.ATP wash step to destabilise this interaction 
(Chamberlain and Burgoyne, 1997). A similar approach was adopted and an additional 
wash step with 2 mM ATP was included during the Ni-NTA purification step (data not 
shown). However this was not effective in removing the ~70 kDa contaminating 
species. Therefore the protein was first eluted from the Ni-agarose column and then 
incubated with 1 mM ATP for 30 minutes at room temperature. The ATP treated 
HSJ1b protein was then diluted two fold to reduce the imidazole content and then 
bound to a second Ni-NTA column and eluted with 200 mM imidazole.  
The elution of the ATP treated HSJ1b protein after Ni-NTA chromatography was 
assessed on a 12% gel (Figure 5.3). From the gel it was observed that the DnaK 
species was found in the unbound and wash fractions (lane 2 and 3, Figure 5.3). It was 
also observed that a fraction of the ATP-treated HSJ1b was present in the flow through 
fraction (indicated by a * on lane 2, Figure 5.3). This could possibly be due to the fact 
that the protein was loaded on the column with 50 mM imidazole (after dilution), 
which might have prevented all of the protein from binding to the Ni agarose. The 
HSJ1b protein eluting from the column was found to be free from the contaminating 
~70 kDa species (lane 5, Figure 5.3). Elution fractions (5-12) were pooled and dialysed 
against buffer containing 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride 
overnight at 4oC to remove the imidazole. 
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Figure 5.3: Elution profile of ATP treated HSJ1b from Ni-NTA column.  
 
Human HSJ1b purified by Ni-NTA chromatography was incubated with 2 mM ATP, 10 mM MgCl2 and      
1 mM DTT for 30 minutes at room temperature. The protein was re-purified by a second Ni-NTA 
chromatographic step to obtain HSJ1b free from contaminating DnaK protein. The ATP treated HSJ1b 
protein was diluted two fold with 10 mM Tris-HCl pH 8.0 prior to loading onto a 4 ml Ni-NTA column 
pre-washed with 10 CV of equilibration buffer (50 mM Tris-HCl pH 8.0, 200 mM NaCl). The column 
was then washed with 5 CV of equilibration buffer and followed by a second wash with 5 CV of 
equilibration buffer plus 20 mM imidazole. The protein was finally eluted in 1 ml fractions in 3 CV of 
equilibration buffer containing 200 mM imidazole. The protein was analysed by SDS-PAGE. Lane 1 
ATP treated HSJ1b loaded onto the column, lane 2 column flow through, lane 3 wash, lane 4 column 
wash with 20 mM imidazole, lane 5 200 mM imidazole elution fractions and lane 6 molecular weight 
marker proteins. HSJ1b is indicated by an asterisk. 
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5.3.4. Comparative study on the recombinant complex and the in 
vitro complex  
The dialyzed Hsc70 and HSJ1b proteins were combined at specific ratios (the values 
are specified in the following sections) and complex formation was initiated by the 
addition of 2 mM ATP. This reconstituted complex will be referred hence forth as the 
in vitro Hsc70/HSJ1b complex. The recombinant rHH complex was purified as 
described in Chapter 3. Representative Hsc70 (lane 1, Figure 5.4), HSJ1b (lane 2, 
Figure 5.4), in vitro Hsc70/HSJ1b complex (lane 3, Figure 5.4) and rHH (lane 4, 
Figure 5.4) proteins samples used in this study were analysed by SDS-PAGE (Figure 
5.4). The proteins prepared for the assay were observed to >85% pure, which was 
deemed sufficient for the following studies. The protein complexes were assessed 
based on their substrate protection efficiency, conformational properties and Hsc70 
polymerisation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: SDS-PAGE analysis of the Hsc70, HSJ1b, in vitro Hsc70/HSJ1b and rHH proteins. 
Hsc70 and HSJ1b Ni-NTA elution fractions were pooled together and dialysed against buffer containing 
20 mM Tris-HCl pH 8.0, 50 mM potassium chloride overnight at 4oC. The dialysed proteins were 
separately concentrated in a 30 kDa cut-off centricon prior to use in assays. The in vitro complex was 
formed by combining Hsc70 and HSJ1b in a 1:1 ratio in the presence of 2 mM ATP. Lane1 is loaded 
with purified Hsc70 protein, lane 2 is purified HSJ1b protein, lane 3 is the reconstituted in vitro 
complex, lane 4 aliquot of the rHH complex and lane 5 Bio-Rad precision plus prestained molecular 
weight marker. 
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5.3.4.1. Prevention of protein aggregation 
An efficient test system for chaperone activity is the ability of the chaperone protein to 
prevent aggregation of a substrate protein (Forreiter and Nover, 1998). According to 
Minami et al., neither the Hsp70 nor the Hsp40 protein alone was capable of protecting 
substrates such as luciferase from thermal stress. The combined action of a 
reconstituted Hsp70 and Hsp40 protein system in the presence of ATP was required to 
maintain luciferase in a soluble state (Minami et al., 1996). The thermal aggregation 
assay was carried out as described in the materials and methods section. The effect of 
proteins (Hsc70 and HSJ1b), either acting alone or as a complex (in vitro or 
recombinant) on maintaining the solubility of luciferase during heat denaturation was 
studied. The assays were performed both in the presence/absence of ATP to understand 
the effect of the nucleotide on the chaperone function. Aggregation of luciferase was 
induced by elevating the temperature to 42oC. After 10 minutes the reactions were 
centrifuged to separate the soluble and aggregated fractions. Samples were analysed by 
SDS-PAGE electrophoresis and the amount of luciferase in each reaction was 
quantified by densitometry. Figure 5.5 is the plot of the percentage of luciferase 
detected in the soluble and insoluble fractions for reactions performed with the 
different chaperone proteins. In Chapter 4, section 4.3.1, we have shown that in the 
absence of chaperone proteins, 81.4% of luciferase is rendered insoluble at 42oC. The 
presence of Hsc70 during thermal aggregation protected almost 60% of luciferase 
(reaction 3, Figure 5.5), while HSJ1b alone protected <50% of luciferase present in the 
reaction (reaction 1, Figure 5.5). The addition of ATP to these reactions resulted in the 
detection of an extra 10% luciferase in the soluble fraction (reactions 2 and 4 
respectively, Figure 5.5). When Hsc70 and HSJ1b were added together in the absence 
of ATP, the resulting in vitro complex could maintain just over 50% of luciferase in 
the soluble fraction. The rHH complex prevented almost 85.7% of luciferase from 
thermal denaturation (reactions 5 and 7, Figure 5.5), a 62% increase compared to the in 
vitro reaction.  However when Hsc70 and HSJ1b were added together in the presence 
of ATP, the resulting in vitro complex could maintain >70% of the substrate in the 
soluble fraction, an additional 20% increase (from 52.3% to 73.6%) in substrate 
protection. The rHH complex was unaffected by the addition of ATP as reported in 
Chapter 4 (reactions 6 and 8, Figure 5.5).  
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Figure 5.5: Prevention of protein aggregation studied using Hsc70, HSJ1b, in vitro Hsc70/HSJ1b complex and the rHH proteins. 
 
0.8 µm of luciferase was thermally denatured at 42oC for 10 minutes in the presence/absence of the 2.1 µg each of Hsc70, HSJ1b, rHH complex and in vitro complex 
formed by combining 2.1 µg each of Hsc70 and HSJ1b. For the reactions containing ATP, the nucleotide was added at a concentration of 2mM. The reaction was 
spun down at 13,000 rpm to separate the soluble and aggregated fractions and analysed by SDS-PAGE. The amount of luciferase present in each fraction was 
quantified by densitometry and the percentage of soluble and aggregated luciferase for each reaction was calculated and plotted on MS Excel. 
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It was interesting to next look at the effect thermal stress at 42oC had on the solubility 
of the individual chaperone proteins i.e., Hsc70 and HSJ1b. The amount of Hsc70 and 
HSJ1b present in the insoluble fraction was measured using as described previously. 
Figure 5.6 is a plot of the percentage of Hsc70 aggregation during the course of the 
assay at 42oC. When the reactions were performed with Hsc70 on its own or in the 
presence of HSJ1b, but in the absence of ATP, almost 27% and 31% respectively of 
Hsc70 was detected in the pellet fraction of the assay (reactions 1 and 3, Figure 5.6). 
Addition of ATP to these reactions (reactions 2 and 4, Figure 5.6) marginally improves 
the Hsc70 solubility.  However, Hsc70 from the rHH complex appears to be more 
resilient to thermal denaturation, as only ~13% of Hsc70 was found in the insoluble 
fraction and its solubility is not ATP dependent (reactions 5 and 6, Figure 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Percentage of Hsc70 rendered insoluble during the thermal aggregation assay. 
 
Luciferase was thermally denatured at 42oC for 10 minutes in the presence of the indicated chaperones 
and 2mM ATP. The reaction was spun down at 13,000 rpm to separate the soluble and aggregated 
fractions. The insoluble and soluble fractions obtained from the luciferase aggregation assay were 
analysed on a 12% SDS-PAGE gel. Hsc70 in the insoluble fraction of the gel, for each reaction, was 
measured using densitometry and plotted as percentage of total Hsc70 present in both the soluble and 
insoluble fractions. 
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Similarly, the percentage of HSJ1b rendered insoluble during the thermal aggregation 
was estimated. Figure 5.7 is the graph of the percentage of HSJ1b detected in the 
insoluble fraction of the assay. In the reaction performed in the presence of only HSJ1b 
33.3% of the protein was insoluble (reaction 1, Figure 5.7). A similar percentage of 
HSJ1b (36.3 %) was aggregated when coupled with Hsc70 but in the absence of ATP 
(reaction 2, Figure 5.7). Addition of ATP causes only a 3% increase in solubility of 
HSJ1b when coupled with Hsc70 in the presence of ATP (the in vitro complex, 
reaction 3, Figure 5.7). It appears that the solubility of HSJ1b is unaffected by the 
presence of its Hsc70 chaperone partner, in the case of in vitro complex. HSJ1b 
complexed as the rHH complex however was 67% less insoluble than its counterpart 
from the in vitro complex. As determined for its Hsc70 partner in the previous section, 
only ~ 14% of HSJ1b was insoluble (reactions 4 and 5, Figure 5.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: Percentage of HSJ1b rendered insoluble during the thermal aggregation assay. 
 
Luciferase was thermally denatured at 42oC for 10 minutes in the presence of the indicated chaperones 
and nucleotide. The reaction was spun down at 13,000 rpm to separate the soluble and aggregated 
fractions and analysed by SDS-PAGE. HSJ1b in the insoluble fraction of the gel, for each reaction, was 
measured using densitometry and plotted as percentage of total HSJ1b present in both the soluble and 
insoluble fractions. 
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From the above analysis, a correlation can be shown between the solubility of 
luciferase and the solubility of both the Hsc70 and HSJ1b proteins. Increased solubility 
of just the Hsc70 is not sufficient for improving the solubility of luciferase, as was 
observed with the in vitro complex. Higher solubility of both Hsc70 and HSJ1b 
subunits of the rHH complex may therefore explains the higher levels of luciferase 
protection observed with the recombinant Hsc70/HSJ1b complex.  
From the percentage of soluble substrate (luciferase), Hsc70 and HSJ1b calculated 
from the previous sections the ratio of interaction between the chaperone-co chaperone 
–substrate moieties during thermal stress was calculated. The results have been 
tabulated in Table 5.2.  
Reactions Actual Ratio Approximated 
ratio 
Hsc70 L  L:H  1:1.2 1:1 
L+ ATP L:H  1:1.2 1:1 
HSJ1b L L:J  1:2 1:2 
In vitro 
complex 
L  L:H:J  1:1.3:1.2 1:1:1 
L+ ATP L:H:J  1:1.2:0.9 1:1:1 
rHH complex L L:H:J  1:1:1 1:1:1 
L+ ATP L:H:J  1:1:1 1:1:1 
Table 5.2: Observed ratio of interaction between Hsc70, HSJ1b and luciferase.  
The ratio was obtained using the densitometric values from Figure 5.5 to 5.7. L represents luciferase, H- 
Hsc70 and J-HSJ1b. 
 
All decimal fractions were approximated to nearest whole number. Observed fractions 
could be the consequence of using densitometry for the quantification, which is 
influenced by variation in gel staining and destaining. In both complexes, the three 
interacting components of the reaction i.e. Hsc70, HSJ1b and luciferase come together 
in a 1:1:1 ratio. Hsc70 on its own bound to luciferase in a 1:1 ratio and HSJ1b appears 
to interact in a 2 to 1 ratio with luciferase.  
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5.3.4.2. Conformational differences 
Limited proteolysis experiments were conducted to probe the potential differences in 
the conformational features of the in vitro complex and the recombinant rHH form. 
The experiment was performed for all four proteins (Hsc70, HSJ1b, the in vitro 
complex and the recombinant complex) using the proteases trypsin and chymotrypsin. 
Proteolysis of the individual Hsc70 and HSJ1b proteins served as references to 
decipher changes in the pattern of proteolytic fragments for Hsc70 or HSJ1b as a 
consequence of complex formation.  
Limited proteolysis by chymotrypsin 
All four proteins, i.e. Hsc70, HSJ1b, in vitro and recombinant complexes were 
digested by chymotrypsin for 10 minutes at 4oC. The digestion products were 
visualised by SDS-PAGE electrophoresis (Figure 5.8). Panel A shows the digestion 
products obtained for Hsc70, panel B for HSJ1b, while panel C and D represent the 
digestion patterns for the in vitro and rHH complexes respectively. From the gel it was 
observed that although Hsc70 was undergoing proteolysis (as observed by decreasing 
intensity of the 73 kDa band in lanes 2 and 3, panel A, Figure 5.8) no major proteolysis 
product could be observed. Detection of minor digestion products was difficult 
because of the presence of minor contaminating protein species (panel A, lanes 2 and 
3, Figure 5.8). However enrichment of a ~ 60 kDa, 50 kDa and ~40 kDa species could 
be observed (indicated by a * in panel A, lanes 2 and 3, Figure 5.8). HSJ1b on the 
other hand undergoes very quick proteolysis at 4oC, resulting in a fragment 
approximately 30 kDa in molecular weight (represented by an arrow mark in panel B, 
lane 2, Figure 5.8). Chymotrypsin proteolysis of the in vitro and recombinant complex 
results in near identical digestion profiles. In both cases, the Hsc70 component appears 
to be largely resistant to proteolysis and no proteolysis product indicative of Hsc70 
digestion is observed (panel C and D, Figure 5.8. As with the individual HSJ1b 
proteolysis reactions, in the complexed state also, the HSJ1b subunit was more 
sensitive to cleavage by chymotrypsin and resulted in a 30 kDa fragment (represented 
by arrow mark, panel C and panel D, Figure 5.8).  
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Figure 5.8: Limited proteolysis studies using chymotrypsin protease 
 
2.5 µg of Hsc70, 2.5 µg of HSJ1b, and 4.4 µg of rHH were incubated with chymotrypsin at 4°C in the presence and absence of ATP (2 mM). For the in vitro complex 
2.5 µg of Hsc70 was combined with 2.5 µg of HSJ1b.The digestions were performed in buffer containing 20 mM Tris-HCl pH 8.0, 50 mM potassium chloride, 3 mM 
magnesium chloride and 2 mM DTT for 10 min. The digestion products were analysed on a 12% polyacrylamide gel stained with Coomassie Blue. The first track on 
the left hand side (lane 1) in each panel is the control protein in the absence of chymotrypsin. Lane 2 in each panel is the proteolysis performed in the absence of ATP 
and lane 3 in the presence of ATP. Panel A: Chymotrysin digestion of Hsc70. Panel B: Chymotrysin digestion of HSJ1b. Panel C: Chymotrysin digestion of the in 
vitro complex. Panel D: Chymotrysin digestion of rHH complex. The arrowhead indicates the putative digestion product of HSJ1b. The * indicates the putative 
digestion product of Hsc70. 
Panel B Panel C Panel D Panel A 
- 
+ 
- 
+ 
+ 
HSJ1b 
Hsc70 
rHH complex 
ATP 
Chymotrypsin 
- 
+ 
- 
- 
- 
+ 
- 
- 
+ 
- 
- 
- 
+ 
- 
+ 
+ 
- 
- 
- 
+ 
+ 
+ 
- 
- 
- 
+ 
+ 
- 
- 
+ 
- 
- 
+ 
- 
- 
+ 
- 
- 
+ 
+ 
+ 
- 
- 
- 
- 
+ 
+ 
- 
+ 
+ 
- 
- 
+ 
+ 
+ 
     1           2          3         1          2          3      
      1          2          3      
       1          2         3      
* 
* 
* 
  
Page 158 
Hsc70 
rHH complex 
In vitro complex 
%
 
o
f u
n
di
ge
st
ed
 
H
sc
70
 
+ 
+ 
+ 
          - 
          - 
          + 
Chymotrypsin
ATP 
Protein 
- 
+ 
+ 
Reaction No: 
In order to determine if the state of association between Hsc70 and HSJ1b altered their 
sensitivity to chymotrypsin, densitomeric tracing of the uncleaved Hsc70 and HSJ1b 
protein remaining following partial chymotrypsin digestion was calculated. Hsc70 
either on its own or as a complex (in vitro or rHH) did not show any visible signs of 
proteolysis and no major proteolysis product could be detected on the SDS-PAGE. 
Despite this almost ~65% of uncomplexed Hsc70 remains uncleaved in the absence of 
ATP. This is reduced to 46% upon addition of ATP to the proteolysis reaction. This 
suggests that in the presence of ATP, the Hsc70 protein's open conformation is more 
accessible to chymotrypsin digestion. For the in vitro complex, when Hsc70 was 
combined with HSJ1b in the absence of ATP, 84.7% of Hsc70 was undigested. 
Addition of ATP causes a 58% increase in cleavage of Hsc70, suggesting that the in 
vitro complex of Hsc70 and HSJ1b in the presence of ATP adopts an open 
conformation. In contrast, 86 % of the Hsc70 subunit from the rHH complex in the 
absence of ATP, and, 77% in the presence of ATP was resistant to chymotrypsin 
proteolysis. This suggests that the Hsc70 subunit of the rHH complex adopts an 
alternate conformation compared to that of the free Hsc70 and the in vitro complex. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: Densitometric analysis of undigested Hsc70 after proteolysis by chymotrypsin 
 
Partial proteolysis by chymotrypsin was performed as described in section 5.2.4 and the digestion 
products were analysed on a 12% polyacrylamide gel stained with Coomassie Blue. Densitometric 
traces of the Hsc70 subunits from the gel (using figure 5.8) allowed the quantification of the amount of 
Hsc70 undigested as a percentage of Hsc70 protein in the control reaction. Reaction 1 is the amount of 
protein in the control reaction not treated with the protease and is assigned 100%, reaction 2 is 
chymotrypsin proteolysis performed in the absence of ATP and reaction 3 chymotrypsin proteolysis 
performed in the presence of 2mM ATP. 
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Similarly using densitometry, the percentage of undigested HSJ1b protein was 
measured for all three reactions (Figure 5.8). Almost 82% of HSJ1b was degraded 
down to its ~30 kDa fragment when proteolysis was performed in the absence of 
Hsc70. Irrespective of the nature of the complex (in vitro or recombinant) the presence 
Hsc70 chaperone partner reduced the rate of proteolysis of HSJ1b. In the absence of 
ATP, almost 54% of HSJ1b from the in vitro complex remained undigested, which 
was just 7% higher than that observed for the recombinant complex (reaction 2, figure 
5.8). The presence of ATP during proteolysis increased the sensitivity of HSJ1b of the 
in vitro complex by 20% (reaction 3, figure 5.8). Thus susceptibility of HSJ1b to 
proteolysis appears to reduce in the presence of its Hsc70 partner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10: Densitometric analysis of undigested HSJ1b after proteolysis by chymotrypsin 
 
Partial proteolysis by chymotrypsin was performed for 10 minutes at 4oC in the presence and absence of 
ATP (2 mM). The digestion products were analysed on a 12% polyacrylamide gel stained with 
Coomassie Blue. Densitometric traces of the HSJ1b fractions from the SDS-PAGE gel (using figure 5.8) 
allowed comparison of the amount of HSJ1b left undigested at the end of the proteolysis reaction as a 
percentage of HSJ1b protein in the control reaction. Reaction 1 is the amount of protein in the control 
reaction not treated with the protease and is assigned 100%, reaction 2 is chymotrypsin proteolysis 
performed in the absence of ATP and reaction 3 chymotrypsin proteolysis performed in the presence of 
2mM ATP. 
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Limited proteolysis by trypsin 
 
Since the proteolysis experiment with chymotrypsin was inconclusive, proteolysis with 
trypsin were undertaken. Reactions were performed at 25oC in the presence and 
absence of ATP as per the protocol of Chamberlain and Burgoyne (Chamberlain and 
Burgoyne, 1997) and the proteolysis fragments were assessed as described in the 
previous section. Trypsin digestion of the in vitro complex in the absence of ATP 
resulted in 4 major polypeptide species (Figure 5.11). The first species was observed 
migrating very close to the undigested Hsc70 protein species at 73 kDa (as seen in 
panel A, comparing the control in lane 1 to the trypsin treated samples in lane 2 and 3, 
Figure 5.11). Another three groups of proteolytic cleavage products migrated at 
approximately 60 kDa, 52-55 kDa and 40-44 kDa. Addition of ATP did not make any 
difference to the sensitivity of the in vitro complex to tryptic digestion (lane 2, panel 
A, Figure 5.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Limited proteolysis studies of the in vitro and rHH proteins using trypsin protease 
 
The two complexes were incubated with trypsin in a ratio of 1:300 (w/w) for 15 minutes at in the 
presence and absence of ATP (2 mM). The digestion products were analysed on a 12% polyacrylamide 
gel stained with Coomassie Blue. Panel A: Trysin digestion of the in vitro complex. Panel B: Trysin 
digestion of rHH complex. The first track on the left hand side in each panel is the control protein in the 
absence of trypsin. Lane 2 in each panel is the proteolysis performed in the absence of ATP and lane 3 
in the presence of ATP.  
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Similarly, the rHH complex was subjected to partial proteolysis by trypsin and the 
digestion products were analysed by SDS-PAGE electrophoresis (panel B Figure 
5.11). Contrary to what was observed for the in vitro complex, Hsc70 of the rHH 
complex was resistant while HSJ1b was more sensitive to trypsin. Two main groups of 
proteolytic cleavage products were detected; one migrating at 73 kDa and the other at 
25 - 27 kDa. A close examination of the 73 kDa band reveals that the band actually 
comprises of two closely migrating species rather than one (lane 3, panel B, Figure 
5.11). This was similar to the observations made on the in vitro complex. Addition of 
ATP causes subtle changes in the digestion pattern. An additional cleavage product 
migrating at approximately 30 kDa is observed (lane 2, panel B, Figure 5.11).  
The striking difference between the in vitro and the rHH complexes is the sensitivity of 
Hsc70 to proteolysis. The percentage of undigested Hsc70 protein in both the 
complexes was calculated (Figure 5.12). In the absence of ATP, almost 73% of Hsc70 
from the rHH complex remained undigested compared to only 28.2% observed for the 
in vitro complex (reaction 2, Figure 5.12). The addition of ATP increased the amount 
of undigested Hsc70 of the in vitro complex to 41.9%, while the effect of ATP on the 
Hsc70 subunit of the rHH complex was negligible (~2%, reaction 3, Figure 5.12). A 
similar comparison on the sensitivity of the HSJ1b fraction could not be made because 
of the ambiguous nature of the identity of the 40-44 kDa species present in the 
proteolysis reaction of the in vitro complex. It has been reported that one of the 
proteolysis fragments resulting from trypsin digest of DnaK migrates at 40-44 kDa 
(Liberek et al., 1991). This coincides with the migration position of the HSJ1b protein 
itself.  
An important conclusion that can be drawn from the trypsin proteolysis is the apparent 
difference in the assembly of HSJ1b with respect to HSc70 for the two complexes. 
From the proteolysis it is apparent that the conformation adopted by the rHH complex 
renders Hsc70 less susceptible to proteolytic attack by trypsin, contrary to what was 
observed for the in vitro complex. 
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Figure 5.12: Densitometric analysis of Hsc70 left undigested after trypsin digestion of the in 
vitro and recombinant complex. 
 
Partial proteolysis by trypsin was performed for 15 minutes at 20oC in the presence and absence of ATP 
(2 mM). The digestion products were analysed on a 12% polyacrylamide gel stained with Coomassie 
Blue. Traces for the Hsc70 fractions were plotted from denstometric analysis of the SDS-PAGE gel and 
compared with the percentage of Hsc70 present in the reaction prior to digestion (reaction 1). Reaction 2 
is trypsin reaction performed in the absence of ATP and in the presence of ATP (reaction 3). 
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5.3.5. Oligomerisation studies 
 
We next decided to study by size exclusion chromatography the extent of 
oligomerisation and complex formation when Hsc70 and HSJ1b were reconstituted as 
an in vitro complex. Hsc70 and HSJ1b were combined in 2:1(w/w) in the presence of 
ATP and loaded onto a Superdex-200 column. The column was equilibrated in the 
buffer specified in section 5.2.6 and the chromatography was performed in buffer 
containing ATP (Panel A, Figure 5.13). As observed for the rHH complex, a peak 
corresponding to the polymerised Hsc70/HSJ1b complex was observed in the void 
volume (represented as peak 1 on the chromatogram in panel A of Figure 5.13). In 
contrast to the well resolved ~220kDa peak obtained for the rHH, the peak in the 
included volume for the in vitro complex was poorly resolved and extended over 
almost 16 ml from fraction 48-60 ml and an additional shoulder peak eluting from 60-
72 mls (represented as peak 2 on the chromatogram in panel A of Figure 5.13). This 
suggests a degree of instability in the interactions of the protein components. However 
analysis of the fractions obtained from the Superdex-200 column by SDS-PAGE 
(Panel B, Figure 5.13) confirms the presence of both the Hsc70 and HSJ1b subunits in 
both the resolved peaks. Visual inspection of the SDS gel revealed that although both 
Hsc70 and HSJ1b subunits co-fractionate together in both elution peaks for both the 
complexes, the stoichiometry of the two subunits for the two peaks were different. In 
peak 1 the Hsc70 and HSJ1b subunits appear to be in a 1:1 ratio (Lanes 1-4, Panel B, 
Figure 5.13), while for peak2, this ratio appears to varying across the fractions for the 
in vitro (Lanes 5-9, Panel B, Figure 5.13), which reiterates our doubts regarding the 
stability of this fraction. 
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Figure 5.13: Oligomeristion studies of the in vitro complex using size exclusion chromatography 
 
Size exclusion chromatography was performed on a Superdex-200 column. Hsc70 and HSJ1b were 
combined in the presence of ATP and loaded onto the column. The column was equilibrated in the 
buffer specified in section 5.2.6 and the chromatography was performed in buffer containing ATP. The 
protein eluting from the column was collected as 1 ml fractions. The absorbance of each fraction was 
determined using Bradford assay. Plot of absorbance at 595 nm for the fractions on the Y-axis versus the 
elution volume (X-axis) was used to develop the elution profile chromatogram. 
Panel A: Elution profile of the in vitro complex from the Superdex-200 column. 
Panel B: SDS-PAGE analysis of the elution of the in vitro complex from the gel filtration column  
Lanes 1-4 fractions 36-39, lane 5 is the Bio-Rad precision plus prestained molecular weight marker 
(broad range) and lanes 6-10 are fractions 56-59.  
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In order to confirm that an in vitro complex was indeed formed, SEC of the purified 
recombinant chaperones. Hsc70 and HSJ1b was performed and compared with the 
elution profiles for rHH and in vitro complex. HSJ1b (figure 5.14, trace in teal) 
primarily eluted as a dimer, but approximately 50% of the protein was detected in the 
void volume, suggesting protein aggregation. Similarly, a large proportion of Hsc70 
(Figure 5.14, trace in blue) was also aggregated and detected in the void volume. The 
rest of the Hsc70 protein eluted as a broad unresolved peak corresponding to species 
having a molecular mass of approximately 150-250 kDa. The formation of an in vitro 
complex between Hsc70 and HSJ1b in the presence of ATP did not result in the 
appearance of a distinct additional peak which would suggest that Hsc70 and HSJ1b 
assemble and interact in an ATP-dependent manner. Instead peak 2 was broad and 
extended over more than 20 ml, and overlapping, when compared, with both the 
individual Hsc70 and HSJ1b elution profiles (indicated by arrow marks in panel B in 
Figure 5.14). This again gives credence to our doubts regarding the stability of the 
interaction of the Hsc70 and HSJ1b in vitro complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: Comparison of the elution profile of Hsc70 and HSJ1b with the in vitro complex. 
 
Size exclusion chromatography was performed on a Superdex-200 column. 50 µg of Hsc70 and HSJ1b 
were separately loaded onto the column. The column was equilibrated and run in 20 mM Tris-HCl pH 
8.0 plus 100 mM potassium chloride. 1 mL fractions were collected after 25 ml of buffer had passed. 
Absorbance of each fraction was determined using Bradford assay. The elution chromatograms for 
Hsc70 and HSJ1b were then superposed with the elution profile obtained for the in vitro complex (ref 
Figure 5.13). 
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Elution volume in ml 
Similarly the elution profile of the rHH complex was compared with the individual 
profiles of Hsc70 and HSJ1b (Figure 5.15).  In Chapter 4, from SEC analysis, the rHH 
protein was determined to be composed of two protein fractions; one a very large 
species in the void volume and the second a dimer of a heterodimer at ~ 220 kDa. 
Upon comparison with the elution profiles of individual Hsc70 (Figure 5.14, trace in 
blue) and HSJ1b polypeptides (Figure 5.15, trace in teal), it was observed that the 
elution position of the 220 kDa fraction, overlapped partly with the Hsc70’s broad 
elution peak, but not with that of the HSJ1b elution. However SDS-PAGE analysis 
performed in chapter 4 has confirmed the presence of both Hsc70 and HSJ1b subunits, 
thereby indicating that the ~220 kDa species represents a distinct additional peak 
bought about by the assembly and interaction of Hsc70 and HSJ1b into a dimer of a 
heterodimer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Comparison of the elution profile of Hsc70 and HSJ1b with the rHH complex on 
SEC. 
 
Size exclusion chromatography was performed on a Superdex-200 column. 50 µg of Hsc70 and HSJ1b 
were separately loaded onto the column. The column was equilibrated and run in 20 mM Tris-HCl pH 
8.0 plus 100 mM potassium chloride. 1 mL fractions were collected after 25 ml of buffer had passed. 
Absorbance of each fraction was determined using Bradford assay. The elution profiles of Hsc70 and 
HSJ1b were then superposed with the elution profile obtained for the rHH complex (ref Figure 4.16). 
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In Chapter 4, analytical ultracentrifugation confirmed that the elution peak in the void 
was apparently a non-aggregated higher order oligomer. This oligomeric fraction may 
be attributed to the polymerisation effect of Hsp40 proteins on Hsp70 (King et al., 
1995). In the absence of AUC data for the in vitro complex, it is difficult to determine 
if the first peak obtained for the in vitro complex is an aggregate or a non-aggregated 
higher order oligomer as determined for the rHH protein. Working on the assumption 
that it represented non-aggregated protein, the differences in oligomerisation 
composition between the rHH and in vitro protein complexes was quantified. Panel A 
in Figure 5.16 is a superposition of the elution profiles of the in vitro and rHH 
complexes from the Superdex 200 column, and the boundaries used to demarcate the 
two peaks have been indicated by the boxed area. Peak 1 has been defined by the blue 
box and peak 2 has been defined by the red box. The area under the curve for the two 
peaks was calculated using this boxed area and the values plotted as percentage of total 
protein in peak1 and peak 2 (panel B, Figure 5.16). Interestingly for the rHH complex 
the percent of protein eluting as the highly oligomerised peak 1 (panel B, Figure 5.16) 
was almost two times that occupied by peak 1 of the in vitro complex (64% and 38% 
respectively). The exact opposite relation was observed for the peak 2 (panel B, Figure 
5.16); the in vitro complex predominantly exists as the non aggregated form (62%) as 
opposed to the 38% calculated for the rHH protein (Figure 5.16). However the 
correlation between the greater oligomerisation and the observed functional superiority 
of rHH is not yet clear.  
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Figure 5.16: Proportion of rHH and in vitro complex as peak 1 and peak 2. 
 
Size exclusion chromatography was performed on a superdex 200 column. The column was equilibrated 
and run in 20 mM Tris-HCl pH 8.0 plus 100 mM potassium chloride. 1 mL fractions were collected 
after 25 ml of buffer had passed. Absorbance of each fraction was determined using Bradford assay. 
Panel A: Comparison of the elution profile of the in vitro complex with the rHH complex. 
Panel B: Distribution of the two peaks for the two complexes was determined by calculating the area 
under the peaks. 
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5.4. Discussion 
The interactions between the HSP40 and HSP70 families have been widely studied 
using a reconstituted Hsp70/Hsp40 in vitro system. Mammalian Hsc70/Hsp40, yeast 
Ssalp/Ydjlp and the Hsc70/Csp are just a few examples of the chaperone/co-chaperone 
complexes studied using this method (Levy et al., 1995; Minami et al., 1996; 
Chamberlain and Burgoyne, 1997). Usually, the in vitro complex is formed by 
combining the individual purified HSP70 and HSP40 family members. Complex 
formation is driven by the addition of ATP which initiates the formation of an Hsp70-
Hsp40 complex driven by the hydrolysis of ATP by the Hsp70 moiety (Russell et al., 
1999).  In this chapter a comparative study of the recombinant rHH complex and the in 
vitro complex was carried out. 
To generate an in vitro complex, Hsc70 and HSJ1b proteins had to be independently 
purified. The Hsc70 and HSJ1b genes cloned into the pET-16b vector were 
successfully over-expressed in E.coli. The proteins were expressed with a 10 X 
histidine tag, such that both proteins could be purified using Ni-NTA chromatography. 
HSJ1b required an additional purification step to remove a major contaminating 
protein species at 70 kDa. This was confirmed to be the E.coli Hsp70 chaperone 
protein, DnaK. Chamberlain and Burgoyne, (1997) reported a similar contamination 
during the expression of recombinant cysteine string proteins (Chamberlain and 
Burgoyne, 1997). An additional Mg.ATP wash step in the Ni-NTA chromatography 
was unsuccessful in eliminating all the contaminating protein. HSJ1b was therefore 
eluted from a preliminary Ni-NTA column and then treated with Mg.ATP for an 
extended period of time. The ATP treated HSJ1b protein was separated from the 
contaminating DnaK species by an additional Ni-NTA chromatographic step. HSJ1b 
isolated by this method was observed to be free from DnaK contamination. Purified 
Hsc70 and HSJ1b proteins were reconstituted together to form an in vitro complex and 
studied along with the rHH complex from Chapter 3. The two complexes differed in 
two aspects. The first being the HSJ1b subunit in the rHH complex is untagged, while 
HSJ1b for the in vitro complex retains the 10 X histidine tag. However previous 
studies have reported that both the His tagged and untagged Hsp40 behaved identically 
in functional assays (Minami et al., 1996). Therefore we decided against cleaving the 
His tag from the recombinant HSJ1b and proceeded to use the His tagged HSJ1b 
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protein. The second difference was that the in vitro complex was formed by combining 
the dialysed Hsc70 and HSJ1b proteins; whereas the rHH protein was not dialysed and 
contained 200 mM imidazole used for the Ni-NTA elution. However we have observed 
that the presence of imidazole or its removal by dialysis does not influence the 
functioning of the rHH complex (determined using the thermal aggregation assay, data 
not shown). Based on this reasoning, it was decided that these differences will not 
influence or bias the results of our study. 
Suppression of substrate aggregation is an essential chaperone activity (Forreiter and 
Nover, 1998). The functional efficiency of the in vitro and recombinant complexes was 
investigated by a thermal aggregation assay. Firefly luciferase has been used routinely 
as the substrate protein for such aggregation studies, where the elevation of 
temperatures to 42oC causes aggregation of luciferase. This aggregation can be 
reduced by the presence of chaperone proteins (Minami et al., 1996; Glover and 
Lindquist, 1998; Wang and Spector, 2001). Using thermal aggregation assays Minami 
et al., 1996 have studied the regulation of mammalian Hsc70 by the DnaJ homologue 
(HDJ1). They reported that the reconstituted Hsc70/HDJ1 complex exhibited an ATP 
dependent increase in luciferase protection levels. In the presence of ATP, the 
Hsc70/HDJ1 complex’s luciferase protection was enhanced by approximately two fold 
(Minami et al., 1996). In contrast to these finding, it was observed that the protection 
capability of the rHH complex used in this study was not nucleotide dependent. The 
recombinant chaperone complex was successful in protecting (85%), of luciferase 
which was unaffected by the addition of ATP. Luciferase protection by the individual 
Hsc70 and Hsc70/HSJ1b in vitro complex was consistent with the observations of 
Minami et al. and exhibited an ATP induced increase in luciferase protection. The 
observed increase in protection was however not as dramatic as the two fold increase 
reported by Minami et al.  
Hsc70 and Hsc70/HSJ1b in vitro complex proteins exhibited substrate protection even 
in the absence of ATP (60.8% and 52.6% respectively). A possible explanation for this 
observation could be the purification protocol used for the isolation of Hsc70. Minami 
et al., purified Hsc70 from bovine brain following the original protocol reported by 
Schlossman et al. This method recommends treating the purified Hsc70 with EDTA to 
improve the ATP dependent activity of the extracted Hsc70 protein (Schlossman et al., 
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1984). Hsc70 used during the course of this study was expressed recombinantly in 
E.coli and purified by single step Ni-NTA chromatography. Therefore the purified 
protein might comprise of a mixed population of ATP dependent and independent 
forms, explaining the observation of functional activity in the absence of ATP. 
Recombinant HSJ1b protein used in this study was also found to be capable of 
maintaining up to 35% of luciferase soluble, suggesting that HSJ1b can possibly 
functional as a chaperone on its own merit. Though the mammalian DnaJ homologue 
(Hdj1) was unable to function as a chaperone (Minami et al.,), other Hsp40’s such as  
the E.coli DnaJ have been shown to behave as chaperones (Szabo et al., 1996; Langer 
et al., 1992). However further investigation is required to confirm HSJ1b’s chaperone 
capabilities. 
A correlation was observed between the solubility of the individual Hsc70 and HSJ1b 
subunits and the solubility of luciferase. For the in vitro complex the percentage 
solubility of Hsc70 subunit was directly proportional to the solubility of luciferase. 
Addition of ATP results in an increase in solubility of Hsc70 which translates into 
increased solubility of the substrate. Most interesting was that this did not result in an 
increased solubility of its co-chaperone partner-HSJ1b. This raises an interesting 
question on the role of HSJ1b during substrate protection in the in vitro form of the 
complex in the presence of ATP. The Hsc70 and HSJ1b proteins involved in forming 
the rHH complex were more resilient to higher temperatures, with almost 85% of both 
the proteins present in the soluble fraction. Thus a higher solubility of both Hsc70 and 
HSJ1b is required for the higher levels of luciferase protection as observed with the 
recombinant Hsc70/HSJ1b complex. This could explain the observed difference in 
luciferase protection between the two complexes.  
This then raises questions on the possible differences in the mechanism of interaction 
of the Hsc70 and HSJ1b proteins of the in vitro and rHH complex with the denatured 
substrate. Formation of the in vitro complex is initiated by the addition of ATP and the 
Hsc70/HSJ1b ternary complex is a post ATP hydrolysis product. Though we have not 
been able to prove conclusively the nucleotide content of the rHH complex, we believe 
the complex isolated from the Ni-NTA column is already in a competent state to 
protect aggregating proteins, without any additional nucleotide requirement. This then 
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strongly suggests that the two complexes are binding denatured luciferase in seemingly 
different ways.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17: Proposed mechanism of action of HSJ1b assisted Hsc70 binding to denatured 
subustrate (using luciferase as an example). 
Panel A) Sequence of events leading to formation of the ternary complex of Hsc70, HSJ1b (J) and 
luciferase (L) for the in vitro complex.  Panel B) Two potential mechanisms (indicated by 1 and 2) for 
the formation of the ternary complex of Hsc70 possibly bound to nucleotide N, HSJ1b (J) and luciferase 
(L) in the rHH complex. 
According to Szabo et al. (1994), luciferase initially binds to DnaJ, which initiates 
ATP hydrolysis by DnaK to form a Luciferase-DnaK-DnaJ complex (Szabo et al., 
1994). Panel A in Figure 5.17 illustrates the mode of action for the in vitro complex 
according to Szabo et al. Although this model might explain the observations for the in 
vitro complex reconstituted from Hsc70 and HSJ1b, it fails to convincingly explain the 
mode of action for the preformed recombinant (rHH) complex. Panel B illustrates a 
hypothetical mode of interaction for luciferase with the rHH complex. It explores the 
possibility that luciferase binds directly to the pre-existing Hsc70/HSJ1b complex. 
Two routes are possible; either the unfolded substrate (i.e. luciferase) binds directly to 
the Hsc70 subunit of the complex (labelled 1 in panel B, Figure 5.17), or the substrate 
first binds to the HSJ1b subunit of the complex (labelled 2a in panel B, Figure 5.17) 
which then hands it over to Hsc70 (labelled 2b in panel B, Figure 5.17). More work is 
required to confirm the exact mechanism. 
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The two complexes exhibited dissimilar substrate protection, which could be due to 
differing conformations. These potential differences between the recombinant 
Hsc70/HSJ1b complex and the in vitro complex were probed by limited proteolysis. 
This technique is used routinely to study the conformation of native proteins and 
associated transitions observed on substrate /cofactor/ ligand binding (Hubbard, 1998). 
In this study, the enzymes chymotrypsin and trypsin were used so that two types of 
specificity could be probed. Chymotrypsin cleaves peptides at the carboxyl side of 
tyrosine, tryptophan, and phenylalanine residues (amino acids contain aromatic rings) 
while trypsin predominantly cleaves peptide chains at the carboxyl side of the amino 
acids lysine and arginine (Stryer et al., 2002). 
Chappel et al., (1986) reported that chymotrypsin digestion of bovine Hsc70 at 37oC 
resulted in a 60 kDa fragment which was subsequently proteolysed to form a 44 kDa 
fragment. We expected the proteolysis pattern from our study to be different from that 
reported by Chappel et al. due to variations in the temperature used for the proteolysis 
experiments. While their results were reported at 37oC, our study was performed at 
4oC. We found that Hsc70 was sensitive to proteolysis by chymotrypsin and more than 
50% of Hsc70 was proteolysed in the presence of ATP. However no major proteolysis 
products could be detected. Three very minor proteolytic fragments (at approximately 
60 kDa, 50 kDa and 40 kDa) could also be observed. But owing to the inherent 
contamination of the protein sample, the validity of these observations is uncertain. A 
longer incubation time may have been more insightful. Chymotrypsin digestion of 
HSJ1b produced only one detectable fragment at approximately 30 kDa. Analysis of 
the HSJ1b protein sequence by GeneRunner software revealed 28 possible 
chymotrypsin recognition sites. 27 out of the 28 sites are clustered together in the first 
171 amino acids, while the 28th site is at Y261. Comparing the sequence analysis with 
the observed proteolytic fragment sizes, it appears that the primary site of cleavage is 
either Y51 or Y261. However this prediction is based solely in bioinformatic analysis 
of the distribution of chymotrypsin sites on the protein sequence and needs to be 
confirmed by N-terminal sequencing or MS/MS of the fragment.  
Partial proteolysis of the in vitro and recombinant complex by chymotrypsin however 
revealed no detectable difference between the digest patterns.  In both the cases, the 
Hsc70 component of the complex appears to be resistant to proteolysis and no 
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discernible cleavage products from the proteolysis of Hsc70 were observed. Based on 
our digestion of HSJ1b alone, it is believed that the major cleavage product migrating 
at ~30 kDa originated from the HSJ1b fraction. Although the basic pattern of digestion 
was consistent for both complexes, there was a difference in the extent of digestion of 
the HSJ1b protein between the complexed and the uncomplexed state. HSJ1b on its 
own was extremely vulnerable to chymotrypsin, resulting in the cleavage of almost 
82% of HSJ1b over the time course of the experiment. However as part of the 
complexes, HSJ1b cleavage was slower as suggested by an increase in the percentage 
of residual HSJ1b- 55% and 42% for the in vitro and recombinant complex 
respectively. The interaction with Hsc70 has a stabilising effect, by either protecting 
the cleavage site on HSJ1b or by inducing a conformational change in HSJ1b which 
then alters protease sensitivity.  
Since proteolysis by chymotrypsin failed to reveal any conformational differences 
between the two protein complexes, proteolysis by trypsin was undertaken. Partial 
tryptic proteolysis was performed on the reconstituted in vitro complex and rHH 
complex at 30oC. The Hsc70 subunits in both the rHH and the in vitro gave rise to a 
~70-71 kDa fragment which differed from the undigested product (73 kDa) by only 1 
or 2 kDa. In Chapter 4, an analysis of the Hsc70 protein sequence by the Generunner 
software established that the only potential cleavage site which can give rise to a 71 
kDa product, does not occur in the native Hsc70 protein sequence, but in the Factor Xa 
site which follows the N-terminal His•Tag® sequence contributed by the pET-16b 
expression vector. The resulting 71 kDa product is therefore the native Hsc70 without 
the histidine tag. In addition, the in vitro complex gave rise to three other major 
proteolytic products. Two of the fragments observed at ~60 kDa and ~52 kDa 
respectively were presumptively the cleavage products of Hsc70. The third fragment at 
~ 40-44 kDa is of disputable origin, as it could possibly be a cleavage product of 
Hsc70 or remnants of undigested HSJ1b protein. The addition of ATP did not affect 
the digest pattern, therefore showing no evidence of a conformational change during 
the assembly of the in vitro complex. Other than the ~71 kDa product, the Hsc70 
subunit of the rHH was completely resistant to tryptic digestion under these 
experimental conditions. Instead the HSJ1b subunit of the rHH was almost completely 
digested. Proteolysis of rHH resulted in  only two prominent digestion fragments, one 
at ~35 kDa, and other at ~27 kDa both apparently originating from the HSJ1b subunit. 
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Addition of ATP resulted in the disappearance of the 35 kDa fragments indicative of 
probably a conformational shift resulting in quicker proteolysis of HSJ1b. 
Bioinformatic analysis of the HSJ1b sequence using GeneRunner software revealed 43 
trypsin recognition sites, uniformly distributed across the protein sequence. Therefore 
this could not provide any reliable clues about a potential site of cleavage which could 
result in a ~27 kDa fragment. Bimston et al., (1998) reported that trypsin digestion of 
Hsp70 yields 58 kDa, 43 kDa, 20 kDa and 18 kDa fragments, which concurs with 
some of the Hsc70 proteolysis fragments obtained for the in vitro complex. The 
addition of Human DnaJ homologue (HDJ-1) did not seem to alter the proteolysis 
results (Bimston et al., 1998). However their report fails to discuss the state of the 
HDJ-1 moiety. In contrast, Chamberlain et al., (1997) reported that digestion of Hsc70 
was significantly enhanced in the presence of cysteine string proteins 1 (Csp1) and 
ATP. Csp1 itself was extremely sensitive to the proteolysis and was undetectable by 
SDS-PAGE (Chamberlain et al., 1997). Contrastingly, in our experiments we observe 
that Hsc70 is in fact less susceptible to tryptic digestion in the presence of HSJ1b and 
ATP. But the digestion of Hsc70 is faster when ATP is not present; implying that in 
the presence of HSJ1b and ATP Hsc70 adpots a “closed” conformation, protecting it 
from proteolysis.  
Data obtained from these proteolysis studies indicate a difference between the in vitro 
and recombinant complexes at a structural level. The Hsc70 with its HSJ1b partner 
isolated recombinantly clearly adopts a different conformation compared to the model 
in vitro complex which has been routinely used in the study of the chaperone/co-
chaperone complex. However, more structural work is required to validate these 
observations. Perhaps N-terminal sequencing of the digest fragments is a way forward 
to identifying the regions on the proteins showing conformational mobility. 
Oligomerisation of the rHH complex has been extensively discussed in chapter 4. So 
we next decided to evaluate and compare the extent of complex formation and 
oligomerisation under in vitro conditions. Pleckaityte and co-workers have studied the 
behaviour of the Hsp70 and Hsp40, when combined together in the presence and 
absence of ATP (Pleckaityte et al., 2003). In the absence of ATP, they did not observe 
an additional elution peak, which could be attributed to complex formation 
(Pleckaityte et al., 2003). Additionally, biochemical analysis by Minami et al., also 
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reported that protection of denatured substrate from thermal aggregation requires the 
combined action of the reconstituted Hsc70 and Hsp40 protein system and ATP 
(Minami et al., 1996) Therefore in this study, we have restricted ourselves to study the 
nature of the complex formation between Hsc70 and HSJ1b under in vitro conditions 
only in the presence of ATP.  
During SEC the rHH protein was found to resolve into two peaks. The first peak eluted 
in the void volume, while the second peak fractionated at an estimated molecular 
weight of ~220 kDa. The oligomeric nature of the first peak from the void volume was 
studied by analytical ultracentrifugation and was confirmed to be a non- aggregated 
protein species, presumably arising from the polymerisation of the HSJ1b with the 
Hsc70. A similar peak is observed for the in vitro complex, suggesting successful 
polymerisation of the two proteins under in vitro conditions. In the absence of AUC 
data, it is difficult to determine if the first peak obtained for the in vitro complex is an 
aggregate or a non-aggregated higher order oligomer as determined for the rHH 
protein. For the second peak, although the elution volumes for both the complexes 
approximately matched, the resolution of the second peak for the in vitro complex was 
very poor, as observed from the broad nature of the elution. An estimate of the 
molecular weight of the second peak in vitro complex cannot be made due to the broad 
nature of the elution spectra. An interesting difference between the two complexes was 
the difference in the extent of oligomerisation of the two complexes. Based on the 
percentage distribution of the two peaks for the two complexes, it is apparent that the 
rHH complex exists predominantly in the oligomerised state, while the in vitro 
complex shows as much as 40% lesser oligomerisation. This suggests Hsc70/HSJ1b 
oligomerisation is more profound in the recombinant scenario than the in vitro one. 
The functional significance of this disparity, although not immediately 
clear/confirmed, could potentially explain the various functional and conformational 
differences that have been observed during the course of this study.  
A comparative study was also performed with the elution profile of the individual 
Hsc70 and HSJ1b polypeptides, to determine if the the peak 2 in the retention volume 
is an additional elution peak, distinct from the elution profiles of the individual Hsc70 
and HSJ1b. If so, it can concluded that this additional peak is due to the assembly of 
the Hsc70/HSJ1b complex, albeit an unstable one. Hsc70 has been observed to exist as 
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a mixture of monomer, dimers and higher order oligomers when bound to ADP, and as 
a monomer in the presence of ATP (Carlino et al., 1992; Toledo et al., 1993; Palleros 
et al., 1993). Recombinant Hsc70 used in our studies was found exist as a 
heterogeneous mixture of dimers and trimers, suggesting that it was probably in an 
ADP bound state. This correlates with our observations from the thermal aggregation 
assay where Hsc70 was found to be functionally competent even in the absence of 
ATP. Recombinant HSJ1b eluted as a dimer. Type I and II Hsp40’s have been shown 
to exist as dimers in solution, and is also functionally essential. Disruption of its 
dimerisation capabilities results in defective chaperone functions for both types of 
Hsp40s (Sha et al., 2000; Li et al., 2003). Another feature that was observed in the 
SEC profiles of both Hsc70 and HSJ1b was that a large proportion of both the proteins 
eluted in the void volume, indicating protein aggregation. This could be time induced, 
due to storage at 4oC during the course of the study. Similar time induced aggregation 
of Hsc70 has also been reported by Borges & Ramos (2006), who have observed 
during the course of their study that long term storage of the protein affected the 
homogeneity of the protein.  
When the individual Hsc70 and HSJ1b elution profiles were superposed with that of 
the reconstituted Hsc70/HSJ1b, the peak 2 in the retention volume coincided with the 
elution profiles of both the individual Hsc70 and HSJ1b. On comparing our results 
with the reported SEC elution profile for the Hsp70/Hsp40 complex from M. ruber, it 
was observed that the authors have also obtained a broad peak coinciding with the 
individual elution profiles of the Hsp70 and Hsp40 (Pleckaityte et al., 2003). Only an 
additional small shoulder can be observed with this broad peak, which in their report 
has been attributed to the formation of the complex (Pleckaityte et al., 2003). However 
due to the broad nature of elution for the peak 2 of the in vitro Hsc70/HSJ1b it was 
difficult to ascertain the presence of an additional unique peak, which could be 
indicative of the assembly and formation of a complex. 
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Summarising, in this chapter we compared the behaviour of the recombinant complex 
(rHH) with the reconstituted in vitro complex with respect to their substrate protection 
efficiency, conformational properties and degree of oligomerisation. The two 
complexes generated by two different protocols display significantly differences in 
their functional properties. Under our experimental conditions, the rHH complex was 
not only superior to the in vitro complex in protecting unfolded substrate; the assembly 
of the Hsc70/HSJ1b complex also appears to be conformationally dissimilar to that of 
the in vitro complex. Taking together all these factors, the recombinant Hsc70/HSJ1b 
complex is an attractive model to study the mechanisms of assembly and working in 
the formation of the Hsc70 chaperone and HSJ1b co-chaperone complex.  
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CHAPTER 6: Analysis of domain variants of Hsc70 and 
their complexes for functional and structural studies 
6.1 Introduction 
One of the primary aims of this thesis was to obtain structural data to elucidate the 
interactions of the Hsc70 and HSJ1b proteins. Results from Chapter 4 indicated that 
the full length Hsc70 /HSJ1b complex isolated using the co-expression strategy was a 
mixture of oligomeric and a ~220 kDa protein species. Preliminary structural analysis 
of the oligomeric species was performed by electron microscopy. The ~220 kDa 
fraction, although suitable for crystallography, did not yield any promising results 
from initial trials performed with Hampton sparse matrix screens.  
An alternate approach to obtain structural information was therefore to dissect the 
Hsc70 protein into functional domain modules which could continue to bind to HSJ1b 
and identify a construct suitable for crystallography. The domain architecture of Hsc70 
has been discussed in detail in Chapter 1. Briefly, Hsc70 is composed of 3 domains. 
The N-terminal region has the 44 kDa nucleotide binding domain (NBD) while the C-
terminal region can further divided into two domains – an 18 kDa peptide binding 
domain (PBD) and a 10 kDa region which is believed to act as a lid over the peptide 
binding domain (Chappell et alI., 1987; Flaherty et al., 1990 Huang et al., 1993 and 
Zhu et al., 1996).  
Using a yeast two hybrid system, Demand et al., have identified potential binding sites 
for the various cofactor proteins such as Hsp40, Hip, Hop and Bag. Figure 6.1 maps 
the potential sites of interaction between the Hsc70 domain and its co-chaperone 
partners in the eukaryotic Hsp70 system. Demand et al., reported that the C-terminal 
region of Hsc70 hosts distinct binding sites for both Hsp40 and Hop, while Hip 
exclusively bind to the NBD (Demand et al., 1998). BAG-1 binds to the NBD of 
Hsc70 in cooperation with the Hsp40, but competes with Hip for the binding site 
(Höhfeld et al., 1997). CHIP (carboxyl terminus of Hsc70-interacting protein) as the 
name suggests has been found to bind to Hsc70 fragments containing amino acids 540 
to 650 and absence of the amino acids abolished this interaction (Ballinger et al., 
1999).  
 
  
Page 181 
 
N PBD Lid NBD 
     
C
Hsp40 Hip 
BAG  
Hsp40 Hop 
Nucleotide binding domain (NBD) 
Peptide binding domain (PBD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Map of potential co-chaperone binding sites  on Hsc70  
The C-terminal region of Hsc70 hosts distinct binding sites for both Hsp40 and Hop, while Hip 
exclusively binds to the NBD (Demand et al., 1998). BAG-1 binds to the NBD of Hsc70 in cooperation 
with the Hsp40, but competes with Hip for the binding site (Höhfeld et al., 1997).  
 
From the study of Demand et al., it was clear that Hsp40 is capable of binding to both 
the N and C-terminal regions of Hsc70. Therefore in this Chapter, work was carried 
out to generate the domain variants of Hsc70 which were still capable of forming a 
complex with HSJ1b. These complexes of the domain variants with HSJ1b were 
isolated by Ni-NTA chromatography. The results section of this chapter is divided into 
two parts. Part A describes the purification of the domain complexes with HSJ1b and 
the biochemical analysis carried out to understand the role of the different domains in 
the complex formation with HSJ1b. Part B deals with the X-ray crystallography work 
carried out with one of the domain complexes. 
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1 – Hsc70 60 kDa fragment (N60) 
2 – Hsc70 Nucleotide binding domain (NBD) 
3 – Hsc70 C-terminal region (CTR) 
4 – Hsc70 C-terminal 10 kDa deletion (CTR∆C)  
 
6.2 Materials and Methods 
6.2.1. Amplification of domain modules 
Primer design 
Primers were designed to amplify the N-terminal 60 kDa fragment (N60), the 
nucleotide binding domain (NBD), C-terminal region (CTR) and the CTR deletion of 
the C-terminal 10 kDa lid region (CTR∆C) from the coding region of the full length 
Hsc70 gene.  The regions amplified by the primers are highlighted in Figure 6.2. 
 
 
 
 
 
Figure 6.2: Amplification of Hsc70 domain modules 
Four functional domain modules were identified and primers were designed to amplify the desired 
region. The four different colour arrow sets represents the four regions amplified using the full length 
pGEMt-Hsc70 plasmid as template. 
The primers designed for the amplification of each domain are listed in Table 6.1. NdeI 
and BamHI restriction sites were introduced at the 5’ and at the 3’ ends respectively of 
each of the amplified products to enable directional cloning of the fragments into a 
suitable vector. 
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Domain  Primers (5’ to 3’ end) Product 
size 
N60 
Fwd GGATCCATATGTCCAAGGGACTGCAGTTGG 1659 bp 
 Rev GATCGGATCCTTAGGCATGTTGCTGCTGG 
NBD 
Fwd GGATCCATATGTCCAAGGGACTGCAGTTGG 
1167 bp 
Rev GATCGGATCCTCACTCAGACTTGTCTCCAGACAAGA 
CTR 
Fwd GATCCATATGGTACTGCTGCTGGACGT 789 bp 
 Rev GATCGGATCCTTAATCAACCTCTTCAATGGTGG 
CTR∆C  
Fwd GATCCATATGGTACTGCTGCTGGACGT 
492 bp 
Rev GATCGGATCCTTAGGCATGTTGCTGCTGG 
Table 6.1: Primer sequence, restriction sites and PCR product size for the domain fragments 
Base pairs underlined and highlighted in red indicate the restriction endonuclease recognition sequence 
introduced into the primers to enable directional cloning of the PCR products. 
PCR conditions 
The construction of the pGEMt-Hsc70 plasmid has been described in Chapter 3. This 
plasmid was used as the template for all the PCR reactions, and all amplifications were 
carried out using the 2X Phusion™ High-Fidelity PCR Master Mix containing the 
proof-reading enzyme, Phusion High-Fidelity DNA Polymerase (NEB). The 
parameters used for the PCR amplification reactions are listed in Table 6.2. 
Segment Number of cycles Temperature (oC) Time in minutes 
Initial denaturation 1 95 1 
Denaturation, 
primer annealing  
and extension 
30 95 
60 
72 
1 
1 
2 for N60 
1.2 for NBD 
1 for CTR 
0.5 for CTR∆C 
Final extension 1 72 7 
Final Hold 1 4 Indefinite 
Table 6.2: PCR conditions for the amplification of the domain modules of the Human Hsc70 
gene 
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6.2.2. Insertion of domain fragments into pET-16b vector 
The individual domain modules were cloned into the pET-16b bacterial expression 
vector. The amplified PCR products and pET-16b vector was digested with NdeI and 
BamHI and prepared for ligation as per protocols described in chapter 2. The vector 
and insert were ligated in a 1:3 ratio and transformed into E. coli DH5α cells using 
protocols previously described in Chapter 2. Clones were confirmed by restriction 
digestion analysis of plasmid DNA isolated from transformed colonies (protocol 
described in chapter 2). DNA sequences were verified by sequencing the plasmids at 
the Advanced Biotechnology Centre (ABC), Imperial College, UK. The plasmids will 
be henceforth referred to as pET-16b-N60, pET-16b-NBD, pET-16b-CTR and pET-
16b-CTR∆C. 
6.2.3. Co-transformation of the Hsc70 domain modules with HSJ1b 
plasmid 
For normal expression studies, pET-16b-N60, pET-16b-NBD, pET-16b-CTR and 
pET-16b-CTR∆C plasmids carrying the N60, NBD, CTR and CTR∆C fragments were 
co-transformed with the pET-24a-HSJ1b plasmid into the E. coli expression strain 
BL21(DE3). For the studies requiring the incorporation of Seleno-l-methionine 
(SelMet), the pET-16b-NBD clones were co-transformed with the pET-24a-HSJ1b 
plasmid into the E. coli methionine auxotroph expression strain- B384(DE3). 
Transformation was carried out as per the protocol described in Chapter 2 and the 
transformed cells were plated onto LB plates containing 50 µg/ml ampicillin and 25 
µg/ml kanamycin and incubated overnight at 37oC. 
6.2.4. Co-expression and purification  
Co-expression studies were carried out at 37oC using the protocol described in Chapter 
3, section 3.2.8. Cells were grown in LB media up to an OD at A595 of 0.6-0.8. 
Protein expression was induced by the addition of IPTG to a final concentration of 0.4 
mM. After induction, cells were grown for a further 3 hrs. Cells were harvested as 
described Chapter 2, Section 2.10.1 and the cell pellet was re-suspended in lysis buffer 
(50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM imidazole and 5% (v/v) glycerol) and 
stored at -80oC until required. Ni-NTA purification of the respective domain 
complexes was performed according to the protocol described for the purification of 
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polyhistidine tagged proteins in Section 2.10.2 of Chapter 2. The elution profiles of the 
recombinant proteins were analysed on a 12% SDS-PAGE gel. 
6.2.5. Expression and purification of Seleno-l-methionine labelled 
protein 
A single colony was grown overnight in 10 ml LB broth supplemented with 50 µg/ml 
of ampicillin and 25 µg/ml kanamycin at 37oC in a shaking incubator. The overnight 
culture was harvested at 3000 rpm for 10 minutes and the cell pellet was washed three 
times with 10 ml of autoclaved water. The pellet was finally resuspended in 2 ml of 
water and used to inoculate 1 l of SelenoMet Medium Base containing SelenoMet 
Nutrient Mix, l-selenomethionine (40 mg/ml), 50 µg/ml ampicillin and 25 µg/ml 
kanamycin. The prepared SelenoMet Medium was provided by Dr. Steve Smerdon 
from NIMR, Mill Hill. 
Cultures were grown at 37oC until an OD of 0.6-0.7 was reached, whereupon protein 
expression was induced by the addition of 0.4 mM IPTG. Induction was continued 
overnight at 20oC. Cells were harvested as described in Chapter 2, Section 2.11.1 and 
the cell pellet was resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 5 mM imidazole, 5% (v/v) glycerol and 5 mM beta-mercaptoethanol) and stored 
at -80oC until required. SelMet-labelled protein was purified by Ni-NTA 
chromatography as described in Section 2.10.2 in Chapter 2. However the eluted 
protein was supplemented with 1 mM DTT to prevent oxidation of the selenium.  
6.2.6. Ion exchange chromatography 
The NBD/J protein elution fractions from the Ni-NTA column were diluted with 50 
mM Tris-HCl pH 8.0 to reduce the NaCl concentration to 25 mM. Ion exchange 
chromatography was performed on a 20 ml Q sepharose column (Sigma). The column 
was equilibrated with 50 mM Tris-HCl pH 8.0, 25 mM NaCl and 5% (v/v) glycerol. 
The protein was applied to the column and then washed with 2 CVs of equilibration 
buffer. The protein was step eluted with equilibration buffer containing 50, 100, 250, 
500 and 1000 mM NaCl. The elution profile was monitored via SDS-PAGE.  In the 
case of selMet-labelled protein 1 mM DTT was included in the chromatography 
buffers. 
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6.2.7. Size exclusion chromatography 
Size exclusion chromatography was performed on a 90 ml Superdex-200 column. The 
column was equilibrated with 20 mM Tris-HCl pH 8.0 with 100 mM KCl. In the case 
of selMet-labelled protein 1 mM DTT was included in the buffer. One ml fractions 
were collected after 25 ml of buffer had passed. The fractions were analysed for 
protein content using the Bradford assay using BSA as a standard. A graph of the 
absorbance on the y-axis and the elution volume on the x-axis was plotted. The peak 
fractions were analysed by SDS-PAGE electrophoresis. 
6.2.8. Partial proteolysis studies 
Proteolysis experiments were performed as described previously in chapter 4, section 
4.2.5. Briefly, 4.4 µg of purified complex was digested with chymotrypsin in a 
protease to protein ratio of 1:300 (w/w) at 4°C for 10 minutes. The digestion products 
were analysed by SDS-PAGE on a 12% polyacrylamide gel and compared with 
undigested protein. 
6.2.9. Thermal aggregation assay  
15 µl reactions were set up, containing 1.27 µM of each domain complex and 0.8 µM 
of the substrate-luciferase. The assay was carried out as described in Chapter 4, section 
4.2.3. The reactions were subjected to thermal shock at 42oC for 10 minutes. The 
insoluble and soluble fractions were separated by centrifugation at 13,000 rpm and 
analysed by SDS-PAGE electrophoresis. The percentage of luciferase in the soluble 
and aggregated fraction was quantified from the gel by densitometry. 
6.2.10. Protein crystallisation  
Purified protein was concentrated using a centricon YM-30 centrifugal Filter Devices 
(Millipore). The final protein concentration was determined via the Bradford protein 
assay (Bradford, 1976) using BSA as a standard. Protein at a concentration of 5 mg/ml 
was used for initial screening. Crystallisation was set up at room temperature using the 
hanging-drop vapour-diffusion method. One µl of protein solution was mixed with the 
same amount of precipitant and the drops were equilibrated against 500 µl of reservoir 
solution.  Preliminary trials were carried out with Crystal Screen and Crystal Screen 2 
from Hampton Research (Cudney et al., 1994; Jancarik & Kim, 1991).  
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6.3 Results  
PART A: ROLE OF THE DIFFERENT DOMAINS IN THE 
INTERACTION WITH HSJ1B 
In order to evaluate the influence of the individual Hsc70 domains in its interaction 
with HSJ1b, a 60 kDa N-terminal fragment (N60) which lacks the 10 kDa region of the 
C-terminus, the nucleotide binding domain (NBD), C-terminal region (CTR) and the 
CTR deletion of the C-terminal 10 kDa lid region (CTR∆C) were generated and used 
in this study. A schematic overview of the domain variants of Hsc70 is presented in 
Figure 6.3. 
Figure 6.3: Domain architecture of full length Hsc70 and its domain variants.  
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6.3.1 PCR amplification of the domains 
Using the pGEMt-Hsc70 plasmid as template, regions coding for the N60 fragment, 
NBD, CTR and CTR∆C modules were amplified. PCR amplification reactions for all 
four fragments were analysed on a 0.8% (w/v) agarose gel (Figure 6.4). From the 
nucleotide sequences the fragment sizes were calculated to be 1659 base pairs for the 
N60 fragment, 1167 base pairs for the NBD, 789 base pairs for the CTR and 492 base 
pairs for the C-terminal deletion mutant (CTR∆C). Product sizes were confirmed by 
agarose electrophoresis (Figure 6.4). Panel A in Figure 6.4 confirms the successful 
amplification N60 fragment. Panel B shows the successful amplification of the NBD 
(lane 1, Panel B, Figure 6.4). Panel C confirms the amplification of the CTR (lane 1, 
Panel C, Figure 6.4) and the (CTR∆C) (lane 2, Panel C, Figure 6.4).   
Figure 6.4: PCR amplification of Hsc70 domains 
PCR reactions to amplify the required coding regions were set up as described in section 6.2.1 using the 
pGEMt-Hsc70 plasmid as the template. 10 µl of each PCR product was subjected to electrophoresis on a 
0.8% (w/v) agarose gel to confirm amplification of the expected size product.  
Panel A) Amplification of the N60 fragment of Hsc70 
Lane 1 shows 10 µl of the PCR product for the N60 fragment of Hsc70, lane 2 contains 6 µl of Promega 
1Kb DNA Ladder (molecular weight marker). 
Panel B) Amplification of the NBD of Hsc70 
Lane 1 is 10 µl of the NBD PCR product; lane 2 contains 6 µl of Promega 1Kb DNA Ladder. 
Panel C) Amplification of the CTR and CTRC domains of Hsc70 
Lane 1 is amplified CTR product, lane 2 is amplification of CTR∆C region and lane 3 contains 6 µl of 
Promega 1Kb DNA Ladder (molecular weight marker). 
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6.3.2 Insertion of the Hsc70 domain fragments into pET-16b 
The amplified PCR product for each domain fragment was purified and digested with 
the enzymes NdeI and BamHI. The fragments were ligated with pET-16b vector 
digested at the NdeI and BamHI restriction sites. Plasmids pET-16b-N60, pET-NBD, 
pET-16b-CTR and pET-16b-CTR∆C were subsequently generated. The clones were 
confirmed by restriction enzyme digestion of the isolated plasmids with NdeI and 
BamHI. The reactions were visualised by agarose gel electrophoresis (Figure 6.5). 
Panel A in Figure 6.5 shows the successful release of the expected insert size from the 
pET-16b-N60 clone (lanes 3 and 4), Panel B confirms insert release for the pET-16b-
NBD clones (lanes 2 and 3), Panel C confirms the insertion of the CTR gene fragment 
into the pET-16b vector in plasmids 1 and 3 (lane 2 and 4), while plasmid 2 (lane 3) 
does not have the desired insert. Similarly, lanes 2 and 3 of Panel D confirm the 
presence of the CTR∆C fragment in pET-16b. 
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Figure 6.5: Confirmation of cloning of the Hsc70 domain fragments into the pET-16b vector 
Single white colonies inoculated and grown overnight with ampicillin were used for plasmid extraction 
by alkaline lysis. 15 µl of the extracted DNA was used for restriction digestion by NdeI and BamHI 
enzymes and visualized on a 0.8% agarose gel. The DNA was visualised by staining with ethidium 
bromide at 0.5 ug/ml and photographed under UV illumination.  
Panel A) Confirmation of N60 clones 
Lane 1 contains 6 µl of Promega 1Kb DNA Ladder (molecular weight marker), lane 2 is plasmid 1 prior 
to restriction digest, lane 3 NdeI and BamHI digestion of the plasmid 1 and lane 4 NdeI and BamHI 
digestion of the plasmid 2.  
Panel B) Confirmation of NBD clones 
Lane 1 contains 6 µl of Promega 1 Kb DNA Ladder (molecular weight marker), lanes 2 and 3 are NdeI 
and BamHI digestion of clones 1 and 2. 
Panel C) Confirmation of CTR clones 
Lane 1 contains 6 µl of Promega 1 Kb DNA Ladder (molecular weight marker) lanes 2, 3 and 4 are NdeI 
and BamHI digestion of clones 1,2 and 3. 
Panel D) Confirmation of CTRC clone 
Lane 1 contains 6 µl of NEB 1 Kb DNA Ladder, lane 2 is plasmid 1 prior to restriction digest, lane 3 
NdeI and BamHI digestion of the plasmid 1 and lane 4 and BamHI digestion of the plasmid 2.  
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6.3.3 Purification of the domain complexes 
6.3.3.1 Ni-NTA chromatography 
Plasmids pET-16b-N60, pET-16b-NBD, pET-16b-CTR and pET-16b-CTR∆C were 
each co-transformed with the pET-24a-HSJ1b plasmid and co-expressed in E. coli 
BL21(DE3) cells. Co-expressed N60/J, NBD/J, CTR/J and CTR∆C/J polypeptides 
were isolated by Ni-NTA chromatography. The proteins were eluted from the Ni-NTA 
column at an imidazole concentration of 200 mM and were analysed by SDS-PAGE 
(Figure 6.6). From the four panels in Figure 6.6 it can be seen that all four domains and 
HSJ1b remained bound to the column after extensive washing and co-eluted when 200 
mM imidazole was applied to the column.  This strongly suggests that all pairs of 
polypeptides form a complex when co-expressed. Panel A in Figure 6.6 shows the 
elution profile of N60/J complex. The eluted complex was composed of a 60 kDa 
polypeptide and a ~40 kDa polypeptide (molecular weight corresponding to the N60 
fragment and migration position of HSJ1b respectively, lanes 6-8, Figure 6.6). Panel B 
in Figure 6.6 shows the elution profile of the NBD/J complex from the Ni-NTA 
column. The NBD has a calculated molecular weight of 44 kDa and the HSJ1b, as 
reported in chapter 3, migrates anomalously at ~40 kDa. Under the electrophoretic 
conditions of this study the two protein components of the  NBD/J complex were  
observed to migrates as a single band at approximately 44 kDa and the two individual 
protein bands could  not be distinguished (lanes 6 and 7, Figure 6.6). Panel C in Figure 
6.6 shows the elution profile of the CTR/J complex from the Ni-NTA column. The 
eluted complex was composed of a 29 kDa CTR polypeptide and a 40 kDa HSJ1b 
polypeptide (molecular weight corresponding to CTR fragment and migration position 
of HSJ1b respectively, lanes 7-9, Figure 6.6). Panel D in Figure 6.6 is the elution 
profile of the CTR∆C/J complex from the Ni-NTA column. The eluted complex was 
composed of a 18 kDa polypeptide and a 40 kDa polypeptide (molecular weight 
corresponding to CTR∆C fragment and migration position of HSJ1b respectively, lane 
8, Figure 6.6).  
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Figure 6.6: Purification of the various Hsc70 domain complexes with the full length HSJ1b. 
Recombinant complexes were expressed in E. coli BL21(DE3) cells by induction with 0.4 mM IPTG for 
three hours at 37oC. The lysed, soluble extract was applied to a Ni-NTA column, extensively washed 
with buffer A and eluted with buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM imidazole and 5% 
glycerol) containing 200 mM imidazole. The polypeptide composition was analysed by SDS-PAGE 
(12% resolving gel), stained with Coomassie Brilliant Blue and photographed.  
Panel A: Isolation of N60/J complex by Ni-NTA chromatography  
Lane 1 soluble extract, lane 2 insoluble pellet, lane 3 column flow through, lane 4 wash with 30 mM 
imidazole, lane 5 Bio-Rad precision plus prestained molecular weight marker (broad range), lane 6-10 
200 mM imidazole elution fractions.  
Panel B: Isolation of NBD/J complex by Ni-NTA chromatography  
Lane 1 soluble extract, lane 2 insoluble pellet, lane 3 column flow through, lane 4 wash with buffer A, 
lane 5 Wash with 30 mM imidazole, lanes 6 & lane 7 200 mM imidazole elution and lane 8 Bio-Rad 
precision plus prestained molecular weight marker.  
Panel C: Isolation of CTR/J complex by Ni-NTA chromatography 
Lane 1 soluble extract, lane 2 insoluble pellet, lane 3 column flow through, lane 4 wash with buffer A, 
lane 5 Wash with 30 mM imidazole, lane 6 Bio-Rad precision plus prestained molecular weight marker, 
lane 7-9 200 mM imidazole elution fractions. 
Panel D: Isolation of CTR∆C/J complex by Ni-NTA chromatography 
Lane 1 soluble extract, lane 2 insoluble pellet, lane 3 Bio-Rad precision plus prestained molecular 
weight marker, lane 4 column flow through, lane 5 wash with buffer, lane 6 overflow from lane 5, lane 7 
Wash with 30 mM imidazole, lane 8 200 mM imidazole elution fraction. 
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The amount of co-expressed HSJ1b polypeptide eluting from Ni-NTA resin was 
observed to differ between the various domain constructs. Both the N-terminal and the 
C-terminal regions of the Hsc70 protein host a binding site for its Hsp40 co-chaperone 
(Demand et al., 1998; Suh et al., 1998). Truncation of the full length Hsc70 into its 
various domains therefore may not alter its interaction and/or binding with the co-
chaperone protein. In the case of the co-expressed complexes, altered binding of the 
domain variants to HSJ1b was studied by quantifying the proportion of HSJ1b 
polypeptide co-eluting with Hsc70 from the nickel column using densitometry. The 
proportion of Hsc70 to HSJ1b was then calculated as percentage of the total 
(Hsc70+HSJ1b) proteins (Figure 6.7). It was noticed that there was only a very slight 
difference in the proportion of HSJ1b bound by the N60 fragment (34%) compared to 
the full length Hsc70 (40%). The CTR region was found to be associated a slightly 
higher percentage of HSJ1b; almost 11% more than the full length Hsc70. The 
CTR∆C/J complex has almost 50% less bound HSJ1b than CTR, indicating that the 
deletion of the C-terminal 10 kDa region has a deleterious effect on the HSJ1b 
interaction with the isolated CTR domain. However deletion of this 10 kDa region 
does not seem to overtly affect the interaction of the N60 fragment with HSJ1b, 
indicating that the NBD rather than the distal 10 kDa region is the major site of HSJ1b 
binding. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7: Effect of Hsc70 domain truncation on its association with HSJ1b protein. 
Each domain construct was co-expressed with HSJ1b and purified over the Ni-NTA column as 
described in the previous sections. The eluted proteins were visualised on a 12% SDS-PAGE gel, and 
the Hsc70 and HSJ1b polypeptides were quantified by densitometry. Variation in the proportion of 
HSJ1b co-eluting with the domain variants and full length Hsc70 from the Ni-NTA column was 
represented as percentage of total (Hsc70+HSJ1b) protein. 
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The Ni-NTA fractions of all 4 domain complexes were then subjected to the next 
purification step – size exclusion chromatography (discussed in section 6.3.3.2).  
Except for the NBD/J complex, the SEC was successful in separating most of the 
contaminating polypeptides for the other domain complexes. Therefore, Ion exchange 
chromatography was undertaken to further purify the NBD/J protein obtained after Ni-
NTA chromatography so that a pure complex that could be obtained for 
crystallographic analysis. The predicted pI for the NBD/J complex is 6.42 suggesting 
that the protein can bind to the anion exchange resin, Q-sepharose.  The protein was 
eluted using a step gradient of NaCl up to 1 M concentration. At 100 mM NaCl, 
elution of the complex was observed (Lanes 4 and 5, Figure 6.8). Lanes 6 and 7 
represent elution fractions obtained using 250 mM NaCl while the sample run in lane 8 
was obtained at 500 mM NaCl. The 100 mM elution fractions were pooled and 
concentrated to bring down the volume prior to loading onto the gel filtration column. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8: Ion exchange chromatography of the NBD/J complex.  
Ion Exchange chromatography was performed using a Q sepharose ion exchange resin.  NBD/J complex 
obtained from Ni-NTA chromatography was bound to Q-sepharose pre-equilibrated with 50 mM Tris-
HCl pH 8.0, 25 mM NaCl and 5% (v/v) glycerol. The bound protein was eluted with an NaCl step 
gradient from 0-500 mM in equilibration buffer. Lane 1 NBD/J  complex load, lane 2 flow through from 
the column, lane 3 50 mM NaCl wash, lanes 4 & 5 100 mM NaCl elution fractions, lanes 6 & 7 250 mM 
NaCl elution fractions, lane 8 500 mM NaCl elution, lane 9 Bio-Rad precision plus prestained molecular 
weight marker proteins. 
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6.3.3.2 Size exclusion chromatography 
SEC was performed to fulfil two purposes. One was to assess the homogeneity of the 
protein since this is an essential requirement for protein crystallography. Aggregation 
of protein has been shown to inhibit crystallisation (Littlechild, 1991). Therefore, size-
exclusion chromatography (SEC) was performed to assess the oligomeric 
compositions of the purified proteins and also to separate any higher order 
oligomers/aggregates from the protein.  
The Ni-NTA elution fractions were pooled and loaded onto a Superdex-200 gel 
filtration column equilibrated with the buffer specified. 1 ml fractions were collected 
and proteins were detected by measuring the protein concentration using Bradford 
assay.  When the N60/J complex was subjected to SEC, the complex resolved into two 
peaks (Panel A, Figure 6.9); Peak 1 at 38 ml was reminiscent of the polymerised peak 
observed for the full length rHH complex (see Chapter 4). The polypeptide 
composition of the N60/J peak 1 was confirmed by SDS-PAGE to contain both the 
N60 and HSJ1b protein subunits (lanes 1-3, Panel A, Figure 6.10). The second peak at 
54 ml has an estimated molecular weight of approximately of 185 kDa, which 
corresponds to the molecular weight of a trimer of the 60 kDa subunits (3*60=180) 
only. SDS-PAGE confirms that the N60/J peak2 protein fractions comprised 
predominantly of the 60 kDa fragment (lanes 4-9, Panel A, Figure 6.10).  
The NBD/J complex gave rise to a single homogenous peak with an apparent 
molecular weight of 130 kDa (Panel B, Figure 6.9). SDS-PAGE revealed a single band 
migrating at approximately 44 kDa – the shared migration pattern of both the NBD and 
HSJ1b (Panel B, Figure 6.10). The NBD/J complex was selected for further structural 
studies based on its clean and homogenous elution from the gel filtration column. 
The CTR/J complex resolved into two fractions (Panel C, Figure 6.9); the apparent 
molecular weight of peak 1 of the CTR/J complex was 560 kDa and represented higher 
order oligomers of the complex, while Peak 2 was poorly resolved between 49-71 ml 
(Panel C, Figure 6.9). Analysis by SDS-PAGE (Panel C, Figure 6.10) shows that both 
peaks contained CTR and HSJ1b moieties, but the diffused nature of resolution of 
second peak suggests possibly a weak interaction between the two protein subunits. 
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When the CTR∆C/J complex was subjected to SEC, the protein complex resolved into 
two fractions over the Superdex-200 column (Panel D, Figure 6.9). Interestingly, 
analysis of the fractions by SDS-PAGE revealed that the CTR∆C/J peak 1 fractions 
comprised only of the HSJ1b protein (lanes 2-4, Panel D, Figure 6.10) and peak 2 was 
composed entirely of the PBD∆C fragment (lanes 6-9, Panel D, Figure 6.10). It 
appears that the CTR∆C/J could not maintain its complexed state over the gel filtration 
column and disassociated into the individual CTR∆C fragment and HSJ1b protein. We 
believe that this could be due to the removal of the C-terminal 10 kDa fragment, which 
weakens/disrupts the binding of HSJ1b to CTR∆C. Table 6.3 summarises the 
estimated molecular mass for the 4 domain complexes as per their resolution over the 
Superdex-200 column. 
Protein Sample Peak Elution Volume in 
ml 
Calculated Molecular Mass in 
kDa 
Peak 1 N60/J 38 655 
Peak 2 N60/J 54 185 
NBD/J 59 135 
Peak 1 CTR/J 41 417 
Peak 2 CTR/J 49-71 276-48 
Peak 1 CTR∆C/J 38 655 
Peak 2 CTR∆C/J 64 84 
Table 6.3: Molecular weight determination of the protein species in the peaks resolved from 
size exclusion chromatography. 
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Figure 6.9: Size exclusion chromatography of the domain complexes 
Size exclusion chromatography was performed on a Superdex-200 column and the protein eluting from the column was collected as 1 ml fractions. Absorbance of 
each fraction was determined using Bradford assay. Plot of Absorbance at 595 nm for the fractions on the Y-axis versus the elution volume (X-axis) was used to 
develop the elution profile chromatogram. 
Panel A: Elution profile of the N60/J complex from the Superdex-200 column. Panel B: Elution profile of the NBD/J complex from the Superdex-200 column. 
Panel C: Elution profile of the CTR/J complex from the Superdex-200 column. Panel D: Elution profile of the CTR∆C/J complex from the Superdex-200 column. 
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Figure 6.10: SDS-Page analysis of the peak obtained during gel filtration of the individual Hsc70 domain/HSJ1b complexes. 
Panel A: N60/J SEC fractions. Lanes 1-3 elution from fractions 36, 37 and 38 respectively, lanes 4-8 protein elution from fraction 60, 57, 56, 55 and 54 
Panel B: NBD/J elution fractions. Lane 1 is the Bio-Rad precision plus prestained molecular weight marker, lane 2 is sample of protein loaded onto the column, lanes 
3-10 protein elutions from fraction 56 to fraction 63. 
Panel C: CTR/J SEC fractions. Lane 1 is the Bio-Rad precision plus prestained molecular weight marker, lanes 2-9 alternate fractions starting at fraction 39 – 52, 
lane 10 fraction 53, lane 11 is the Bio-Rad precision plus prestained molecular weight marker, lane 12-19 protein elution’s from fraction 54 to fraction 61. 
Panel D: CTR∆C/J elution fractions Lane 1 is sample of protein loaded onto the column, lanes 2-4 elution from fraction 38,40 and 42 respectively, lane 5 is the Bio-
Rad precision plus prestained molecular weight marker, lanes 6-10 protein elution from fraction 60, 62, 64, 66 and 68. 
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Next, using the data obtained from the size exclusion chromatography studies, the 
region on Hsc70 essential for its binding to HSJ1b and extent of oligomerisation was 
studied. The gel filtration profiles of the domain complexes were compared with the 
full length rHH complex and the results of the comparison are shown in Figure 6.11. 
The comparison was performed with the NBD/J, CTR/J and N60/J complexes and not 
with the CTR∆C/J complex since we had established in the previous section that it 
does not form a stable complex with HSJ1b.  
From Panel A, Figure 6.11, it is apparent that although the isolated N-terminal NBD 
was capable of binding to HSJ1b, the gel filtration profile of the NBD/J complex was 
devoid of any higher order oligomeric protein species. On the other hand the isolated 
C-terminal CTR is found to be perfectly capable of undergoing oligomerisation similar 
to the full length complex (Panel B, Figure 6.11). The degree of oligomerisation of the 
CTR/J complex was approximately 70% that of the intact rHH complex (Panel D, 
Figure 6.11). From Panel A and B it can be concluded that oligomerisation of Hsc70 
and HSJ1b complex requires the C-terminal of Hsc70.  
The next step was to pinpoint which region in the CTR - the C-terminal 18 kDa PBD 
or the 10 kDa lid region, was responsible for the oligomerisation. This was ascertained 
using the N60/J complex, since the N60 fragment differs from the full length Hsc70 
only by the deletion of the C-terminal 10 kDa lid domain. From Panel C in Figure 
6.11, it is clearly seen that although the presence of the 18 kDa PBD partially restored 
oligomerisation, however the observed oligomerisation was only one third of the 
capabilities of the full length rHH complex (Panel D, Figure 6.11). Therefore, the 
presence of the 18 kDa PBD alone is not sufficient to induce polymerisation and the C-
terminal 10 kDa appears to be vital for the polymerisation of the complex. 
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Figure 6.11: Comparison of SEC profiles of the individual Hsc70 domain/HSJ1b complexes with the SEC profile of full length complex 
Size exclusion chromatography was performed on a superdex 200 column. 1 ml fractions were collected from the column after 25 ml of buffer had passed. Protein 
concentration of alternate samples was determined by Bradford assay, and the concentration was plotted to obtain the elution trace for each complex.  
Panel A: Comparison of the chromatogram of the full length rHH complex with NBD/J. Panel B: Comparison of the chromatogram of the full length rHH complex 
with CTR/J. Panel C: Comparison of the chromatogram of the full length rHH complex with N60/J. Panel D: Degree of polymeristaion of the domain complexes. 
Area under peak 1 was calculated from the elution chromatogram plotted for each domain complex and percentage of total protein existing as a higher oligomeric 
species was calculated and plotted using MS Excel. 
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6.3.4 Changes in functional properties due to 10 kDa C-terminal 
deletion 
From the SEC data, it was concluded that the 10 kDa C-terminal fragment of Hsc70 is 
essential for stable HSJ1b binding, and also functional oligomerisation of the rHH 
complex. The effect the deletion of this 10 kDa region has on the functional properties 
of the chaperone/co-chaperone complex was studied using the N60/J domain complex 
in comparison with the full length rHH complex. Two assays were used; first, was the 
thermal aggregation assay to study the capacity of the complexes to protect denatured 
substrate and second, was a modified malachite green colourimetric assay to monitor 
stimulation of ATP hydrolysis in both the protein complexes.  
6.3.4.1 Protection of luciferase from thermal aggregation 
Thermal aggregation studies were carried out as described in the previous chapters 
using luciferase as substrate. Aggregation of luciferase was initiated by elevating the 
temperature to 42oC. The percentage of soluble and insoluble luciferase, after thermal 
aggregation, was measured densitometrically and plotted as percentage of total 
luciferase in the reaction (Figure 6.12). It was previously established that in the 
absence of the chaperone proteins, 81.4% of luciferase aggregated during a 10 minute 
incubation at 42 °C (refer Chapter4, section 4.3.1). However, when the full length rHH 
complex was present during thermal inactivation, 85.7% of the total luciferase protein 
remained soluble (reaction 3, Figure 6.12). This was reduced to 40% when the N60/J 
complex was used instead of the intact rHH complex without the addition of ATP 
(reaction 1, Figure 6.12). Intriguingly, the N60/J complex displayed a >70% ATP 
dependent increase in luciferase protection (increase from 40% to 68.2%, reaction 2 in 
Figure 6.12). This ATP dependent increase in luciferase solubility has so far not been 
observed for the full length complex. Ungewickell et al have previously shown that the 
N60 fragment is sufficient for the the binding of auxilin and for the in vitro uncoating 
of clathrin-coated vesicles (Ungewickell et al., 1997). In our case, the N60/J complex 
is sufficient for protecting luciferase from aggregation, although not to the same extent 
as the intact rHH complex. Also, the N60/J and the rHH show differences in their ATP 
requirements for substrate protection, suggesting mechanistic differences in the two 
protein complexes. 
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Figure 6.12: Luciferase protection studies using N60/J and full length rHH complexes. 
 Luciferase was thermally denatured at 42oC for 10 minutes in the presence of the indicated chaperones 
and nucleotide. The reaction was spun down at 13,000 rpm to separate the soluble and aggregated 
fractions and analysed by SDS-PAGE. The amount of luciferase present in each fraction was quantified 
by densitometry and the percentage of soluble and aggregated luciferase for each reaction was 
calculated and plotted using MS Excel. 
  
Page 203 
6.3.4.2 ATP-Hydrolysis assay 
We next compared the effect of the C-terminal 10 kDa truncation on the ATPase 
activity of the full length rHH complex using the N60/J complex. Stimulation of the 
basal ATPase activity was evaluated by measuring the phosphate released from the 
system using a modified malachite green colourimetric assay. Upon addition of 2 mM 
ATP, 41 nmols of Pi/mg/min was released by the rHH complex, compared to the 22 
nmols of Pi/mg/min measured for the N60/J complex (Figure 6.13).  The phosphate 
release measurements for the N60/J complex was approximately 50% less than that 
observed for the full length complex. Thus in the case of the Hsc70 and HSJ1b 
complex, the deletion of the of the 10-kDa fragment from the C terminus of Hsc70 
does not completely abolish its ATPase activity, but it does have a deleterious effect 
on it.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13:  ATP hydrolytic capability of  N60/J amd full length rHH complexes 
The rHH and N60/J complex proteins (0.5 mM) were incubated with 2 mM ATP at 37oC, and the 
amount of phosphate release was monitored colourimetrically using a modified Malachite Green non-
radioactive assay. Readings were taken at 620 nm and phosphate release was calculated from the 
phosphate standard curve. Three independent experiments were performed, and the average and 
standard deviation were calculated. 
 
 
 
rHH complex N60/J complex 
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6.3.5 Conformational changes due to 10 kDa C-terminal deletion 
Limited proteolysis experiments were conducted to probe the potential differences in 
the conformational features of the N60/J complex and the recombinant rHH form. The 
digestion products were visualised by SDS-PAGE electrophoresis (Figure 6.14). Panel 
A shows the digestion products obtained for the N60/J complex and panel B for the 
intact rHH complex. From the time course experiments carried out in Chapter 4, it was 
observed that proteolysis could be observed within 10 minutes of incubation with 
chymotrypsin, and therefore this time period was considered to be sufficient for our 
studies with the N60/J complex. Our previous studies have also shown that in the rHH 
complex, the Hsc70 component appears to be largely resistant to proteolysis, while the 
HSJ1b subunit clearly was more sensitive to cleavage by chymotrypsin resulting in a 
~28-30 kDa cleavage product (represented by arrow marks in Panel B, Figure 6.14). 
The proteolysis pattern obtained for the N60/J complex partly resembled that of the 
full length rHH complex. The characteristic ~28-30 kDa HSJ1b cleavage product was 
observed, but more interestingly the N60 fragment of Hsc70 also showed signs of 
proteolysis (represented by * lane 2 and 3, Panel A, Figure 6.14), which were not 
detected with the full length Hsc70. This indicates that the C-terminal 10 kDa fragment 
of Hsc70 may play a role of a shield to protect the Hsc70 full length protein from 
proteolysis, as observed for the rHH protein. Removal of this domain (as is the case for 
the N60 fragment) renders the Hsc70 protein moiety susceptible to the protease 
chymotrypsin. Thus the distal C-terminal 10 kDa region appears to be crucial for the 
chaperone/co-chaperone interaction, since the removal of this zone alters both the 
functional and conformational properties of the Hsc70/HSJ1b interaction. 
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Figure 6.14: Limited proteolysis studies of  N60/J amd full length rHH complexes using 
chymotrypsin protease 
4.4 µg of both the protein complexes were incubated with chymotrypsin at 4°C in the presence and 
absence of ATP (2 mM). The digestions were performed in buffer containing 20 mM Tris-HCl pH 8.0, 
50 mM potassium chloride, 3 mM magnesium chloride and 2 mM DTT for 10 min. The digestion 
products were analysed on a 12% polyacrylamide gel stained with Coomassie Blue. The first track on 
the left hand side (lane 1) in each panel is the control protein in the absence of chymotrypsin. Lane 2 in 
each panel is the proteolysis performed in the absence of ATP and lane 3 in the presence of ATP. Panel 
A: Chymotrysin digestion of the N60/J complex. Putative N60 domain proteolysis products are 
indicated by a * Panel B: Chymotrysin digestion of rHH complex. The arrowhead indicates the major 
digestion product of HSJ1b. 
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PART B: STRUCTURAL STUDIES 
6.3.6 Structural studies of the domain complexes 
Based on size exclusion chromatography the NBD/J complex was found to be the most 
promising construct for structural studies. In order to determine if the NBD/J complex 
was functionally active, ATPase activity was measured using a modified malachite 
green colourimetric assay. It was observed from the phosphate release measurements 
that the NBD/J complex exhibited approximately 7 fold lower phosphate release 
(Figure 6.15). This is not unusual, as it has been previously demonstrated that the ATP 
hydrolysis activity of the isolated NBD is not stimulated by Hsp40 co-chaperones 
(Laufen et al., 1999).   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15: ATPase activity of  the NBD/J complex compared with the rHH complex 
The full length rHH and NBD/J complex proteins (0.5 mM) were incubated with 2 mM ATP at 37oC, 
and the amount of phosphate release was monitored colourimetrically using a modified Malachite Green 
non-radioactive assay. Readings were taken at 620 nm and phosphate release was calculated from the 
phosphate standard curve. Three independent experiments were performed, and the average and 
standard deviation were calculated. 
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6.3.6.1 Crystallisation of NBD/J complex 
The 135 kDa NBD/J peak fractions from SEC were pooled and concentrated with a 30 
kDa cut off centricon. The purity of the protein was confirmed by SDS-PAGE before 
the crystallisation trials were undertaken (Lane 1, Figure 6.16). On a 15% gel, both the 
HSJ1b and NBD polypeptides could be distinguished and the protein prepared for 
crystallisation trials was estimated to be >95% pure. 
 
 
 
 
 
 
 
 
 
 
Figure 6.16: SDS-PAGE analysis of the concentrated NBD/J protein 
Elution fractions from the SEC were pooled together and concentrated in a 30 kDa cut-off centricon. 
Prior to setting up the crystallisation trials, 1 µl of the concentrated protein was then loaded on 15 % 
SDS-PAGE gel to check the sample purity. Lane1 is loaded with 1 µl of the concentrated NBD/J 
complex and lane 2 Bio-Rad precision plus prestained molecular weight marker. 
 
The NBD/J protein was screened using the commercial Hampton Crystal Screens 1 
and 2 using protein at a concentration of 5 mg/ml. This was determined to be the 
optimal concentration for crystallisation trials as instant precipitation was observed in 
crystallisation trials set with a protein concentration above 5 mg/ml. Initial 
crystallisation trials were set up using the hanging drop vapour diffusion method. One 
µl of the protein was mixed with an equal volume of reservoir buffer and the trays 
were incubated at room temperature. Crystals were observed after 5 days in the 
conditions listed in Table 6.4.  Further screens were also set up at the Molecular 
structure facility at NIMR, London, but no other crystals were obtained. 
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Table 6.4: Crystallisation conditions identified for the NBD/J complex from Hampton Crystal 
Screen 1 
The crystals obtained from conditions 15 and 22 of Hampton crystal screen  are shown 
in Figure 6.17. Crystals from condition 15 appeared as overlapping plates (Panel A, 
Figure 6.17) and condition 22 gave rise to wafer thin needle-like crystals (Panel B, 
Figure 6.17). For low-temperature measurement, the crystals were dipped into a drop 
of cryo solution prepared by the addition of glycerol as cryoprotectant at a final 
concentration of 20% (wvv) to the identified crystallization solution, flash frozen in a 
nitrogen-gas cryostream at 113 K and stored until diffraction analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.17: NBD/J crystals obtained from screening with Hampton Crystal screen 1. 
Crystals were obtained using the hanging drop vapour diffusion method, with NBD/J co-expressed 
protein at 5 mg/ml, under Hampton crystal screen 1 conditions 15 (Panel A) 0.1 M sodium cacodylate 
trihydrate pH 6.5, 30% (v/v) PEG 8000, 0.2 M ammonium sulphate and 22 (Panel B) 0.1 M Tris 
hydrochloride pH 8.5, 30% (v/v) PEG 4000, 0.2 M sodium acetate trihydrate.   
 
 
 
 Condition 15 Condition 22 
Buffer, pH 0.1 M Sodium cacodylate trihydrate pH 6.5 0.1 M Tris hydrochloride pH 8.5 
Precipitant 30% (w/v) PEG 8000 30% (w/v) PEG 4000 
Salt 0.2  M Ammonium sulphate 0.2  M Sodium acetate trihydrate 
Panel B Panel A 
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6.3.7 Structure solution for crystals from condition 22 
X-ray analyses were performed at the Diamond synchrotron facility at Oxford. The 
crystal diffracted up to 2.75 Å. The structure was analysed at NIMR, Mill Hill by 
Dr.Steve Smerdon, who provided us with the refined structure to carry out further 
analysis. Figure 6.18 shows the typical diffraction pattern for the crystals obtained 
from condition 22. The collected data was processed using the HKL-2000 program 
package using DENZO (Otwinowsky and Minor, 1997) and the resulting intensities 
scaled using SCALEPACK (Otwinowsky and Minor, 1997).  
 
 
 
 
 
 
 
 
 
 
Figure 6.18: Diffraction pattern of NBD/J crystals obtained from condition 22 of Hampton 
crystal screen . 
 The solvent content of the crystal was determined by calculating the Mathews’ 
coefficient (Matthews, 1968). Based on the solvent content and the expected molecular 
weight of the protein sample, an estimate can be made on the number of molecules in 
the asymmetric unit. The calculation was performed using the matthews_coef program 
from the CCP4 programme suite (Dodson et al., 1997). Working with a molecular 
weight of 79.7 kDa (44 kDa for the Hsc70 NBD + 35.7 kDa for HSJ1b), the solvent 
content calculated allowed for the presence of 2 molecules in the asymmetric unit. The 
structure solution was initiated by molecular replacement using MOLREP (Vagin & 
Teplyakov, 1997). The bovine Hsc70 ATPase domain with bound ADP (PDB id: 
3HSC) was used as the model for molecular replacement. The electron density map 
was examined using WinCoot (Emsley and Cowtan, 2004). The structure solution 
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obtained from the data collected for the condition 22 crystal matched exactly with the 
structure of 3HSC. No extra density was observed either for the HSJ1b protein or for 
any bound nucleotide. Crystals obtained from Condition 22 were therefore the 
unliganded NBD without its HSJ1b partner. The model developed was subjected to 
molecular refinement using REFMAC. The cell parameters details are shown in Table 
6.5.  
Apo-Hsc70 NBD 
Space group P1211 
Cell parameters (Å) 
 
a 73.2    
b 77.8     
c 75.3     
 
α  90 
β 100.6 
γ  90 
Resolution range (Ǻ) 14.934 -  2.756 
Total No. of reflections  
                       
 
21513 
Table 6.5: Cell parameters for the Apo form of the Nucleotide binding domain of Hsc70  
The stereochemical quality of the protein structure was analysed by running the 
PROCHECK v.3.5.4 suite of programs (Laskowski et al., 1993) on the  
Stuctural Analysis and Verification Server. Figure 6.19 is the Ramachandran’s plot 
generated for the structure. Ramachandran’s map is the plot of the phi and psi angles 
of the amino acids to yield a conformational map (Ramachandran et al., 1963). The 
structure has 87.8% of the residue in the core region (red region on the plot, labelled A, 
B, L in Figure 6.19), 11.3% residues in the additional allowed regions (labelled a, b, l, 
p in Figure 6.19), 0.75% residues in the generously allowed regions [labelled ~a, ~b, 
~l, ~p in Figure 6.19] and just 0.1% in the disallowed region.  
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Figure 6.19: Ramachandran plot of the apo form of the nucleotide binding domain of Human 
Hsc70. 
The Ramachandran plot was generated using the PROCHECK v.3.5.4 suite of programs on the  
Stuctural Analysis and Verification Server. The colouring/shading on the plot represents the 
different regions described in Morris et al., (1992). The red areas correspond to the "core 
favoured" regions, the yellow areas corresponds to the additional allowed regions, while the off-white 
areas represent the generously allowed regions. Residues in generously allowed and disallowed regions 
are labelled in red. 
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6.3.8 General features of the apo-NBD structure 
Preliminary crystallographic analysis showed that the protein crystal belongs to the 
monoclinic lattice. Further processing and scaling confirmed the space group to be 
P1211. The cell parameters are a = 73.2 Å, b =77.8 Å, c = 75.3 Å, α= γ = 90o, β = 
100.6o. The crystal has two chains (A and B) in the asymmetric unit (Figure 6.20). In 
Figure 6.20 a cartoon representation of chain A and chain B of the apo form of the 
NBD is shown. The sub-domains were assigned based on previous structural 
characterisations of the nucleotide bound NBD structures (Flaherty et al., 1994; Zhang 
and Zuiderweg, 2004). The Hsc70 NBD comprises of two lobes. Lobe I extends from 
residue 1-188 and 361-384, while lobe II is formed of the remaining residues. Each 
lobe can be further distinguished into two sub-domains – IA (coloured red in Figure 
6.20) and IB (coloured yellow in Figure 6.20) for lobe I and IIA (coloured green in 
Figure 6.20) and IIB (coloured orange in Figure 6.20) for lobe II (Zhang and 
Zuiderweg, 2004).   
 
 
 
  
 
 
 
Figure 6.20: Structure of the apo form of the Nucleotide binding domain (NBD) of Human 
Hsc70. 
Ribbon representation of the NBD of human Hsc70 generated by Pymol. Chain A and B are both 
shown. The division of the NBD into lobe I and II and the assignment of sub-domains IA, IB and IIA, 
IIB are depicted in red, yellow, green and orange respectively on Chain A. Chain B is shown in purple. 
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The structure was analysed using the Protein Interfaces, Surfaces and Assemblies 
(PISA) service, version 1.18 (Krissinel and Henrick, 2007) offered on the Protein 
Databank in Europe (PDBe) site. PISA is an interactive tool for the exploration of 
macromolecular interfaces and prediction of probable quaternary structures. The 
solvation energy (∆G) and buried surface area for the two chains were calculated. The 
results are tabulated in Table 6.6. For chain A, of the total 382 amino acids in the 
protein chain 346 of them are surface exposed residues. The solvent accessible area for 
this chain is 17508.5 Ǻ2 and the solvation energy for folding (∆G) is -352 Kcal/mol. 
As expected, the corresponding values obtained for Chain B match very closely to 
those of Chain A. Analysis of protein interfaces between Chain A and B did not reveal 
any specific interactions that could result in the formation of stable quaternary 
structures. Therefore the dimeric structure obtained is most probably due to the crystal 
packing and not indicative of the quaternary structure adopted by the protein in 
solution. 
 
 Chain  
 Surface  
 
 ∆G, Kcal/mol  
 Nres   Area, Å2  
A  346    17508.5    -352.0  
B  350    17455.9    -352.4  
Table 6.6: Solvation energy and solvent-accessible surface area of the two chains A and B of 
the apo form of the Nucleotide binding domain (NBD) of Human Hsc70. 
Nres is the number of amino acids present on the surface of the protein, ∆G is the solvation energy for 
folding and the Area represents solvent-accessible surface area of the structure, in Å2. 
6.3.9 Alignment studies 
Next, comparison of the apo form of the nucleotide binding domain with selected 
nucleotide bound entries in the Protein Data Bank (PDB) was carried out using the 
Protein structure comparison service (SSM) at European Bioinformatics Institute  
(http://www.ebi.ac.uk/msd-srv/ssm) authored by E. Krissinel and K. Henrick. The 
structures used in the analysis are as follows: (i) Bovine Hsc70 NBD in the ADP 
bound state (3HSC), (ii) E175S mutant of bovine Hsc70 NBD in the ADP bound state 
(1NGA), (iii) Bovine Hsc70 NBD in the ANP (Phosphoaminophosphonic acid-
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adenylate ester) bound state (1NGI) and (iv) D199S mutant of bovine Hsc70 NBD in 
the ATP bound state (1NGE). These structures are referred to by their PDB codes in 
the following sections. 
6.3.9.1 Overall alignment 
The conformation of the apo and liganded forms of the Hsc70 NBDs were compared 
using the Secondary Structure Matching tool (Krissinel and Henrick, 2004) from the 
PDBe services. The programme compares 3-dimensional structures of proteins and 
provides the Cα alignment of the compared structures. The apo structure of the Hsc70 
NBD superimposed well with the liganded conformations, with an average r.m.s. 
deviation of 0.7 Å for the main-chain C  atoms. The root mean square deviation 
(RMSD) values and corresponding Q-scores for each of the structure used in the study 
is tabulated in Table 6.7. The Q-score is a quality function of Cα-alignment, and takes 
into account the alignment length and RMSD. A Q-score of 1 is possible only in the 
case of identical structures (Krissinel and Henrick, 2004). From the RMS deviation 
and the Q-score (tabulated in Table 6.7) obtained for the superimposition of the apo 
NBD with other structures from the Pdb database, we can draw the conclusion that the 
differences in the Cα chain of the liganded and unliganded states of the NBD is 
minimal.  
PDB 
Identifier 
Protein information RMSD  Q-score       
3hsc:A Bovine Hsc70 NBD with bound ADP 0.747    0.922             
1ngi:A Bovine Hsc70 NBD +ANP +Ca2+ 0.715    0.9117             
1nga:A Bovine Hsc70 apo NBD +ADP +Mg2+ 0.764    0.9243        
1nge:A Bovine Hsc70 apo NBD +ATP +Mg2+ 0.736    0.9088        
Table 6.7: RMSD and Q-scores for the Cα alignment of the apo form of the NBD with the 
nucleotide bound forms 
This was not surprising since previous studies analysing the native and mutant NBD’s 
in complex with different nucleotides have not revealed conformational changes 
between the different nucleotide dependent forms (O'Brien and McKay, 1993, Flaherty 
et al., 1994). Alignment of 11 bovine Hsc70 NBDs, with different nucleotide 
occupancy, all superimposed with a pairwise RMSD of <0.5Å, suggesting structural 
rigidity of the NBD (Zhang and Zuiderweg, 2004). Figure 6.21 shows a pairwise 
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IIB 
IB 
IA 
IIA 
overall alignment of the apo NBD structure obtained in this study (coloured blue) with 
the ADP bound structure of the bovine Hsc70 (Pdb id:3HSC, coloured red), which 
illustrates this observation. As expected, no major structural changes could be 
detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.21: Overall alignment of the human Hsc70 apo-NBD with the bovine ADP bound form 
(3HSC) 
Chain A of the human apo-NBD structure was superimposed with the ADP bound structure (pdb 
id:3HSC). The figure shows an overlay of the ribbon representations with the apo-NBD represented in 
blue while the ADP bound form is in red. The image was generated using Pymol. 
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6.3.9.2 Sub-domain alignment 
Although the crystal structures have not shown major conformational changes between 
the different nucleotide bound states, NMR analysis has revealed the existence of 
flexibility and movement in the NBD (Zhang and Zuiderweg, 2004). Therefore, 
instead of studying the overall movement of the whole NBD, the relative movement of 
the two sub-domains of the NBD i.e lobe I and lobe II was assessed. A comparison 
was carried out between the human apo structure and the bovine ADP bound structure 
(Pdb id: 3HSC). The crystal structures were both visually analysed and structurally 
superimposed using PyMOL.22 (DeLano, 2002). The two structures were studied by 
firstly superimposing the Lobe I of the NBD, and then the matrix thus obtained was 
used to transform the whole molecule. Figure 6.22 shows that the two structures which 
were very closely aligned (refer Figure 6.21), now records a displacement of lobe II of 
the NBD with respect to lobe I. Inspection of lobe II in Figure 6.22 shows a previously 
undetected movement in the loop and helical regions of the sub-domain IIB of lobe II 
(indicated by an arrow) depending on the liganded/unliganded state of the NBD.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.22: Sub-domain alignment of the human Hsc70 apo NBD with the ADP bound form 
The superimpositions were generated by Pymol. The figure shows an overlay of the ribbon 
representations of apo-NBD (blue) with the ADP bound NBD (Pdb id: 3HSC, red). Lobe I residues 
(shown in green) alone were aligned and the transformed matrix was applied to the whole molecule. The 
resulting superimposition reveals displacement in lobe II.  
Lobe I Lobe II 
IIB 
IB 
IA 
IIA 
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Distance measurements showed that some of the residues in the helix and loop 
connecting helix I and II of 3HSC were displaced by > than 2Ǻ. Figure 6.23 shows the 
displacement of sub-domain IIB of lobe II of 3HSC (trace in red) with respect to the 
apo form (trace in blue). Distances between a few equivalent Cα atoms in the loop 
region of sub-domain IIB in lobe II are indicated in the figure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.23: Superimposed Cα trace of the apo form of human Hsc70 and the bovine ADP bound 
form  
The ADP bound (Pdb id: 3HSC) and the apo NBD structures are shown in red and blue, respectively. 
The two structures were superimposed as described previously using lobe I residues and the relative 
movement of lobe II was observed. The distances (in Ǻ) between a few equivalent Cα atoms in the two 
states are marked in the sub-domain IIB of lobe II. 
.  
Similar alignment studies of the human apo NBD structure were also performed with 
1NGI, 1NGA and 1NGE structures which were the ANP, ADP and ATP bound forms 
of the bovine NBD. The results obtained were similar to that obtained with the 3HSC 
structure (data not shown). This clearly indicates that the lobe II of the apo state of the 
NBD takes up an alternate position to that observed in the liganded state, irrespective 
of the bound ligand (ADP, ANP or ATP). Flexibility in sub-domain IIB has been 
reported in the crystal structure of the bovine Hsc70 NBD bound to the BAG domain 
(Sondermann et al., 2001). The movement observed in sub-domain IIB assumes 
2.87 
2.49 
1.8 
1.95 
1.79 
2.60 
2.12 
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additional significance since it lines the nucleotide binding cleft along with sub-
domain IB (Zhang and Zuiderweg, 2004). 
6.3.9.3 Alignment of residues involved in inter sub-domain 
interaction  
The nucleotide binding domain structure has been observed to adopt two 
conformations. The “closed” form has been observed in crystal structures obtained in 
the nucleotide bound state (Flaherty et al., 1990, 1994; O’Brien et al., 1996; Zhu et al., 
1996; Chang et al., 2008) and in the nucleotide free state (Jiang et al., 2007; Shida et 
al., 2010). The “open” form has been reported for the human Hsc70 NBD/BAG 
domain complex (Sondermann et al., 2001), the bovine Hsc70 nucleotide-free NBD-
SBD fragment (Jiang et al., 2007) and the human Hsp70 NBD and ATP-bound yeast 
Sse1 complex (Polier et al., 2008).  Shida et al., have identified that in the closed 
conformation, an interaction exists between the Glu268 from sub-domain IIB with 
Tyr15 and Lys56 from sub-domains IA and IB, respectively, which is absent in the 
open conformation. They concluded that this interaction is with Glu268 is crucial for 
maintaining the geometry of the closed form. We therefore looked into the existence of 
interaction between the Glu268 and Tyr15 and Lys56. Using Pymol, the distance 
between Glu268 and Tyr15 and Lys56 was measured (Figure 6.25). Glu268 is 5.11 Ǻ 
from Tyr15 and 6.23 Ǻ from Lys56.  From these measurements, it can be concluded 
that Glu268 is too far away to interact with either Tyr15 or Lys56, and therefore the 
apo form of Hsc70 NBD exists in an open conformation. 
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Figure 6.24: Distance of Glu268 from Tyr15 and Lys56 in the open-form NBD 
The distances between Glu268 from sub-domain IIB to Tyr15 and Lys56 from sub-domains IA and IB 
were measured using Pymol. The sub-domains IA, IB and IIB are depicted in red, yellow and orange 
respectively. Glu268, Tyr15 and Lys56 are depicted in stick mode. The distances( in Ǻ) between the 
residues are displayed on the blue dashed lines.  
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Lys56 
IIB 
IB 
IA 
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6.3.9.4 Alignment of residues involved in ligand binding 
NMR studies on the NBD from the Hsp70 of Thermus thermophilus revealed that 
conformational changes observed in the apo state are localised in the ligand binding 
site. (Revington et al., 2004) In particular sub-domain IA and IIB have been implicated 
(Revington et al., 2004). In the previous section relative movement of lobe II with 
respect to lobe I was established, therefore the next step was to analyse the effect of 
this displacement in the ligand binding site. The side chains of the NBD involved in 
making polar contacts with ADP was identified using the 3HSC structure. The PISA 
service on the PDBe site was used for this purpose. Using Pymol, the 3HSC residues 
involved in ligand binding were aligned with the corresponding residues from apo 
NBD structure (Figure 6.25). Panel A in Figure 6.25 reveals the position of the amino 
acids necessary to make contact with ADP and their relative position with respect to 
ADP in the 3HSC crystal structure. Panel B in Figure 6.25 now displays the relative 
position of the equivalent residues of the aligned apo NBD structure with respect to 
3HSC. Residues from the apo structure are in blue and the corresponding residues 
from 3HSC are in red. The relative shift in the positioning of these residues in the apo 
state from their ligand bound state positions was measured (Panel B of Figure 6.25). 
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Figure 6.25: Displacement of residues involved in nucleotide binding 
Residues involved in making polar contacts with ADP were identified suing the 3HSC structure. 
Selected amino acids residues and ADP are depicted in stick mode. Residues from 3HSC are depicted in 
red and those from the apo-NBD are in blue Hydrogen bonding interactions between nucleotide and the 
3HSC residues are displayed as red dashed lines. The difference in positioning of equivalent residues 
from 3HSC and apo-NBD are emphasised by black dotted lines. The distanc (in Ǻ) between the 
equivalent residues from 3HSC and apo-NBD is also shown. The figure was generated using PyMol. 
Panel A shows the positioning and mode of interactions of the identified residues from 3HSC with 
ADP. Panel B shows the relative position of the equivalent residues of the apo structure when aligned 
sub-domain wise with 3HSC 
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Some of the residues such as Arg342, Ser 275, Arg 272 and Lys 271 were displaced by 
more than 1.5Ǻ. The effect of such a displacement in the positioning of the key 
residues in the nucleotide binding cleft on their interaction with ADP was studied. This 
was achieved by measuring the hypothetical hydrogen bonding distance between the 
displaced residues of the apo structure and corresponding atom on ADP (Table 6.8). 
The position on the amino acid from which the measurements were made is also 
indicated within brackets in column 3 of Table 6.8. These values were then compared 
with the known values obtained for the 3HSC structure. The values are tabulated in 
Table 6.7. Ser 275, Gly 339, Ser 340 and Lys 271 (coloured red in Table 6.8) show an 
increase in hydrogen bonding distance in the apo form of almost 1 Å. This suggests 
that conformation of the nucleotide binding cleft in the apo NBD form displaces some 
of the key residues such that it is not conducive to forming contacts with this ligand.  
 
Table 6.8: The hydrogen bonding distance (Å) between the residues involved with nucleotide 
binding and ADP. 
Residues in red are displaced by almost 1 Ǻ in the apo NBD structure when compared with the bovine 
ADP bound structure (3HSC).  
 
 
 
 
No 
Position on 
ADP 
Residue 
Information 
Distance between 
the amino acid and 
ADP in 3HSC 
Distance between the 
amino acid and ADP 
in the apo state 
 1  ADP [ N6 ]  ARG 272[ O  ]  3.71 3.30 
 2  ADP [ N1 ]  SER 275[ OG ]  2.69 3.89 
 3  ADP [ O1B]  GLY 202[ N  ]  3.04 2.75 
 4  ADP [ O3B]  TYR  15[ N  ]  2.82 3.08 
 5  ADP [ O3B]  THR  13[ N  ]  3.47 3.21 
 6  ADP [ O3B]  THR  14[ N  ]  2.71 2.72 
 7  ADP [ O3B]  THR  14[ OG1]  2.51 2.71 
 8  ADP [ O1A]  GLY 339[ N  ]  2.91 3.97 
 9  ADP [ O4']  SER 340[ N  ]  3.50 4.36 
 10  ADP [ O3']  LYS 271[ NZ ]  3.48 3.75 
 11  ADP [ O2']  LYS 271[ NZ ]  2.60 3.35 
 12   ADP  [ N7 ]  ARG 342[ NH1]  3.38 3.09 
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6.3.10 Structure solution for crystals from condition 15 
The structure of crystals obtained from condition 15 was analysed by Dr. Steve 
Smerdon at the NIMR facility, Mill Hill. The crystal diffracted up to 2.2 Å. Figure 
6.26 shows the typical diffraction pattern for the crystals. Preliminary crystallographic 
analyses showed that the protein crystal belongs to the monoclinic lattice and further 
processing and scaling confirmed the space group to be P1211. The cell parameters are 
a = 61.8 Å, b = 86.06 Å, c = 114.3 Å, α = γ = 90o, β = 96.7o. The collected data was 
processed and scaled as described in the earlier section. Structure solution was initiated 
by molecular replacement using MOLREP using the Hsc70 ATPase domain with 
bound ADP (PDB id: 3HSC) as a phasing model. However molecular replacement was 
unsuccessful and no satisfactory solution could be obtained.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.26: Diffraction pattern of NBD/J crystal obtained from condition 15 of Hampton crystal 
screen  
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As a means of obtaining phase information which was required to solve the structure 
for the protein in crystals obtained from condition 15, production of seleno-l-
methionine substituted NBD/J protein was undertaken. SelMet labelling was achieved 
by inhibition of methionine biosynthesis (Doublié, 1997), in a methionine auxotrophic 
E. coli strain, in this case B834 [DE3]. The NBD/J complex was expressed in a 
minimal medium supplemented with SelMet as described in Materials and Methods 
(section 6.2.5) to produce proteins where the methionine residues are replaced with 
seleno-L-methionine. The NBD/J complex was purified using the same sequential 
chromatographic steps as those used for the native protein. Figure 6.27 compares the 
gel filtration elution profile of the SelMet labelled NBD/J protein with the native 
protein to confirm that the oligomerisation of the NBD/J complex remains unchanged 
with the incorporation of the selenium label.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.27: Comparison of the SEC elution profile of the native NBD/J complex with the SelMet 
labelled NBD/J complex. 
Native NBD/J protein was expressed in BL21(DE3) and SelMet labelled NBD/J protein was expressed 
in B834 [DE3]. Both proteins were purified from Ni-NTA and Ion exchange chromatography following 
the protocols described previously. Size exclusion chromatography was performed on a Superdex-200 
column and the protein eluting from the column was collected as 1 ml fractions. The absorbance of each 
fraction was determined using Bradford assay. 
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Protein from the size exclusion chromatography was concentrated as before and trials 
were set up at a protein concentration of 5 mg/ml. Using the crystallistaion condition 
identified for the native protein a single crystal was obtained which was deformed and 
therefore not usable. Panel A in Figure 6.28 is an image of the crystal obtained. 
Repeated attempts at crystallising the SelMet NBD/J protein resulted in crystalline 
clusters from which a single crystal could not be isolated. Panel B in Figure 6.28 is an 
example of the clusters observed in the drops. Therefore, optimisation of the 
crystallisation condition was undertaken at the Molecular Structure facility, NIMR by      
Ms. Lesley Haire. Crystals were obtained using the condition 20% (vwv) PEG8K, 0.2 
M ammonium sulphate and 0.1 M MOPS pH 7.5. Panel C in Figure 6.27 represents the 
seleno-l-methionine-labelled crystals of NBD/J protein. However no selenium signal 
could be detected from the data collected using these crystals and therefore the 
structure remains unsolved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.28: Optimisation of crystallisation conditions to obtain crystals of the selenium labelled 
NBD/J protein. 
The deformed crystals in Panel A and B were obtained when crystallised under the same crystallisation 
condition as the native crystals. Panel C represents the well defined crystals obtained after optimisation 
of crystallisation conditions.  
Panel B 
Panel C 
Panel A 
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6.4 Discussion 
In this chapter, the biochemical and structural work carried out using domain variants 
of the Hsc70 protein has been described. Studying the behaviour of the domains in 
complex with HSJ1b will contribute to understanding the nature of the interaction of 
the full length Hsc70 with HSJ1b. 
In order to evaluate the role of the individual Hsc70 domains in thier interaction with 
the HSJ1b partner protein, the 44 kDa N-terminal nucleotide binding domain (NBD) 
and the C-terminal hydrophobic region (CTR) were expressed individually. The N-
terminal region has the 44 kDa NBD and is involved in nucleotide binding and 
hydrolysis (Chappell et al., 1987; Flaherty et al., 1990 and Huang et al., 1993). The 
isolated 44 kDa NBD exists as a monomer and has been crystallised in ATP and ADP 
bound forms (DeLuca-Flaherty et al., 1988; Flaherty et al., 1990). The Km values 
obtained for ATP hydrolysis by the NBD in isolation have been observed to be equal 
to that of the full length Hsc70 (O’Brien et al., 1993). NMR studies (Garimella et al., 
2006) and biochemical analysis using BIAcore (Suh et al., 1998) have determined that 
the NBD hosts the primary site of interaction for the J-domain of the Hsp40 co-
chaperone family.  
The C-terminal region (CTR) is further divided into two domains – an 18 kDa peptide 
binding region (PBD) involved in recognition of substrate moieties and a 10 kDa 
region which is believed to act as a lid over the peptide binding domain (Zhu et al., 
1996). Wang et al., have demonstrated using the S-peptide of RNase-A as substrate, 
that the 18 kDa PBD is sufficient for peptide binding. The 18 kDa fragment displayed 
an affinity of 8 µM, which matched the value obtained for the full length Hsc70 (Wang 
et al., 1993). The requirement of the 10 kDa lid fragment for the functioning of the 
Hsc70 has been debated. Reports in the literature have concluded that the 10 kDa lid 
region might not be relevant for Hsc70’s chaperone functions (Ungewickell et al., 
1997; Wilbanks et al., 1995). However, Demand et al., have used the yeast two hybrid 
system to demonstrate that the 10 kDa C-terminal region of Hsc70 provides non 
overlapping binding sites for interacting protein cofactors such as the Hsp40 family 
members and Hop (Hsc70-Hsp90-organizing protein, Demand et al., 1998).  
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It has already been established that the isolated C-terminal region of the Hsc70 can be 
highly oligomerised and therefore been implicated for the self-association property of 
the full length Hsc70 (Benaroudj et al., 1997). However there are conflicting reports as 
to whether self-association in Hsc70 is brought about by the 18 kDa peptide binding 
domain or the 10 kDa lid region. Using sedimentation velocity and gel filtration 
studies, Fouchaq and co-workers came to the conclusion that Hsc70 oligomerisation 
was due to the 18 kDa PBD (Fouchaq at al., 1999), while the crystal structure of the 10 
kDa lid region demonstrated that this region played a role in the self association of 
Hsc70 (Chou et al., 2003). Therefore, to understand the oligomerisatin of rHH 
complex, two c-terminal deletion mutants were engineered. Tsai et al, 1994 reported 
that deletion of the C-terminal 10 kDa region generates a functional 60 kDa fragment 
which displays ATPase properties similar to that of the full length Hsc70 protein (Tsai 
et al., 1994). A 60 kDa N-terminal fragment (N60) which lacks the 10 kDa fragment of 
the C-terminus was constructed. A second deletion mutant was also made of the CTR 
lacking the 10 kDa lid region (CTR∆C), essentially the isolated PBD.  
Thus 4 fragments of Hsc70 i.e NBD, CTR, N60 and CTR∆C were selected for the 
domain-wise study on the interactions of Hsc70 with HSJ1b. All four constructs were 
successfully amplified and cloned into the pET-16b vector. Each domain fragment was 
co-expressed with HSJ1b (referred to as ‘J’ in these complexes) and the N60/J, NBD/J, 
CTR/J and CTR∆C/J complexes were subsequently isolated by Ni-NTA 
chromatography. 
Gassler et al., used SPR spectroscopy to assess the physical interaction between the 
NBD, CTR and N60 fragments of E.coli DnaK with DnaJ (Gassler et al., 1998). DnaJ 
was shown to interact with either the full length DnaK or the N60 fragment and not 
with the other isolated domains (Gassler et al., 1998). However NMR perturbation 
experiments had previously shown evidence of physical association of the J-domain of 
DnaJ with the DnaK’s NBD (Greene at al., 1998). Although no direct evidence is 
available to show the binding of mammalian Hsp40’s to the isolated CTR, the distal 10 
kDa region has been shown to host a secondary site of interaction with the Hsp40 
family members, as identified by Demand et al., using the yeast two hybrid systems 
(Demand et al., 1998).  
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The co-expression system used previously to successfully isolate the full length Hsc70 
and HSJ1b protein complex was employed to see if it is possible to isolate the 
complexes between HSJ1b and Hsc70 domains. From the analysis of the co-expressed 
protein elutions from the Ni-NTA, all four domain fragments co-eluted with HSJ1b. 
While N60/J, NBD/J and CTR/J complexes were expected, detection of CTR∆C/J was 
unexpected since the 18 kDa PBD is not known to host any interaction sites for Hsp40 
family members. Subsequently, size exclusion chromatography confirmed that while 
60/J, NBD/J and CTR/J were stable complexes, CTR∆C/J was not. The CTR∆C/J 
complex disassociated over the gel filtration column.  
Closer analysis of the isolated complexes of the deletion mutants however revealed 
that the deletion mutants exhibited altered levels of binding to HSJ1b. Removal of the 
10 kDa C-terminal region in the N60 construct marginally reduced its ability to bind 
HSJ1b when compared with the intact Hsc70 (ref figure 6.7).  While binding of HSJ1b 
to the CTR mutant was comparable to that of the full length Hsc70, the CTR∆C/ J 
showed almost 50% reduction in the amount of bound HSJ1b. This clearly suggests 
that, although the Hsc70 NBD is the primary site of interaction between Hsc70 and 
HSJ1b, the binding of HSJ1b to Hsc70 is also mediated via the 10 kDa C-terminal 
region and deletion of this region weakens and disrupts the binding.   
Oligomeric properties of the domain complexes 
Polymerisation of Hsc70 has been suggested to be a regulatory event necessary to 
maintain the chaperone in an inactive state (King et al., 1995a). Sucrose density 
gradient and non denaturing electrophoresis studies performed on cell lysates 
containing BiP (Hsp70 from the endoplasmic reticulum) indicates that polymerised 
BiP was observed to be free of protein substrates, while the monomeric form was 
found associated with protein substrate (Freiden et al., 1992). In the previous chapter, 
it was observed that the the rHH protein resolves into two fraction over the gel 
filtration column. The first peak eluted in the void volume, while the second peak 
fractionated at an estimated molecular weight of ~220 kDa. The oligomeric peak 1 
from the SEC could be a result of the polymerisation of the Hsc70 by HSJ1b, and 
subsequent co-polymer formation. HSJ1b subunit was found associated with the Hsc70 
subunit in both the polymeric SEC fractions. An important area of focus in this chapter 
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was to therefore establish the region on Hsc70 essential for this polymerisation that 
was observed during the course of this study.  
Oligomerisation state of the isolated N60/J, NBD/J, CTR/J and CTR∆C/J complexes 
was studied by size exclusion chromatography. The NBD/J complex was completely 
non-oligomeric. This indicated that the perceived polymerisation event was driven by 
the C-terminal region of Hsc70. This was confirmed by gel filtration of the CTR/J 
complex. 44% of CTR/J protein existed as higher order oligomers, compared to the 
64% calculated for the intact Hsc70/HSJ1b complex. However, only 22% of the N60/J 
complex existed in a polymerised state. The N60 fragment has both the NBD and PBD 
and only lacks the 10 kDa C-terminal portion of Hsc70. The reduced polymerisation of 
the N60/J, despite the presence of the 18 kDa PBD of the CTR, incriminates the 10 
kDa C-terminal region in the polymerisation of the Hsc70 in the presence of HSJ1b.  
The results presented in this chapter clearly indicate that the deletion of this distal 10 
kDa lid region directly affects the formation of the Hsc70 polymer with HSJ1b co-
polymer as observed by the gel filtration profiles of N60/J and CTR∆C/J complexes.. 
Previously the 10 kDa lid region (from rat) has been implicated for its role in the self-
association of Hsc70 (Chou et al., 2003). This is the first report on its possible role in 
HSJ1b mediated polymeristaion of Hsc70. It remains to be confirmed if the 
observations holds true for other members of the Hsp40 family or if this was specific 
for the interaction of Hsc70 and HSJ1b proteins.  
Functional and conformational changes due to deletion of 10 kDa lid region 
The effect the deletion of the C-terminal 10 kDa region has on the functional 
properties of the Hsc70/HSJ1b complex was studied using the luciferase protection 
assay and by measuring the ATPase activity or the N60/J domain complex and the full 
length, rHH complex. The N60/J complex showed evidence of ATP dependent 
protection luciferase from thermal stress. Almost 70% of luciferase was maintained 
soluble by the N60/J complex in the presence of ATP. The ATP hydrolysis activity 
(measured by phosphate release) of the N60/J complex was 50% less than that 
obtained for the full length rHH complex. Contradictory reports are available on the 
functional capabilities of the N60 fragment, and the effect of the missing distal 10 kDa 
C-terminal lid region. Leng et al., demonstrated that the ATPase activity of the bovine 
N60 fragment can be successfully stimulated with the rat DnaJ-like protein, RDJ1 
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(Leng et al.,1998). Similarly, Ungewickell et al., have shown that auxillin J-domain 
interacts with the N60 fragment and is successful in the uncoating of clathrin baskets 
(Ungewickell et al., 1997).  This was in direct contradiction to previous results from 
Chappel et al., who reported that the bovine Hsc70’s N-terminal 60 kDa fragment did 
not have clathrin binding activity (Chappel et al., 1987). Furthermore, Hu and Wang 
reported that a stable complex of the N60 fragment with S-carboxymethyl α-
lactalbumin (CMLA), an unfolded protein could not be detected by native gel 
electrophoresis (Hu and Wang, 1996). From the results for our functional studies on 
the N60/J complex, it was observed that the N60/J complex used in this study could 
function as a chaperone, albeit in a reduced capacity, and this therefore suggests that 
the distal 10 kDa region plays an important functional role.  
Conformational differences between the two constructs were studied by partial 
proteolysis. A key feature identified in the studies carried out on the intact 
Hsc70/HSJ1b complex is the susceptibility of the HSJ1b to digestion by chymotrypsin. 
This feature was conserved in the N60/J complex. Interestingly, the N60 moiety of the 
N60/J complex also showed signs of proteolysis. This was not the case for the full 
length rHH complex; Hsc70 appeared to be totally impervious to digestion under 
similar experimental conditions. This indicates that the conformation adopted by the 
N60/J results in the exposure of a chymotrypsin site(s) on the Hsc70 fragment which 
were previously protected. Since the main difference between the full length Hsc70 
and the N60 fragments is the 10 kDa lid region, this region might conceal 
chymotrypsin recognition sites on the full length Hsc70 which become exposed in the 
N60 fragment and therefore makes it susceptible to proteolysis.  
A few important conclusions can be drawn from the biochemical studies conducted on 
the complexes of the domain fragment with HSJ1b.  
1) Using the co-expression system, a physical interaction of the isolated N-terminal 
NBD and C-terminal region (CTR) with HSJ1b has been shown. The interaction 
with the CTR is dependent on the distal 10 kDa region, because CTR∆C was 
incapable of stably binding with HSJ1b. Removal of the 10 kDa region clearly 
impacts the interaction of HSJ1b with the Hsc70 modules, which agrees with the 
prediction of Demand et al., that it hosts a binding site for the Hsp40 cofactor. 
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2) The C-terminal 10 kDa lid region has been implicated in self association of Hsc70.    
The studies carried out this chapter reveal for the first time that this region also 
plays an integral role in the HSJ1b mediated polymerisation of Hsc70, and the 
subsequent co-polymer formation. 
These conclusions provide useful insights especially regarding the regions on the 
Hsc70 critical for mediating the interaction with its Hsp40 co-chaperone partner, in 
this case HSJ1b. 
X-ray crystallographic studies 
Of the four domain complexes studied only the NBD/J complex was studied by X-ray 
crystallography. X-ray crystallography is a powerful tool to determine the 3-
dimensional structure of proteins (Smyth and Martin, 2000). However the bottleneck 
in this process is growing protein crystals of sufficient size and quality suitable for 
diffraction studies. Under appropriate conditions the solubility of the protein in the 
sample can be manipulated to reach a state of supersaturation, which favours the 
formation of crystals (Gernert et al., 1988). One of the most important factors for 
protein crystallisation is the sample purity and homogeneity. Protein contamination or 
the presence of aggregates can inhibit crystal growth (McPherson, 1999). Based on the 
observations of the gel filtration profiles of each complex, only the NBD/J complex 
eluted as a homogenous peak and was also estimated to be > 98% pure when assessed 
by gel electrophoresis. Electrophoresis on a 15% SDS gel over an extended time 
period also resolved the closely migrating NDB and HSJ1b protein bands, confirming 
the presence of both protein species. Taking these facts into consideration, only the 
NBD/J complex domain complex was deemed suitable for cyrtsallographic studies 
Prior to crystallisation the protein was concentrated and observed to be stable during 
concentration. At higher concentrations the protein was no longer soluble and 
precipitated out of solution. Therefore crystallisation trials were performed at a protein 
concentration of 5 mg/ml. The formation of protein crystals is dependent on a large 
number of variables including the type of buffer and pH of buffer, precipitant, salt 
solution, concentration of protein and temperature (Smyth and Martin, 2000).   
Initial crystallisation trials were performed using a sparse matrix screen. These are 
collection of crystallisation conditions which have been shown to produce protein 
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crystals and were conceptualised by Jancarik and Kim (Jancarik and Kim, 1991). 
Several commercial screens are available which allows screening around a vast range 
of parameters. The initial screen for the NBD/J complex was carried out using the 
Hampton Crystal Screens. Crystal screen 1 and crystal screen 2 have 50 and 48 
conditions respectively. Crystallisation trials were set up using the hanging drop 
vapour diffusion technique. Crystals were obtained under 2 of the Hampton crystal 
screen  conditions – condition 15 and condition 22. The structure solution for the 
crystals obtained from condition 22 was straightforward and was solved by Molecular 
replacement (MR). MR uses the phase information from a previously solved crystal 
structure similar to the unknown structure and performs mathematical operations to 
generate a model for the unknown structure (Tickle and Driessen, 1996). Several 
structures of the NBD of the Hsp70 proteins are available in the PDB database. The 
ADP bound form of the bovine Hsc70 NBD (Pdb id: 3HSC) was used to generate a 
starting model for the structure solution. However, no extra density corresponding to 
the HSJ1b protein could be detected. Crystals obtained under condition 22 therefore 
contained just the individual NBD and not a complex of NBD and HSJ1b. Interestingly 
the NBD showed no density for any nucleotide; therefore the crystal represented the 
apo state of the Human Hsc70’s nucleotide binding domain (1-386 amino acids).  
This is the first report for the apo structure of the NBD from the Human Hsc70. In 
2007, Jiang et al., published the apo structure of the NBD from bovine Hsc70, along 
with the structure of the complex of bovine NBD and auxilin’s J- domain.  Structural 
analysis carried out during the course of our study revealed that the structure of the 
Human apo NBD is identical to that of the Bovine apo NBD, possibly due to the high 
levels of homology in the amino acid sequence. Limited proteolysis studies carried out 
by Buchberger et al., 1995, shows that DnaK (E. coli Hsp70) exhibits three 
conformations dictated by the absence of nucleotide, ATP bound state and ADP bound 
state respectively (Buchberger et al., 1995). Similar observations were made from the 
proteolysis experiments carried out using Hsp70 from Saccharomyces cerevisiae 
(Ssa1p, Fung et al., 1996). Intriguingly no significant difference in the overall 
conformation could be detected between the apo form and the nucleotide bound forms 
when structural superimposition of the NBD structures was carried out. The lack of 
detectable conformational change can be explained by the observations of Buchberger 
et al., that nucleotide dependent conformation change is dependent on interdomain 
  
Page 233 
communication and probably localised in the C-terminal region of DnaK (Buchberger 
et al., 1995).  
Next analysis was carried out to study the possibility of subtle sub-domain movements 
which could remain undetected when studying the overall alignment. Relative 
movement of lobe II with respect to lobe I of the apo structure was compared with the 
ADP bound structure (3HSC). The alignment studies revealed movement in sub-
domain II B of lobe II in the apo NBD. This was an interesting observation because the 
structure of DnaK’s NBD in complex with GrpE crystallised in the nucleotide free 
form also displays an outward rotation of sub-domain II B rotated by almost 14o 
(Harrison et al., 1997). A similar shift in this sub-domain was detected in the structure 
of the Hsc70 NBD in the presence of BAG-1domain (Sondermann et al., 2001). An 
NMR study the 44-kDa Hsc70 NBD from Bos taurus in the ADP.Pi state revealed that 
the NBD is dynamic and the four sub-domains (IA, IB, IIA, IIB) can reorient 
themselves, depending on the experimental conditions (Zhang and Zuiderweg, 2004).  
They suggest that the relative movement of both domains IB and IIB plays a role in 
nucleotide binding and release (Zhang and Zuiderweg, 2004). Therefore we carried out 
a study into the positioning of residues implicated in ligand binding and discovered 
they were displaced in the apo structure, compared to the ADP bound form. Some of 
the residues like Arg342, Ser 275, Arg 272 and Lys 271 were displaced by more than 1 
Å. These are all crucial residues which make up the adenine binding pocket. For 
example, Arg272 is involved in forming a salt bridge across to Glu268 (Flaherty et al., 
1991). The Glu268 in turn has been implicated to be crucial for the inter sub-domain 
interaction (Shida et al., 2010).  Inter sub-domain interactions of the Glu268 with 
Tyr15 and Lys56 define the closed state of the NBD. In the open form this interaction 
is absent. The previously reported structures of the apo NBD of bovine Hsc70 and 
human Hsp70 display a closed conformation (Jiang et al., 2007; Shida et al., 2010). 
Intriguingly, the apo structure obtained during the course of this study was observed to 
be in the open conformation. The “open” form has been reported for the Hsc70 
NBD/BAG domain complex (Sondermann et al., 2001), the Hsc70 nucleotide-free 
NBD-SBD fragment (Jiang et al., 2005) and the Hsp70 NBD/ATP-bound Sse1 
complex (Polier et al., 2008), indicating that the presence of co-factor or the SBD 
promotes this conformation. It is possible that since the human Hsc70 NBD in our 
study was crystallised in the presence of the HSJ1b cofactor, it has adopted the open 
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conformation, in its apo state. The NBD did not crystallise in complex with the HSJ1b, 
possibly due to potential differences in solubility of the two proteins. However, despite 
the differences in the sub-domain interactions observed between the nucleotide free 
form of Hsc70’s NBD and the ADP bound form, the physiological and functional 
significance of a nucleotide free state for Hsc70 in vivo is not yet clear.  
Determination of a structure solution for the protein crystals obtained from condition 
15 of Hampton crystal screen  was unfortunately not as straightforward as the previous 
case. Although the crystal gave high resolution diffraction data (2.2 Ǻ), a structure 
solution was not forthcoming. MR was attempted with several starting models such as 
the ADP bound NBD (3HSC), the bovine Hsc70’s NBD in complex with the J-domain 
(2qwn) and the J-domain of Human Hsp40 (1HDJ).  All attempts failed to provide a 
solution. From the many trials it is apparent that the crystal most probably did not 
contain the NBD fragment and therefore might not represent the complex of NBD and 
HSJ1b. It therefore raises the possibility that the protein crystallised under condition 
15 is the Human HSJ1b protein. To date there is no full length structure reported for 
any member of the Hsp40 family. There are several structures of the various domains 
in isolation such as the conserved J-domain, carboxyl terminus and zinc finger-like 
domain as well as the peptide binding fragment (Qian et al., 1996; Lu and Cry, 1998; 
Huang et al., 1999 and Li et al., 2003). It is possible that MR with the J-domain 
structures were unsuccessful because the J-domain corresponds to only 78 amino acids 
on the HSJ1b sequence and is therefore too small to provide a MR solution. 
Since the MR experiments failed to provide the phase information required for solving 
the structure, Selenomethionine (SelMet) labelling of the NBD/J protein was 
undertaken. Selenomethionine is an amino acid containing selenium, and is 
incorporated into the protein in the place of the amino acid methionine (Cowie and 
Cohen, 1957). Structure of the SelMet incorporated crystals can be determined by 
multi-wavelength anomalous diffraction (MAD) methods (Doublie, 1997; 
Hendrickson, 1991). Selenium is a heavy atom and is useful in providing phase 
information for the structure (Strub et al., 2003). Another important factor to consider, 
is the number of methionines in the protein sequence. A good rule of thumb is to verify 
that the protein being labelled has at least one methionine for every 10 kDa of the 
protein. This is necessary for efficient and detectable incorporation of selenium. From 
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an analysis of the protein sequences for the NBD fragment (44 kDa) and HSJ1b (35.5 
kDa) there are six and three methionines respectively, which should be sufficient for 
the detection of the signal. The NBD/J protein was co-expressed in E. coli strains 
auxotrophic for methionine, and purified following the same purification protocols as 
the native protein. Size exclusion chromatography confirmed that elution profile of the 
native NBD/J and SelMet labelled protein was the same. Optimisation of the original 
crystallisation condition was required to obtain crystals of the SelMet incorporated 
NBD/J protein. However analysis of the diffraction data collected from the SelMet 
crystals revealed that the incorporation of selenium is very low and therefore failed to 
help provide a structure solution.  
Results from this chapter raise important questions on the actual role of the distal 10 
kDa region in the interaction of the Hsc70 and HSJ1b. This region appears to be 
crucial for the chaperone/co-chaperone interaction, since the removal of this zone 
alters binding, functional and conformational properties of the 70/40 interaction. Also, 
the structure of the NBD of the human Hsc70 in its Apo form was successfully solved 
in its open conformation. Diffraction data has been collected for native and SelMet 
labelled crystals obtained under a different crystallisation condition. However the 
structure remains elusive. 
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7.1 Summary of Results 
The main objective of this thesis was to produce a stable form of an Hsc70/HSJ1b 
complex which could be used in the elucidation of the structural details of the 
interactions between the Hsp70 and Hsp40 protein families. The first hurdle towards 
achieving this aim was the production of a stable Hsp70-Hsp40 complex protein which 
could be used for structural studies and biophysical analysis.  
In Chapter 3, we reported the successful purification of an intact Hsp70/Hsp40 
complex from bacteria using a co-expression system. We expressed and purified a 
recombinant Hsp70/Hsp40 complex from E.coli using human Hsc70 and HSJ1b as 
representatives of the Hsp70 and Hsp40 families respectively. The human Hsc70 was 
amplified from cDNA prepared from HB4a cells and inserted into the pET-16b vector, 
allowing the Hsc70 protein to be expressed with an N-terminal 10 x histidine tag. The 
full length human HSJ1b gene was cloned into the pET-24a vector with a stop codon 
immediately after the coding sequence, and therefore the HSJ1b protein was expressed 
with neither an N-terminal nor C-terminal Histidine tag. The Hsc70/HSJ1b complex 
was isolated using a single step Ni-NTA chromatography. Both Hsc70 and HJj1b 
subunits were observed in the higher concentration imidazole elution fractions. The 
untagged HSJ1b protein could only elute with such high imidazole levels only if it was 
complexed with the 70 kDa histidine tagged Hsc70. The complex formation between 
the two subunits was further confirmed by 2-dimensional electrophoresis. Thus, we 
have used a novel method for the purification of recombinant chaperone/co-chaperone 
complex formed in vivo (albeit under recombinant conditions) without any external 
manipulation. 
Biochemical characterization of the recombinant complex, rHH, was carried out in 
Chapter 4. The chaperone activity of rHH complex was assessed by its ability to 
prevent thermal aggregation of a substrate (luciferase in this study). It was observed 
that revealed that the chaperone complex can protect ~85% of substrate protein 
(luciferase) from thermal aggregation, and retain it in the soluble fraction but this 
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luciferase was found to be inactive. It was observed that the recombinant complex was 
capable of preventing luciferase aggregation up to a molar ratio of 1:1 beyond which 
the efficiency reduced by almost 60%. The first important observation from this 
chapter was that the rHH complex appears to function in an ATP independent fashion. 
The presence of denatured substrate did not alter the ATPase activity of Hsc70. The 
lack of a requirement for ATP or ATP hydrolysis displayed by the rHH complex was 
an interesting finding, since most studies performed with a reconstituted Hsp70/Hsp40 
chaperone/co-chaperone complex have stressed on the importance of ATP for the 
functioning of the complex. The rHH complex is already in a competent state to 
protect aggregating proteins, without any additional nucleotide requirement. The 
functional behaviours displayed by the rHH complex could be explained only if the 
NBD of Hsc70 in the rHH complex contained a bound nucleotide. Unfortunately, we 
have been unable to conclusively prove if the NBD is ATP/ADP bound or nucleotide 
free.  
Limited proteolysis experiments provided useful insights into the arrangements of the 
HSJ1b subunits with respect to Hsc70 in the rHH complex. Both subunits appear to be 
well folded, but the HSJ1b was extremely susceptible to proteolysis while Hsc70 was 
resistant. This suggests that the HSJ1b subunit was more exposed and therefore more 
accessible of the two subunits. It is possible that in the quaternary structure, the HSJ1b 
plays the role of a shield, which prevents the proteolysis of the core Hsc70 subunits.    
Analysis of the rHH complex by gel filtration, revealed the existence of two forms of 
the complex. SDS-PAGE analysis confirmed the presence of both the Hsc70 and 
HSJ1b subunits in both the rHH forms. The first form (peak 1), although eluting in the 
void volume of the superdex 200 column, was confirmed to be non-aggregated by 
analytical ultracentrifugation and its molecular weight was estimated to be 1.1 MDa. 
This fraction represented higher order oligomers of the rHH complex, which we 
believe represents the product of Hsc70 polymerisation by HSJ1b. The second form 
(peak 2) had an estimated molecular weight of 220 kDa, indicating the rHH complex 
existed as a dimer of an Hsc70/HSJ1b dimer. Using ATP, we have shown the cyclic 
disassociation of peak 1 to form peak 2, which in turn disassociates into the individual 
Hsc70 and HSJ1b components. It is not clear if the observed disassociation is due to 
ATP binding or ATP hydrolysis. A similar conversion of peak 1 to peak 2 was 
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observed in the presence of denatured luciferase. The full length complex was found to 
be unsuitable for X-ray crystallographic studies due to its highly heterogenous 
oligomeric composition. Instead electron mcroscopic studies were pursued. 
Preliminary results from negative staining have proved to be very exciting and 
intresting. However due to heterogeneity of the peak 1 fractions, caused probably due 
to the dissociation of the complex during the uranyl acetate staining procedure, further 
image processing could not be pursued.  
Most investigations into the interactions of the Hsp70 proteins with their Hsp40 co-
chaperone partners have used a reconstituted system. The data from our 
characterisation studies of the recombinant complex did not concur with the published 
reports carried out using a reconstituted complex. Therefore it was necessary to 
ascertain if the observations from our study was unique for the recombinant complex, 
or if it was due to the choice of Hsp70 and Hsp40 proteins used in our study. For this 
purpose, in Chapter 5, an in vitro Hsc70/HSJ1b complex was formed by 
reconstitution, and its functional properties were studied and compared with that of the 
recombinant system. Interestingly, the in vitro system displayed ATP dependent 
luciferase protection, as reported previously for the reconstituted systems such as 
Hsc70/HDJ-1 proteins, Hsp70 and Hsp40 proteins from Meiothermus rubber and 
Hsc70/CSP interactions. Conformational differences were observed between the two 
systems when treated with the protease trypsin. The Hsc70 and HSJ1b subunits 
interact differently in the two models, since the Hsc70 subunit appears to be more 
sensitive to proteolysis in the in vitro complex than in the rHH complex. Thus the 
recombinant Hsc70/HSJ1b complex is potentially a more robust model to study the 
mechanisms of assembly and working in the formation of the Hsc70 chaperone and 
HSJ1b co-chaperone complex.  
We next generated domain variants of Hsc70 capable of binding to HSJ1b in Chapter 
6 to study the regions on the Hsc70 critical for mediating the interaction with its Hsp40 
co-chaperone partner, in this case HSJ1b. It was observed that removal of the distal C-
terminal 10 kDa region impacts on the interaction of HSJ1b with Hsc70 and that 
furthermore this region is crucial for the formation of the Hsc70/HSJ1b co-polymer. 
This region was further found to be conformationally essential, since deletion of this 
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10 kDa fragment, left the remaining N-terminal 60 kDa vulnerable to proteolytic 
cleavge.  
The NBD/J domain complex was determined to be suitable for X-ray crystallographic 
studies, because of its purity and homogeneity.  Crystallisation trials yielded two 
protein crystals from condition 15 and 22 of Hampton crystal screen . Both crystals 
belonged to the P1211space group. A structure solution for the data collected from 
crystals of condition 22 was initiated by molecular replacement using the bovine 
Hsc70 ATPase domain with bound ADP (PDB id: 3HSC) as the model. The structure 
was determined to be the unliganded Hsc70 NBD without its HSJ1b partner. This is 
the first report for the apo structure of the NBD from the Human Hsc70. The structure 
of the Human apo NBD was found to be identical to that of the bovine apo NBD, 
possibly due to the high level of homology in the amino acid sequence. When 
structural superposition was carried out between the apo form and the nucleotide 
bound structures available in the PDB database, no significant difference in the overall 
conformation was observed. However, we detected displacement of sub-domain II B of 
lobe II in the apo NBD, when the relative movement of the two sub-domains of the 
NBD was assessed relative to the position of their position in the bovine NBD 
structure. Another interesting finding was regarding the residues involved in the inter 
sub-domain interactions - Glu268 from sub-domain IIB with Tyr15 and Lys56 from 
sub-domains IA and IB, respectively. Our structure was observed to be in the open 
conformation, signified by the lack of interaction between the Tyr15, Lys56 and 
Glu268. This is a novel conformation for the nucleotide-free NBD structure because all 
previous open conformations of the NBD have been reported in the presence of the 
Hsp70 co-factors (Sondermann et al., 2001; Polier et al., 2008) or the SBD (Jiang et 
al., 2005).  
A structural solution for the data collected from crystals of condition 15 diffracting 
with a resolution of up to 2.2 Å could not be obtained using existing methodology. All 
attempts using molecular replacement have so far failed to provide a solution. From 
the many trials with the existing structures in the PDB database, it is apparent that the 
crystal probably does not contain the NBD fragment and therefore might not represent 
a complex of NBD and HSJ1b. However it does raise the interesting possibility that 
the protein crystallised under condition 15 is the human HSJ1b protein and to date 
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there is no full length structure reported for any member of the Hsp40 family. SelMet 
labelling of the NBD/J protein was undertaken to obtain the phase information 
required for solving the structure. Crystals of the labelled protein were successfully 
obtained. However data collection revealed that the signal from the incorporation of 
selenium was poor and therefore failed to help provide a structure solution. 
7.2 Future work 
The recombinant complex is an attractive tool to further our understanding of the 
Hsp70/Hsp40 interactions from a fresh perspective. The future line of investigation 
will look to improve our functional and structural understanding of the recombinant 
complex and has been explained in detail in the following section. 
• Identification of endogenously bound nucleotide 
So far in this study we have been unsuccessful in identifying if the recombinant 
complex was isolated with a bound nucleotide. However this information is crucial to 
better understand the behaviour of the complex with respect to substrate protection and 
ATP hydrolysis. This can be undertaken by HPLC as discussed in this thesis. However 
the efficiency of different nucleotide extraction methods needs to be optimised. Mass 
spectroscopy might be another alternative.  
• Repeating SelMet labelling studies for the NBD/J complex 
Selenium labelling of the NBD/J complex was undertaken in an attempt to solve the 
structure for the crystals obtained from condition 15 of Hampton crystal screen . 
However this experiment was performed only once, and was not sucessfull the first 
time. Therfore SelMet labelling needs to be repeated to confirm if structure 
determination is possible using the existing methodology. Failing this, alternative 
phasing techniques such as heavy metal derivatives of the crystals may be undertaken.  
• Improving sample homogeneity for electron microscopy 
Preliminary analysis of the rHH protein by negative staining revealed discrete 
particles. However the particles were hetergeneous in size and shape. Improving 
sample homogeneity for EM work will be the focus of our future work. The smaller 
particles observed indicate possible dissociation from the larger complex possibly as a 
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result of uranyl acetate staining and therefore fixation with glutaraldehyde will be 
undertaken to see if this can reduce the proportion of disassociation. 
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